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This PhD thesis focuses on the neuro-regulatory role of the brain on bone 
homeostasis and development, a vibrant area of research at the intersection of bone 
biology and neurobiology.  In this project, we have uncovered a new member of the 
parathyroid-hormone family, Pth4, and characterized its function as a novel brain-derived 
key regulatory signal of bone mineral metabolism during embryonic development and 
adult homeostasis in fish. 
This project is cross-disciplinary and combines cutting-edge approaches from 
comparative genomics, cell and developmental neurobiology, reverse genetics, bone 
physiology and evolutionary biology. Comparative analyses of vertebrate genomes reveal 
that the Pth4 is an ancient parathyroid hormone in vertebrates, but secondarily lost in 
eutherian mammals. Transgenic fish lines and loss-of-function experiments by targeted 
laser ablation enabled mapping a subset of hypothalamic Pth4-expressing neurons with 
axonal projections to the brainstem and spinal cord.  These play an essential role in larval 
bone mineralization. We demonstrate that pth4 expression is directly regulated by 
Runx2a, and that Pth4 can activate downstream cAMP signaling mediated by Pth 
receptors. Gain-of-function experiments by pth4 ectopic expression in transgenic 
zebrafish demonstrate that Pth4 can alter bone mineral density and calcium/phosphorus 
levels as well as affect expression of genes involved in phosphate homeostasis. Our 
findings culminate in a new model for the evolution of the PTH family roles in bone 
mineral homeostasis in the context of the vertebrate transition from aquatic to terrestrial 
environments. 
We feel this PhD project will have broad interest not only for researchers of Bone 
Biology and Neurobiology, but also Developmental and Cell Biology, Comparative 
Genomics and Evolutionary Biology. Furthermore, we believe that the discovery and 
functional characterization of Pth4 will have the potential to translate novel strategies for 
intensive finfish culture (design of new phosphate improved diets) and novel therapeutic 
agents to treat human bone diseases. 
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1. Bone mineral homeostasis 
Minerals are essential elements for numerous biological processes in the body. They 
act as co-factors for enzyme reactions, modulators of cellular pH, second messengers, 
stabilizers of organic molecules, participants of electrochemical gradients and structural 
elements in tissues such as skeleton (Favus et al., 2006; Stathopoulou et al., 2012). 
Because of the great importance that minerals have for the health of the organism, 
homeostasis becomes a crucial state to maintain internal mineral equilibrium and avoid a 
wide range of disorders.  
Particularly, calcium and phosphorus are the most abundant minerals in vertebrates 
and they are closely related in the development of their main biological role: bone 
mineralization (Lewis-McCrea and Lall, 2010; Moe, 2008; Stathopoulou et al., 2012). 
Thus, bone mineral homeostasis refers to the tight balance of the intracellular and 
extracellular levels of calcium and phosphorus in three target organs: intestine (site of net 
absorption), kidney (site of net excretion) and bone, which is the major storage site of 
both elements in the body (Peterlik, 2010). Although simply stated here, the regulation of 
the bone mineral homeostatic system is intricate and involves a complex crosstalk 
between systemic and local factors. Moreover, bone mineral balance depends on animal 
species, the stages of the life cycle, skeletal mineral requirements, calcium and 
phosphorus supply as well as other ions supply (as interactions with other ions can alter 
the handling of calcium and phosphorus) and a variety of pathologies (Favus et al., 2006). 
 
1.1 Calcium and phosphorus distribution 
The relative distribution of calcium and phosphorus through the vertebrate body has 
mainly been reported in humans. Unlike calcium, phosphorus is never in its elemental 
form in biological systems, and is predominantly present in the body as stable inorganic 
phosphate (Pi) but also as organic phosphate forms (i.e., phospholipids, phosphoproteins, 
nucleotides and some carbohydrates) (Bansal, 1990; Dean et al., 2015). The skeleton 
stores almost all of the body´s calcium (~99%) and about 85% of the whole-body 
phosphate in form of hydroxyapatite (HA), a rigid calcium-phosphate complex (Favus et 
al., 2006; Moe, 2008). The rest of calcium and phosphate are distributed into intracellular 
fluid (ICF) and extracellular fluid (ECF). Only 1% of the whole-body calcium is 
distributed into ICF and ECF including the serum, which in turn represents approximately 
0.1% of total body calcium (Favus et al., 2006; Moe, 2008). In humans, about 45-50% of 
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total serum calcium is biologically active and corresponds to ionized calcium that can be 
freely interchangeable with pools in bone, intracellular or extracellular sites. Non-ionized 
serum calcium is bound to plasma proteins (~41-47%) mainly albumin and globulins or 
complexed with other anions (~6-10%) such as citrate and phosphate (Dean et al., 2015; 
Favus et al., 2006). In regard to phosphorus, ICF and ECF contain ~14 and ~1% of the 
whole-body phosphate, respectively. In the serum, ~10% of phosphate is bound to 
proteins, ~35% complexed to sodium, magnesium or calcium and ~55% is present as 
freely available ionized Pi, where the forms H2PO4
- 
and HPO4
2- 
coexist at physiological 
pH (Bansal, 1990; Favus et al., 2006; Moe, 2008). Therefore, ionized calcium and Pi 
represent approximately half of the total serum levels and form the two metabolically 
active mineral fractions in the body. 
Fish skeleton contains the same relative composition of calcium and Pi than that in 
humans. Most of the whole-body calcium (~99%) is stored in the skeletal tissue and from 
20% to 40% is found in scales (Lovell, 1998). Also, about 85-90% of the total content of 
phosphate is found in bone, teeth and scales (Lovell, 1998). However, information on the 
relative proportion of the different species of calcium and phosphate in the serum 
(including the readily interchangeable ionic forms) is scarce due to the technical 
challenge of performing accurate measurements (reviewed in Dean et al., 2015).  
 
1.2 Calcium and phosphorus dynamics: an ecological perspective 
Vertebrates are supposed to have some degree of independence of external 
environment to maintain bone mineral homeostasis as calcium and Pi can be exchanged 
among serum, ICF and bone, if required (Favus et al., 2006). Nevertheless, homeostasis 
ultimately depends on minerals from external sources such as the diet (i.e., mineral 
intake) and the available minerals in the surrounding environment (i.e., mineral uptake). 
The major difference between aquatic and terrestrial vertebrates with respect to mineral 
dynamics is the ability of uptake minerals dissolved from seawater and freshwater. Unlike 
terrestrial vertebrates where calcium and phosphorus are exclusively of dietary origin, 
both absorbed through intestine (Kiela and Ghishan, 2016; Stathopoulou et al., 2012), fish 
are able to uptake minerals from surrounding water and adjust the requirements according 
to dietary intake (Lewis-McCrea and Lall, 2010). The calcium concentration is about 
10mM in seawater and up to 3mM in freshwater environments and its concentration in the 
serum of most marine fish species is about 4mM or 2mM in freshwater fish (Bouillon and 
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Suda, 2014; Dean et al., 2015). Moreover, the intracellular ionized calcium is 
approximately 1000-fold lower than in ECF, so that this chemical gradient favors calcium 
entry into the cell (Bouillon and Suda, 2014; Favus et al., 2006). Thus, the calcium 
concentration in water normally provides a sufficient source of this ion for cell function 
and survival. Skin and branchial epithelium are involved in calcium absorption, being the 
latter the greatest contributor, mainly in freshwater fish (Flik and Verbost, 1993). 
Branchial epithelium is the major contact site between fish and surrounding water as gills 
contain a high number of ionocytes (i.e., ion-transporting cells) or also named chloride 
cells (Flik and Verbost, 1993). The chloride cells mediate the transepithelial calcium 
uptake via calcium transporters such as Na
+
/Ca
2+
 exchanger (Ncx1), Ca
2+
-ATPase-1 
(Pmca1) and transient receptor potential family, vanilloid type 5/6 (Trpv5/6) (Liao et al., 
2007; Vanoevelen et al., 2011). Moreover, in marine environments the oral epithelium is 
another important uptake site since fish drink significant volumes of calcium-rich 
seawater to compensate the osmotic water loss (Guerreiro et al., 2002).  
The scenario is completely contrary as far as phosphorus is concerned since the levels 
of dissolved phosphorus in the freshwater and seawater are generally very low and not a 
source enough for body functions. Additionally, no phosphate transporters are known in 
the branchial epithelium of fish. Therefore, in fish as in humans, the main external source 
of phosphorus is essentially the dietary intake (Lall, 2002; Lovell, 1998).  
In order to maintain the mineral homeostasis taking into account the particular fish 
requirements, serum calcium and phosphate concentration are tightly regulated. Minerals 
are mostly absorbed through gills (mainly calcium uptake) and intestine (calcium and 
phosphorus dietary intake) (Abbink et al., 2006; Flik and Verbost, 1993; Lewis-McCrea 
and Lall, 2010). Subsequently, minerals enter the blood and are principally transported 
throughout the body, stored in the skeleton (Lovell, 1998) and excreted through urine or 
reabsorbed by the kidneys, depending on the immediate needs (Guerreiro et al., 2010). 
Besides, branchial efflux, intestinal excretion and mobilization from the skeleton occur to 
achieve the optimal bone mineral balance in the fish body (Abbink et al., 2006; Rotllant et 
al., 2005; Witten and Huysseune, 2009). 
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The skeleton is the main mineral storage in the vertebrate body and takes part in the 
regulation of mineral metabolism via bone remodeling. Bone provides calcium and 
phosphate through bone resorption to compensate the inadequate availability of minerals 
and maintain relatively constant the ionic levels in blood. Conversely, if the serum 
calcium and phosphate levels are high, both minerals are deposited in the skeleton for 
storage (Kini and Nandeesh, 2012). On this basis, the other important difference between 
aquatic and terrestrial vertebrates from an ecological point of view is the involvement of 
the endoskeleton in the calcium and phosphate homeostasis. As mentioned before, fish 
have unlimited access to calcium through gills and so, calcium deficiencies are not very 
common. Only certain calcium shortage conditions could cause resorption of scales 
instead of the endoskeleton resorption (Witten and Huysseune, 2009). However, due to 
the phosphate bioavailability is more critical than that of calcium, hypophosphatemic 
conditions would be more likely to trigger the bone remodeling in fish (Lall and Lewis-
McCrea, 2007; Witten and Huysseune, 2009).  
 
1.3 Bone remodeling  
Bone is the structural framework of the vertebrate body but, beyond this support 
function, bone is a highly dynamic and metabolically active tissue that responds to 
mechanical signals as well as mineral demands (Raggatt and Partridge, 2010; Sims and 
Gooi, 2008). These functions require a continuous bone turnover throughout life, which is 
carried out by the coordinated action of osteoblasts (i.e., bone forming cells), osteoclasts 
(i.e., bone resorbing cells) as well as osteocytes (i.e., entrapped cells inside the bone 
matrix) (Hadjidakis and Androulakis, 2006). In mammals, bone remodeling is triggered 
by osteocytes as these cells act as local sensors and respond to surrounding mechanical 
signals and factors regulating mineral homeostasis through coordination of bone surface 
cells (Seeman, 2009). The bone remodeling process starts with the osteoclasts formation, 
the osteoclast-mediated bone resorption, a reversal period and a long period of bone 
matrix formation mediated by osteoblasts that is followed by the mineralization of new 
bone matrix (Sims and Gooi, 2008) (Figure 1).  
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Figure 1. Schematic representation of bone remodeling. The lining cells cover the bone surface in the 
“resting state” to prepare the matrix for osteoclast attachment. The differentiation of osteoclasts starts and 
active osteoclasts degrade the old mineralized bone matrix (“resorption”). After osteoclasts leave the bone 
surface, specific mononucleated phagocytic cells remove demineralized matrix from bone surface in a 
“reversal” phase, and the bone formation is stimulated. Bone “formation” and “mineralization” are 
mediated by mature osteoblasts to lead a newly deposited and mineralized bone matrix. Finally, the surface 
of the bone returns to a “resting state” where the osteoblasts differentiate into osteocytes or lining cells. 
 
 
In teleosts, bone remodeling also involves coupled actions of bone formation by 
osteoblasts and bone resorption by osteoclasts. However, bone remodeling is behind a 
great diversity of bony tissues. Similar to mammals, more basal teleosts (such as 
cyprinids and salmonids) mostly have a cellular bone with osteocytes, osteoblasts and a 
prevalence of multinucleated osteoclasts. Basal osteichthyans (i.e., bony fish) are the 
common ancestor that would give rise to basal teleosts and tetrapods (clade to which 
mammals belong) with similar bony features. Across evolution, osteocytes and 
multinucleated osteoclasts have been preserved during the first wave of freshwater 
reinvasion by seawater basal teleosts (i.e., “primary freshwater fish”) (Figure 2). After 
100 million years of evolution in seawater, advanced teleosts (such as perciforms) 
developed a lacking-osteocytes bone (i.e., acellular bone) and a predominance of 
mononucleated osteoclasts. Both characters were maintained when the advanced teleosts 
reinvaded the freshwater (i.e., “secondary freshwater fish”) (Apschner et al., 2011; Witten 
and Huysseune, 2009) (Figure 2). As a consequence, the bone cellular composition 
presents a wide diversity in teleosts and, therefore, fish that live in fresh or seawater have 
different bone types. Even, the cyprinid zebrafish (Danio rerio) that is considered a 
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“primary freshwater fish”, has a cellular endoskeleton as that in mammals but also 
acellular scales and fin rays (Meunier, 1989). 
 
 
Figure 2. (A) Relationships between phylogeny, environment and the presence of osteocytes in teleosts. 
Adapted from (Apschner et al., 2011). (B and C) Light microscopy images of transverse cross-sections of 
bones from basal and advanced teleosts. (B) Carp (Cyprinus carpio) cellular bone shows lacunae and 
canaliculi; black arrows indicate osteocytes/lacunae. (C) Tilapia (Oreochromis aureus) acellular bone; 
white arrows indicate the layered structure characteristic of this bone. Note the absence of lacunae. Adapted 
from (Shahar and Dean, 2013). 
 
 
Although the bone remodeling process is normally related to osteocyte-containing 
bone, in absence of osteocytes, the acellular fish bone is also capable to remodel (Atkins 
et al., 2014). Because of that, it has been hypothesized that other cells (e.g., osteoblasts) 
could trigger remodeling via alternative routes. Hence, osteocytes seem not to be the only 
regulators of bone resorption in teleosts. The evolution of acellular bone from cellular 
bone and the dominance of lacking-osteocytes bone in advanced teleosts have been 
supposed to bring some functional advantage, but to this day it remains undiscovered 
(Shahar and Dean, 2013) (Figure 3).  
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Figure 3. Simplified phylogeny illustrating the evolution of bone type across the vertebrate lineages. The 
Actinopterygii (ray-finned fish) are expanded to show the repeated loss of osteocytes and transition to 
acellular bone. Adapted from (Doherty et al., 2015). 
 
 
On the other hand, teleosts with mononucleated osteoclasts have also been shown to 
reabsorb bone as they have the typical markers of multinucleated osteoclasts, such as 
tartrate resistant acid phosphatase (TRAP) or cathepsin and, therefore, a bone resorption 
process different from their mammalian counterparts has been described (Nemoto et al., 
2007). Apart from mononucleated and multinucleated osteoclasts, bony osteocytes also 
participate in the resorption via osteocytic osteolysis (Witten et al., 2000). Another 
resorption-related process described in both teleosts and mammals is the halastic 
demineralization, in which a loss of minerals is produced without affecting the bone 
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matrix (Kacem and Meunier, 2003). Hence, a variety of bone resorption processes are 
connected to the wide variety of bony cellular types. 
 
2. Regulation of bone mineral metabolism 
An intricate and endogenous molecular control is responsible for bone mineral 
metabolism in vertebrates. The maintenance of adequate calcium and phosphate levels 
involves a coordinated interrelationship of numerous systemic and local factors mainly 
acting in intestine, kidney and skeleton (Favus et al., 2006). Thus, this controlled process 
is carried out by endocrine factors, cell-signaling products acting in a paracrine/autocrine 
fashion, neural signals and complex feedback loops. 
 
2.1  Systemic and local control: an overview 
Historically, parathyroid hormone (PTH), vitamin D (1,25(OH)2D) and calcitonin 
(CT) have been regarded as the most important hormones for bone mineral metabolism in 
mammals (Bergwitz and Jüppner, 2010; Mundy and Guise, 1999; Potts, 2005). In contrast 
to the regulation of calcium balance, which has been extensively studied over the years, 
relatively little is known about the regulation of phosphate homeostasis. In the past 
decade, genetic analysis information from human disorders of mineral metabolism has led 
to the discovery of novel hormones involved in phosphate balance. Particularly, the 
identification and characterization of fibroblast growth factor 23 (FGF23) and other bone-
derived local factors (e.g., phosphate regulating gene with homologies to endopeptidases 
on the X chromosome, PHEX),  have revealed new pathways regulating the bone mineral 
metabolism (Bergwitz and Jüppner, 2010; Sapir-Koren and Livshits, 2011).  
Similar to mammals, the bone mineral homeostasis in fish has traditionally been 
linked to the hormonal control of calcium (Guerreiro and Fuentes, 2007), and only 
secondarily, of phosphate. Newly identified factors in mammals but also in fish have been 
investigated in different teleost species to explore conserved or alternative regulatory 
pathways. In fish, calcium and phosphorus balance is under endocrine and 
paracrine/autocrine regulation and related to osmoregulation and dietary mineral intake 
(Figure 4). Hormones such as stanniocalcin (Stc), parathyroid hormone-like hormone 
(Pthlh) or Fgf23 have been reported to participate in bone mineral metabolism in fish 
(Elizondo et al., 2010; Guerreiro et al., 2001; Guerreiro et al., 2010; Huitema et al., 2012; 
Tseng et al., 2009). Nevertheless, the action of other hormonal factors such as calcitonin 
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or vitamin D seems not to be completely understood in fish and contradictory results have 
been published (reviewed in (Lall and Lewis-McCrea, 2007; Witten and Huysseune, 
2009)). 
 
 
Figure 4. Complex network of systemic and local factors involved in bone mineral homeostasis in 
mammals (left side) and teleosts (right side). Normal physiological levels of serum phosphate and calcium 
are maintained by the interplay of intestinal absorption from diet (in mammals and teleosts), branchial 
absorption from surrounding waters (in teleosts), kidney reabsorption and mobilization/mineralization in 
skeleton (in mammals and teleosts). Similar endocrine factors, local signals acting in paracrine/autocrine 
pathways and negative feedback mechanisms preserve the homeostasis in both mammals and teleosts. 
 
On the other hand, the inorganic forms of phosphate itself, acting in an 
autocrine/paracrine manner, are important for the bone mineralization control in both 
mammals and fish. Particularly, the tight balance of inorganic phosphate/ pyrophosphate 
(Pi/PPi) levels in the bone environment has been reported to be crucial for the proper 
bone mineralization (Sapir-Koren and Livshits, 2011). PPi is a mineralization inhibitor 
since it prevents Pi from crystallizing with calcium ions to form the hydroxyapatite on the 
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extracellular bone matrix (Terkeltaub, 2001). At molecular level, two important factors 
regulate the Pi/Pii balance in fish: ectonucleoside triphosphate/diphosphohydrolase 5 
(entpd5) and ectonucleotide pyrophosphatase phosphodiesterase 1 (enpp1), promoting the 
Pi or PPi generation, respectively (Apschner et al., 2014; Huitema et al., 2012). 
In addition to this complex network of endocrine, autocrine, and paracrine signals, 
recent studies have pointed out the importance of the vertebrate brain as a central 
regulator of bone homeostasis and remodeling, which directly influences on the calcium 
and phosphate balance (reviewed in (Quiros-Gonzalez and Yadav, 2014; Takeda, 2008)).  
The discovery that the brain regulates the bone mineral homeostasis has provided a new 
paradigm for our understanding of bone biology. Thus, three main pathways have been 
defined in the neural control of bone mass in mammals (Figure 5). The first pathway 
involves neuroendocrine factors from hypothalamic neurons which are processed through 
pituitary gland (e.g., gonadotrophin hormone releasing hormone (GnRH), thyrotropin 
releasing hormone (TRH), growth hormone releasing hormone (GHRH) and oxytocin). 
The second pathway entails hypothalamic neuropeptides directly released into the 
bloodstream (e.g., pro-opiomelanocortin-derived peptides (POMC) and cocaine-and 
amphetamine-regulated transcript (CART), neuropeptide Y (NPY) and agouti-related 
peptide (AgRP) (Driessler and Baldock, 2010; Quiros-Gonzalez and Yadav, 2014). The 
third pathway consists of efferent neural signals that control bone mass through the 
sympathetic (SNS) and parasympathetic nervous systems (PSNS) (Bajayo et al., 2012; De 
Vernejoul, 2013).  However, the neural regulation of bone mass and its molecular 
pathways remain completely unexplored in fish.  
 
 
 
 
 
Figure 5. Neural pathways of bone homeostasis control in 
mammals. (I) Neuroendocrine factors from hypothalamus are 
first processed through pituitary gland and then released into the 
blood (red dots).  (II) Neuroendocrine factors from hypothalamus 
released directly into the blood (blue dots). (III) Autonomic 
nervous system regulates bone mass via sympathetic (SNS) and 
parasympathetic nervous systems (PSNS) (green dots). 
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In particular, the parathyroid hormone (PTH) family of peptides play key roles in 
skeletal mineral metabolism and in regulating embryonic development of the skeleton and 
other tissues across vertebrates (Broadus, A. and Stewart, 1994; Kronenberg, 2006; 
Pinheiro et al., 2010; Potts, 2005). In teleosts, PTH family peptides are present and they 
participate in the regulation of calcium and phosphate homeostasis (Guerreiro et al., 
2007). Despite the different environmental challenges between terrestrial and aquatic 
vertebrates, PTH family fundamentally conserves and diversifies its physiological 
properties in fish.  
 
2.2 Parathyroid hormone family 
Parathyroid hormone (PTH) family is composed of structurally-related secreted 
peptides that mediate their actions through three G protein coupled receptors (GPCR) 
(Venkatakrishnan et al. 2013). They contain hydrophobic pre-sequences (signal peptide) 
and pro-sequences with dibasic cleavage sites. Both pre-pro sequences are cleaved off in 
the endoplasmic reticulum and in the trans-Golgi network before secretion. Typically, 
these peptides share a conserved PTH domain in the N-terminal region of the mature 
protein as well as three amino acids motifs (MHN, MHD or LHD), important for their 
functionality (Figure 6) (Gardella et al., 2006; Guerreiro et al., 2007; Pinheiro et al., 
2010).  
 
 
 
Figure 6. Schematic diagram of the human PTH structure. Grey boxes depict pre, pro sequences and mature 
peptide. Colored amino acid sequence shows the hPTH (1-34) biologically active peptide and MHN motif is 
underlined. 3D modelling of hPTH (1-34) was performed with Swiss-Model (Biasini et al., 2014).  
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There are three known parathyroid hormone peptides in mammals termed parathyroid 
hormone (PTH), parathyroid hormone related protein or parathyroid hormone-like 
hormone (PTHrP, PTHLH) and tuberoinfundibular peptide 39 (TIP39 or PTH2) and they 
mediate the actions through two different receptors: parathyroid hormone type I receptor 
(PTH1R) and type II receptor (PTH2R). PTH secreted by parathyroid glands (PTGs) is 
the major endocrine regulator of calcium-phosphate metabolism and bone turnover. It acts 
in bone, kidney and indirectly in intestine interacting with numerous local and systemic 
factors in order to restore normal serum mineral levels in a negative feedback loop 
(Brown, 1993; Mundy and Guise, 1999; Potts, 2005). PTHLH, characterized by a 
widespread spatial distribution, participates mainly in the embryonic development of the 
skeleton in an autocrine/paracrine fashion (Kronenberg, 2006; Philbrick et al., 1996) and 
promotes the calcium mobilization during the fetal-placental transport (Kovacs et al., 
1996) and lactation (Neville et al., 2002; VanHouten et al., 2004) that seem to be the only 
times in which this hormone usually enters the circulation. In addition, PTH and PTHLH 
act in bone through PTH1R where they exert a complex and paradoxical effect depending 
on a type of pharmacological dose. Continuous exposure to the hormone promotes bone 
resorption but, however, an intermittent dose stimulates bone formation  (Datta and 
Abou-Samra, 2009; Silva et al., 2011). Although PTHLH has been shown to increase 
bone mass in rodent osteoporosis models, PTH induce a more potent anabolic effect 
(reviewed in (Esbrit and Alcaraz, 2013)). For this reason, the recombinant human PTH(1-
34) (Figure 6) and PTH(1-84), are the only approved anabolic agents up to date for the 
treatment of osteoporosis  (Cosman et al., 2017; Jilka, 2007; Moen and Scott, 2006; 
Silverman and Nasser, 2011). In this line, current research is aimed to develop more PTH 
analogues to optimize the actions on bone. TIP39 (PTH2) shows weak amino acid 
sequence similarity to PTH and PTHLH and although its physiological roles are not 
completely understood in many species, its expression in thalamic and hypothalamic 
areas has suggested regulation of nociception, anxiety and depression (Danks et al., 2011; 
Dimitrov et al., 2010; Dimitrov et al., 2013; Usdin et al., 1999). 
In fish, the PTH family acquires a higher complexity where six peptides and three 
receptors have been identified so far suggesting functional diversification in bone mineral 
homeostasis. Thus, the family consists of two forms of Pth (Ptha, Pthb), two of Pthlh 
(Pthlha and Pthlhb), Tip39 (Pth2) and a newly identified Pth-like (Pth-l) (reviewed in 
(Guerreiro et al., 2007)).  Pthlh, the first Pth family member identified in fish, seems to be 
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the main hypercalcemic factor in teleosts and it is also involved in skeletal development, 
while Pth presents contradictory functions in calcium homeostasis. The same as in 
mammals, Pth2 appeared not to be involved in bone mineral control (Papasani et al., 
2004). Moreover, Pth-l was isolated by in silico analysis from Takifugu rubripes and 
synthetic Pth-l peptide showed a potent calciotropic action in sea bream (Sparus auratus) 
scales and calcium uptake (Canario et al., 2006); however, further studies were not 
performed. 
 
2.2.1 Parathyroid hormone 
Despite fish lack parathyroid gland, efforts have been made to find PTH homolog 
genes especially after the isolation of the other Pthlh family members in teleosts 
(Flanagan et al., 2000; Power et al., 2000). To date, two distinct types of PTH have been 
identified in pufferfish (Tetraodon fluvialis and Takifugu rubripes) (pPtha) and (pPthb) 
and in zebrafish (Danio rerio) zPth1a and zPth1b (previously named zPth1 and zPth2, 
respectively), with high homology in the first 34 amino acid of the mature protein 
(Canario et al., 2006; Danks et al., 2003; Gensure et al., 2004). Spatial expression studies 
by RT-PCR and whole mount in situ hybridization have shown zpth1a mRNA in cells 
along the lateral line and dorsal zone to notochord as well as in the midline of neural tube; 
while zpth1b gene showed a similar expression pattern to that of zpth1a but not in central 
nervous system cells. On the other hand, immunohistochemical assays using fugu Ptha 
antiserum revealed expression of Pths in neuromasts of the lateral line, but also in the 
calcifying jaw of zebrafish which suggested a possible role in skeletal development 
(Hogan et al., 2005). It has also been shown expression of pth1a and pth1b in gills of 
zebrafish and pufferfish (Okabe and Graham, 2004). Knockdown of pth1a in zebrafish 
showed defects in the jaw development and branchial arches, where the expression of a 
chondrocyte marker (collagen 2a1a) was also decreased (Kwong and Perry, 2015). 
Moreover, it has been pointed out that the tetrapod PTGs and the gills of fish are 
evolutionarily related structures. PTGs arose from endodermal pharyngeal pouches and 
their formation is under the control of a crucial regulatory gene, Gcm-2 (Okabe and 
Graham, 2004). Thus, it has been suggested that Pth in fish could play a key role in 
calcium homeostasis similar to mammals (Canario et al., 2006; Okabe and Graham, 
2004).  
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Surprisingly, few functional studies based on fish Pth roles in bone mineral 
homeostasis have been conducted and published. Suzuki et al. (2011) found that synthetic 
pPtha acts directly on the goldfish scales stimulating osteoclast activity to mobilize 
calcium through in vitro and in vivo assays. However, this hypercalcemic action of pPtha 
was not found in sea bream scales, only pPthb appreciably stimulated inositol 
triphosphate (IP3) signaling in scales culture and neither peptide had any effect in calcium 
influx in larvae (Canario et al., 2006). Additionally, overexpression and loss of function 
studies have recently shown that only zpth1a seems to be involved in maintaining Ca
2+
 
homeostasis in zebrafish (Lin et al., 2014). A recent study in zebrafish found that in 
response to the acclimation procedure in low calcium water,  the gene expression of 
zpth1a, but not zpth1b, was increased as well as the ionocytes differentiation and 
epidermal stem cells (Kwong and Perry, 2015). Therefore, the precise function of Pths in 
fish still remains unclear and needs to be accurately investigated. 
 
2.2.2 Parathyroid hormone-like hormone  
Pthlh was the first PTH peptide isolated in fish and the most functionally 
characterized. Initial studies by Parson et al. (1978), using mammalian PTH antiserum, 
had shown evidence of a PTH-like factor in the pituitary extracts of cod (Gadus morhua) 
and eel (Anguilla anguilla) with hypercalcemic effects in rainbow trout (Parsons et al., 
1978). In 1991, Fraser and colleagues found the presence of Pthlh in the pituitary of coho 
salmon (Oncorhynchus kisutch) and in 1993 Danks and co-workers identified this factor 
in plasma and in the pituitary gland of sea bream using an antiserum against human N-
terminal (1–16)PTHLH, suggesting a PTHLH role in fish calcium homeostasis (Danks et 
al., 1993; Fraser et al., 1991). Subsequently, the development of molecular biology 
techniques allowed the isolation and molecular characterization of pthlh in diverse fish 
species and in numerous tissues such as gills, operculum, kidney, pituitary gland, brain, 
saccus vasculosus, muscle, skin, spleen, liver and intestine (Abbink and Flik, 2007). In 
pufferfish genome two pthlh were identified and cloned, pthlha and pthlhb (Canario et al., 
2006; Power et al., 2000) as well as in zebrafish; however, only a single pthlh gene 
(pthlha) has been isolated in sea bream (Flanagan et al., 2000). Unlike in mammals, 
several recent studies have outlined the importance of Pthlh in systemic acid-base 
regulation and ion balance in fish (Gregório et al., 2014). It has been reported that the 
increase of circulating Pthlh in sea bream larvae and adults stimulates the calcium uptake 
through branchial and intestinal epithelium, raising blood calcium levels (Abbink et al., 
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2006; Fuentes and Figueiredo, 2006; Guerreiro et al., 2001). Likewise, it seems to 
mediate mineral mobilization estradiol-induced during vitellogenesis via gills and 
intestine (Fuentes et al., 2007). This hypercalcemic effect is supported by specific actions 
of Pthlh in scales by reducing osteonectin gene expression (extracellular matrix-Ca
2+
 
binding protein) (Redruello et al., 2005) and through the increase of osteoclast activity for 
calcium mobilization (Rotllant et al., 2005). In addition, a recent study has demonstrated 
that intermittent administration of Pthlh in sea bream larvae caused a modification of the 
bone proteome (Anjos et al., 2013). Besides its role in calcium metabolism, 
phosphatotropic effect has been found in winter flounder Pseudopleuronectes 
americanus. Pthlh stimulated renal phosphate secretion while promoted calcium uptake in 
primary culture of kidney proximal tubule cells (Guerreiro et al., 2010). In regard to the 
involvement in embryonic development of the skeleton, a study in zebrafish found that 
Pthlh has a conserved role to that of mammals during early development. It has shown 
that the two Pthlh co-orthologs showed different craniofacial expression patterns: pthlha 
is expressed in elements of the pharyngeal skeleton (ceratobranchial, ceratohyal and 
teeth) and pthlhb is detected in hypertrophic chondrocytes at the posterior border of the 
hyosimpletic and opercular. Loss-of-function studies in zebrafish using antisense 
morpholino oligonucleotides (MOs) showed that they play different roles in craniofacial 
skeletogenesis through interactions with their upstream regulator Sox9 and downstream 
target Runx2. Knockdown of pthlha and pthlhb caused an inhibition or delay in bone 
mineralization and deformities in the development of the cartilage structures, 
respectively. Based on these findings, a hypothesis has been proposed respect to a 
possible dual role of Pthlh: as a paracrine hormone for chondrogenesis and osteogenesis 
during development and as a circulating hormone for serum calcium-phosphate 
homeostasis and osmoregulation (Yan et al., 2012). 
 
2.2.3 Parathyroid hormone receptors 
Three receptors that mediate actions of PTH family of peptides in vertebrates have 
been identified. These GPCR interact with signaling molecules such as hormones and 
neurotransmitters, and the mechanism of ligand recognition as well as the signal 
transduction have been widely studied (Venkatakrishnan et al., 2013). First, the 
interaction between the N-terminal domain of the receptor and C-terminal domain of the 
ligand takes place, which contributes predominantly to binding affinity; afterwards, an 
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interaction between the juxtamembrane region of the receptor and the N-terminal portion 
of the ligand will contribute to signaling (Figure 7).   
 
 
Figure 7. Interaction model between the biologically active ligand PTH(1-34) and PTH1R described in 
humans (Gardella and Jüppner, 2000). Representation of the “U”-shaped structure of hPTH(1-34) for the 
interaction with the receptor. The C-terminal domain of the ligand interacts with the N-terminal domain of 
the receptor to increase the binding affinity. Subsequently, the N-terminal domain of the ligand binds to 
juxtamembrane region of the receptor to stimulate the cascade signaling through G protein activation. After 
G protein activation, the Gα subunit binds and activates the adenylate cyclase which catalyzes the 
conversion of ATP into cAMP. 
 
In mammals, two receptors were isolated (i.e., PTH1R and PTH2R) but, in teleosts, 
a third receptor was uncovered, Pth3r (Rubin and Juppner, 1999). PTH1R is activated by 
both PTH and PTHLH and triggers 3´-5´cyclic-adenosine-monophosphate/protein kinase 
A (cAMP/PKA) cascade more robustly than phospholipase C/protein kinase C 
(PLC/PKC) pathway (Gardella and Jüppner, 2001).  PTH2R binds PTH only in mammals, 
however its endogenous ligand is PTH2 (Papasani et al., 2004). The discovery in fish of 
PTH family ligands and their receptors gave rise to a comprehensive analysis by cell 
culture assays of the pharmacological properties of receptors and ligand specificity in 
mammals and teleosts. Despite the phylogenetic distance between these two lineages, 
peptides and receptors from fish and mammals are able to interact with each other and 
trigger signaling activation which indicates a strong molecular conservation. Thus, zPth1a 
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activates with higher potency zPth1r (renamed as Pth1ra) than zPth1b but both peptides 
have equal potency to hPTH1R and zPth3r (renamed as Pth1rb) (Gensure et al., 2004). 
hPTH, hPTHLH and fuguPthlh activate Pth1ra and Pth1rb in zebrafish, nevertheless, 
hPTH was less potent in zPth1rb than the other two PTHLH peptides (Rubin and Juppner, 
1999). zPth1rb, initially described as PTHLH selective, showed not to be ligand-specific 
since it also binds PTH-like ligands. Bovine TIP39 (bTIP39) displays higher efficiency 
than hPTH in the activation of zPth2r and zPth2r(43), the splice variant which lacks 17 
amino acids in the amino-terminal extracellular domain (Hoare et al., 2000a).  
Although the activation profiles of the zebrafish receptors by PTH family peptides 
have been widely evaluated in vitro, the spatial distribution of receptors in zebrafish and 
in other teleosts has been less characterized, being mostly examined by RT-PCR. In sea 
bream scales pth1ra transcripts were detected and pth1rb was amplified in intestine 
(Rotllant et al., 2005; Rotllant et al., 2006), but both were isolated in vertebral bone as 
well (Anjos et al., 2013). A study on renal mineral transport in winter flounder showed 
pth1ra and pth1rb transcripts in kidney extracts, specifically in proximal tubule cells 
(Guerreiro et al., 2010). On the other hand, pth2r mRNA was isolated in catfish kidney 
(Rubin et al., 1999) and in scales of goldfish (Suzuki et al., 2011) but its expression was 
considerably lower compared to that of pth1ra in sea bream. In zebrafish, the spatial 
expression of pth2r has been analyzed in brain, eye, notochord, otic vesicles,  pharyngeal 
arches, ovary and testis (Bhattacharya et al., 2011; Kwong and Perry, 2015). As far as 
zebrafish pth1ra is concerned, RT-PCR studies showed gene expression in brain, gills, 
intestine, kidney and bone, among other examined tissues (Kwong and Perry, 2015). 
Expression of zebrafish pth1rb gene was abundantly expressed in gills and bone (Kwong 
and Perry, 2015). 
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3. Bone mineral metabolism-related disorders in fish farming 
In fish farming, mineral deficiencies have been related to a wide variety of skeletal 
malformations and physiological disorders. Calcium uptake from waters is adjusted 
according to dietary intake and in this sense deficiency of calcium has not been detected 
in marine fish (Lewis-McCrea and Lall, 2010). On the other hand, phosphorus must be 
supplied by the diet as intestinal absorption is the main source of Pi intake (Lall, 2002). 
Because of that, phosphate enriched diets continue to be commonly used in fish farming 
to ensure growth and prevent bone mineral disorders. Nevertheless, the amount of 
phosphate from diet must be carefully balanced to minimize the urinary and fecal 
excretions and reduce phosphate outputs in the environment without compromising fish 
health (Lall, 2002). Phosphate enriched effluents from fish farming represent a serious 
environmental problem since it affects to the quality of water causing eutrophication in 
aquatic ecosystems (Cho and Bureau, 2001; Hixson, 2014).  
Diverse studies have shown that skeletal and metabolic disorders arise not only from 
phosphate depletion but also from excessive phosphate bioavailability. These conditions 
create an important Ca
2+
:Pi imbalance, a permanent load on hormonal regulatory systems, 
and, ultimately, lead to the appearance of diseases and malformations, reduced growth or 
even death. Phosphate deficiencies, caused by shortage of dietary phosphorus or 
starvation, produce an increase in the frequency of bone mineral disorders in fish (Table 
1). It has been reported that because of phosphate deficiency, the increase in the number 
of osteoclasts could promote bone resorption causing impaired mineralization and several 
skeletal deformities in fish species (Lall and Lewis-McCrea, 2007; Roy et al., 2002; 
Witten and Hall, 2003). Soft bones and curved spines were observed in Atlantic salmon 
(Salmo salar) (Baeverfjord et al., 1998) as well as deformed vertebral bodies in haddock 
(Melanogrammus aeglefinus) (Roy et al., 2002). Alterations in neural and hemal spines 
were found in Atlantic halibut (Hippoglossus hippoglossus), being scoliosis the most 
frequent skeletal abnormality (Lewis-McCrea and Lall, 2010).  Furthermore, phosphate 
deficient diet was reported to alter the mineralization of newly synthesized bone matrix in 
Atlantic salmon leading to uncoupling between bone formation and mineralization 
(Witten et al., 2016). Interestingly, an increase of bone resorption as well as skeletal 
anomalies were not observed (Witten et al., 2016), unlike other investigations where the 
lack of mineralization is related to bone resorption and appears to be responsible for the 
development of multiple deformities in phosphate shortage conditions. In addition, 
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phosphate insufficiency produces metabolic disturbances that may lead to impairment of 
growth performance and reduced body mass (Sugiura et al., 2004; Witten et al., 2016). 
Because of fish can store phosphorus in skeletal structures to compensate for high 
serum levels, excess of phosphate ions over the immediate needs in haddock contributes 
to increase the number of osteoblasts and enhance mineralization of bone matrix (Roy et 
al., 2002; Roy and Lall, 2003). Also, hyperphosphatemic conditions have been reported to 
affect the synthesis of protein as well as zinc absorption inducing a decrease of growth 
rate in rainbow trout (Oncorhynchus mykiss) (Satoh et al., 1996). 
 
Table 1. Physiological disorders and skeletal malformations reported in several fish species under 
phosphate deficiency (Lall, 2002; Lewis-McCrea and Lall, 2010; Roy et al., 2002). 
 
Species Common disorders 
Atlantic halibut (Hippoglossus hippoglossus) Skeletal deformity (scoliosis, hemal and neural spines 
abnormalities). 
Atlantic Salmon (Salmo salar) Reduced bone mineralization (soft bones), skeletal 
deformity (twisted spines), reduced growth and poor 
feed conversion. 
Channel catfish (Ictalurus punctatus) Reduced bone mineralization, reduced growth and poor 
feed conversion. 
Chinook salmon (Oncorhynchus tshawytscha) Poor feed conversion. 
Common carp (Cyprinus carpio) Reduced bone mineralization, skeletal deformity, 
cranial deformity, reduced growth and increased 
visceral fat. 
Japanese eel (Anguilla japonica) Reduced growth and anorexia. 
Red sea bream (Chrysophrys major) Reduced bone mineralization, skeletal deformity 
(curved and enlarged spongy vertebrae), reduced growth 
and poor feed conversion 
Haddock (Melanogrammus aeglefinus) Reduced bone mineralization, skeletal deformity 
(curvature vertebrae), increased number of osteoclasts 
and reduced growth. 
Rainbow trout (Oncorhynchus mykiss) Reduced bone mineralization, skeletal deformity, 
reduced growth and poor feed conversion. 
 
In these circumstances, one of the main concerns to long-term sustainability of world 
aquaculture is to minimize phosphate discharges in natural waters without compromising 
fish health and welfare. Therefore, in order to understand the animal requirements and 
establish new feed formulations it is essential to characterize the regulation of bone 
mineral homeostasis in fish. 
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As mentioned earlier, PTH family is involved in mineral homeostasis and bone 
remodeling in vertebrates. A new member, pth-like (pth-l) has recently been in silico 
identified in pufferfish (Takifugu rubripes) but, however, information on its biological 
function and mechanisms of regulation is virtually inexistent. Therefore, the fundamental 
scientific objective of this PhD dissertation is to perform the molecular and functional 
characterization of the pth-l gene (here renamed pth4) in a model vertebrate species, the 
zebrafish (Danio rerio). To this end, we will focus on the following specific objectives: 
 
1- Molecular analysis of the novel pth4 gene in zebrafish (Chapter 1). To address this 
goal, we carried out the in silico gene analysis, the molecular cloning and the 
spatio-temporal gene expression determination. 
 
2- Evolutionary analysis of the pth4 gene in the context of the entire PTH family 
(Chapter 1). Phylogenetic analysis and comparative genomic of conserved synteny 
were used to study the pth4 gene evolution and to elucidate the relationships 
among family members. 
 
3- Characterization of the pth4 promoter and its transcriptional regulation (Chapter 
2). To achieve that, we generated reporter transgenic zebrafish lines and explored 
in vivo the target genomic regions upstream to pth4 coding sequence through 
promoter deletions, site-directed mutagenesis and knockdown studies. 
 
4-  In vivo functional characterization of pth4 gene (Chapters 3 and 4). For this 
purpose, we used a gain-of-function approach based on transposon-mediated 
genome manipulation and a targeted laser cell ablation approach.
  
 
 
 
CHAPTER 1 
 
Molecular And Evolutionary 
Analysis Of pth4 Gene  
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1. Abstract 
The parathyroid hormone (PTH) family includes PTH, parathyroid hormone-like 
hormone (PTHLH) and tuberoinfundibular peptide 39 (TIP39 or PTH2), which were 
proposed to be ohnologs that arose through two rounds of whole genome duplication in 
the base of vertebrate radiation. A novel PTH family member, initially named parathyroid 
hormone like (Pth-l), has recently been identified in non-mammalian vertebrates. In 
teleosts, a single in vitro study reported a possible hypercalcemic role for Pth-l, but 
further studies were not carried out. In the present study, we isolated and characterized 
the pth-l gene (here renamed pth4) in zebrafish. Expression studies showed that pth4 gene 
is specifically expressed by two clusters of cells in the hypothalamic area across zebrafish 
ontogeny. Additionally, we performed comparative genomics studies to elucidate the 
relationships among family members and to provide insights about the molecular and 
functional evolution of PTH family of peptides in vertebrates. We revealed that Pth4 is 
the fourth ohnolog belonging to PTH family and it was lost in the eutherian mammals 
after eutherian-metatherian split.  
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2. Introduction 
The parathyroid hormone (PTH) family is made up of three structurally related 
peptides including PTH, parathyroid hormone-like hormone (PTHLH) and 
tuberoinfundibular peptide 39 (TIP39 or PTH2) in mammals. They were proposed to be 
ohnologs originated via two rounds of whole genome duplication (1R/2R WGD) that took 
place during the early vertebrate evolution (Bhattacharya et al., 2011; Dehal and Boore, 
2005). This small family acquired a higher complexity in teleosts where six peptides have 
been identified so far. Two duplicated paralogs genes of PTH (i.e., ptha and pthb) 
(Canario et al., 2006; Danks et al., 2003; Gensure et al., 2004) and PTHLH (i.e., pthlha 
and pthlhb) (Flanagan et al., 2000; Power et al., 2000; Yan et al., 2012) are present as a 
consequence of the specific genome duplication that teleosts fish underwent (named 
teleost genome duplication (TGD) or third round (3R) of genome duplication) (Braasch 
and Postlethwait, 2012). However, just a single-gene has been identified for pth2 and pth-
like (pth-l). Pth-l peptide, initially identified by in silico analysis in pufferfish (Takifugu 
rubripes) (Canario et al., 2006), was also found in other non-mammalian vertebrates such 
as amphibians (Xenopus laevis) and chicken (Gallus gallus), but it was absent in humans 
(Pinheiro et al., 2010).  
Apart from PTH2, all PTH family members share a significant similarity in the first 
34 amino acids of the mature protein, which is an important region for signaling and 
biological activity (Guerreiro et al., 2007; Pinheiro et al., 2010; Usdin et al., 1999). Thus, 
PTH, PTHLH and PTH-L peptides have been reported to participate in mineral 
homeostasis, bone remodeling and skeletal development across vertebrates (Broadus, A. 
and Stewart, 1994; Canario et al., 2006; Kronenberg, 2006; Pinheiro et al., 2010; Potts, 
2005). In mammals, PTH is the master endocrine regulator of calcium and phosphate 
homeostasis and bone turnover (Mundy and Guise, 1999; Potts, 2005) whilst PTHLH 
mainly participate in the development as a bone-derived paracrine factor (Kronenberg, 
2006). In fish, duplicated Pthlh forms were reported to have a more defined role in 
calcium-phosphate balance and skeletal development than Pth (reviewed in (Guerreiro et 
al., 2007)). Concerning Pth-l, it should be noted that synthetic pufferfish Pth-l (1-34) was 
reported to stimulate calcium uptake and in vitro ion mobilization from sea bream (Sparus 
aurata) scales (Canario et al., 2006). Similar in vitro calciotropic effect in calcium 
transport was showed using Xenopus and chicken Pth-l (1-34) (Pinheiro et al., 2010).  
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These taxon-specific differences are likely related to the transition from aquatic to 
terrestrial environments that occurred during the evolution of vertebrates. Thus, new 
mechanisms for controlling bone mineral homeostasis and skeletal development probably 
became associated with the evolution of the PTH family and possibly facilitated the 
transition from an aquatic to terrestrial lifestyle, which was accompanied by much greater 
stress on the skeleton.  
One of the last identified members of the PTH family is the Pth-l and its biological 
function has not yet been characterized. In this study, we first isolated pth-l gene (here 
renamed parathyroid hormone 4, pth4) in zebrafish by in silico analysis, performed the 
molecular characterization of the gene and studied the pth4 expression across zebrafish 
development. In addition, phylogenetic and comparative genomics studies were 
performed for reexamination of the PTH family evolution and to test the hypothesis that 
pth4 is the fourth PTH ohnolog. Based upon these finding, a change in the nomenclature 
of the vertebrate PTH family was proposed. 
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3. Materials and methods 
3.1 Zebrafish 
Fish (Zebrafish, Danio rerio) were cultured as previously described (Westerfield, 
2007) and staged by hours post fertilization (hpf) or days post fertilization (dpf)  
following standard criteria (Kimmel et al., 1995). Experiments were performed with a 
TU-WT strain (Tuebingen (TU), Nüsslein-Volhard Lab). Embryo medium was 
supplemented with 0.003% (w/v) 2-phenylthiourea to inhibit embryo pigmentation 
(Westerfield, 2007). For in situ hybridization, dechorionated embryos and larvae were 
fixed overnight at 4°C in 4% paraformaldehyde in 1X PBS, washed in PBS, dehydrated 
through a methanol series and stored at -20 °C in 100% methanol. Ethical approval (Ref: 
AGL2014-52473R) for all studies was obtained from the Institutional Animal Care and 
Use Committee of the IIM-CSIC Institute in accordance with the National Advisory 
Committee for Laboratory Animal Research Guidelines licensed by the Spanish Authority 
(RD53/2013) and conformed to European animal directive (2010/63/UE) for the 
protection of experimental animals. 
 
3.2 DNA cloning 
The putative zebrafish pth4 gene was identified by searching the zebrafish genome 
database (Zv9) with translated Basic Local Alignment Search Tool (tBLASTn; 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the previously identified sequence of 
zebrafish Pth1a, Pth1b, Pth2 (Tip39), Pthlha and Pthlhb paralogs (Accession No.: 
NM_212950, NM_212949, NP_991140, NP_001019798.2 and NP_001036789.1, 
respectively). Full-length cDNA was isolated by using sequence-specific primers (5´-
CTCTGTGACCGCACGCCT-3´ and 5´-GGCTTCACACTGCGCAG-3´) in 5′ and 3′ 
SMART RACE (rapid amplification of cDNA ends) cDNA amplification kit (Takara 
Bio), and sequenced by Sanger. The zebrafish pth4 gene sequence has been submitted to 
the EMBL/GenBank database with Accession No. KT182088.1. 
 
3.3 RNA isolation and RT-PCR 
Temporal expression of pth4 was determined by RT-PCR. Total RNA was isolated at 
0, 3, 6, 9, 12, 14 hpf and 1, 2, 3, 4, 5 and 6 dpf using Trizol reagent (Invitrogen) and first 
strand cDNA was synthesized according to the Maxima First Strand cDNA Synthesis Kit 
(Thermo Fisher Scientific) protocol starting with 500 ng of total RNA. The partial 
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sequence of pth4 was amplified using DreamTaq DNA Polymerase (Thermo Scientific) 
and specific primers (5´-GTCTGAAGCGTCTGATCTGG-3´ and 5´-
ACCGGTTTCTCCGGTTCTCCGAG-3´). 18S ribosomal cDNA amplification was used 
as a positive control (5´-TCGCTAGTTGGCATCGTTTATG-3´ and 5´-
CGGAGGTTCGAAGACGATCA-3´).  
 
3.4 In situ hybridization 
Whole mount in situ hybridization (WISH) was performed using digoxigenin-labeled 
antisense riboprobes as previously described (Rotllant et al., 2008). Antisense and sense 
riboprobes were made from linearized full-length zebrafish pth4 and pth2 cDNA, 
previously cloned into pGEM-T Easy vector (Promega). First, pth4 coding sequence was 
cloned into pGEM-T Easy vector (Promega) using primers 5´-
AAGCTTACCATGTTGAAGATGCAGAGATCTCAG-3´ and 5´-
CTCGAGTTATTTCTCCGGTTCTCCGAG -3´. For plastic sections, embryos with ISH 
staining were fixed, dehydrated, Epon embedded, cut into 4 μm rostro-caudal transverse 
sections, mounted with EUKITT as previously described (Westerfield, 2007) and imaged 
with a Leica DM2500 microscope. In situ hybridization of adult sections (360 dpf) 
zebrafish followed methods as described (Cerdá-Reverter et al., 2000). Samples were 
fixed in 4% paraformaldehyde and 0.1 M phosphate buffer, for 2 days at 4°C, dehydrated 
and embedded in Paraplast (Sherwood, St Louis). Serial 10 μm rostro-caudal transverse 
sections were cut using a rotary microtome. Sections were mounted on 3-
aminopropyltriethoxylane (TESPA) treated slides, air-dried at room temperature (RT) 
overnight and stored at 4°C under dry conditions and used for hybridization within one 
month. Images were captured with a Leica M165FC stereomicroscope. 
 
3.5 Phylogenetic analysis and comparative genomic of conserved synteny 
Multiple sequence alignment was made by MUSCLE pctid-log algorithm, corrected 
manually for inconsistencies and trimmed to decrease the total number of gaps. 
Phylogenetic analysis was inferred by maximum likelihood using PhyML 3.0 subjected to 
LG substitution model, a bionj starting tree improved by NNI, and computing aLRT SH-
like branch support (Guindon et al., 2010). Analyses of conserved synteny were 
performed using automated pipeline tools of the Synteny Database variant Ens61 
(Catchen et al., 2009). Dot-plots represent the chromosomal distribution of human 
ohnologs (a special type of paralogs resulting by whole-genome duplication (Wolfe, 
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2000)) of gene neighbors of the PTH family. The first 20 Mb of human chromosome 11 
(Hsa11), which includes the human PTH gene, were analyzed taking the genomes of the 
urochorate Ciona intestinalis and the cephalochordate Branchiostoma floridae as 
outgroups for the identification of ohnologs resulting from the first and second rounds of 
vertebrate genome duplication (VGD1 and VGD2) (for details see (Cañestro et al., 
2009)). Clusters in the Synteny Database were obtained by coupling results from the 
reciprocal best hit BLAST pipeline with the use of a 50- or 25-gene sliding window 
analysis that links orthologous chromosome segments of two species by conserved 
synteny (Catchen et al., 2009). The Synteny Database is especially useful to provide 
evidence of ohnologs gone missing (OGM) by uncovering the putative chromosomal 
region that still preserves paralogous syntenic conservation, but has lost a certain ohnolog 
of interest (Cañestro et al., 2009; Catchen et al., 2011). 
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4. Results 
4.1 Identification and genomic characterization of the pth4 gene 
Using BLAST analysis, we identified a previously unannotated new zebrafish 
paralog of the pth gene family on zebrafish chromosome Dre22: 597996-600181 
(GRCz10) that we call pth4. Results from 5´- and 3´-RACE revealed that the pth4 full-
length transcript was 809 bp long and consists of an open reading frame of 366 bp, a 94 
bp 5´-UTR and a 349 bp 3´-UTR (Figure 1). Aligning the cDNA to the genome sequence 
predicted that the pth4 gene structure consists of 2 exons and 1 intron. The pth4 cDNA 
predicted translation was a 121 amino acids sequence that contained a secretion signal 
sequence of 24 amino acids in the N-terminus (http://cbs.dtu.dk/services/SignalP/), as 
expected for PTH peptides. Predicted cleavage sites 
(http://www.cbs.dtu.dk/services/ProP/) should yield pre-pro sequences of 31 amino acids 
and a mature peptide of 90 amino acids. Protein sequence analysis revealed conserved 
regions including a dibasic cleavage site (RR) and an MHD motif. 
 
Figure 1. A schematic diagram of the zebrafish pth4 locus shows a two exons structure separated by an 
intron of 1,377 bp and 2,283 bp of the genomic region upstream of pth4 transcription start site (TSS). Boxes 
depict exons with white regions indicating 5´-UTR (94 bp) and 3´-UTR (349 bp). TSS is denoted by (+1). 
Below the amino acid sequence shows putative pre-pro sequences of 31 amino acids outlined with dashed 
lines and mature peptide of 90 amino acids is in grey box. Dibasic cleavage site (RR) and MHD motif are in 
bold. PTH consensus domain is underlined.  
 
4.2 Temporal and spatial expression of pth4 during ontogeny 
We examined the spatial expression of pth4 by ISH in zebrafish. Starting at 24 hpf, 
embryos displayed pth4 expression in two bilateral spots in the lateral ventral 
diencephalon corresponding to the region of the developing hypothalamus (Figure 2A, B). 
We observed a gradual number and movement of cells within the two bilateral clusters 
during development (Figure 2A–F). At 3 dpf, pth4 appeared to be specifically expressed 
by two subsets of neurons in the lateral hypothalamus, distant from pth2-expressing cells 
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(Figure 2G, H). In adult fish (360 dpf), bilateral cell clusters were detected in the dorsal 
zone of the periventricular hypothalamus (Figure 2I). Expression of endogenous pth4 was 
never detected by ISH outside this hypothalamic area in embryonic and later stages. 
Analysis of temporal expression of pth4 by RT-PCR (Figure 2J) revealed that pth4 was 
maternally transcribed, being detected in embryos as early as 0 hpf and showing a 
progressive decrease until 9 hpf. Zygotic expression of pth4 appeared to increase from 12 
hpf through subsequent development and then to increase at 4, 5, and 6 dpf. 
 
Figure 2. Spatial and temporal expression of pth4 
transcripts in zebrafish. (A, C, E) Lateral and (B, D, F) 
ventral view of whole mount in situ hybridization of 
pth4 expression of 1, 2, and 3 dpf wild-type zebrafish 
embryos. Staining with the pth4 antisense probe 
showed expression in bilaterally symmetric regions of 
the developing hypothalamus. (G) Rostrocaudal 
transverse sections (4 μm thick) of Epon-embedded, 
double whole mount in situ hybridization of pth2 (red 
arrow heads) and pth4 (black arrowheads) in 3 dpf 
zebrafish (H) and identified pth4 expression domains 
in the lateral hypothalamus. (I) Rostrocaudal 
transverse section (10 μm thick) of paraffin-
embedded, ISH of pth4 expression in adult zebrafish 
displayed pth4 transcripts exclusively in bilateral cell 
clusters located in the dorsal zone of the 
periventricular hypothalamus. (A-F) Gradual 
movement of the expression domain during 
development from caudoventral to a more rostrodorsal 
situation with reference to the eye position. (J) RT-
PCR analyses of the temporal expression pattern of 
pth4 mRNA. Abbreviations: e, eye; Hd, dorsal zone of 
the periventricular hypothalamus; hy, hypothalamus; 
Hv, ventral zone of the periventricular hypothalamus; 
m, midbrain; t, telencephalon; TPp, periventricular 
nucleus of posterior tuberculum; 3v, third ventricle. 
Scale bars: 100 μm (A–G); 5 μm (I). 
 
 
 
 
4.3 Phylogenetic analysis and evolutionary origin of the pth4 gene 
The alignment of PTH peptide family amino acid sequences showed a highly 
conserved PTH domain (from amino acid 36 to 79 in Figure 3) among PTH, Pth4 and 
PTHLH. In particular, the cleavage sites (KR and RR) located before the mature protein 
are conserved in all PTH family members as well as MHN/MHD/LHD motifs and 
residues key for interaction with the receptors (Figure 3). 
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Phylogenetic analyses inferred by maximum likelihood and rooted with Pth protein 
sequences from the cephalochordate Branchiostoma floridae (On et al., 2015b) showed 
that zebrafish Pth4 belongs to a well-supported clade that includes Pth4 from other 
teleosts and from spotted gar, coelacanth, chicken, turtle, and two marsupial mammals: 
opossum and Tasmanian devil (Figure 4A). However, we could identify no Pth4 genes in 
human, mouse, or any eutherian mammalian genomes in Ensembl-v79. 
 
Figure 4. Phylogenetic and conserved synteny analysis of PTH related proteins. (A) A phylogenetic tree 
inferred by maximum likelihood showing the relationship between PTH4 proteins and other proteins of the 
PTH, PTH2, and PTHLH families. (B) Dotplot analysis shows the distribution of paralogs (black dots) of 
the PTH neighbor genes in the first 20 Mb of human chromosome 11 (Hsa11 on the x axis) throughout all 
chromosomes of the human genome (y axis) using both the amphioxus Branchiostoma floridae and the 
ascidian Ciona intestinalis genomes as outgroups. Yellow shadow areas highlight conserved syntenic 
regions that probably originated in two rounds of WGD that took place during early vertebrate evolution 
(Dehal and Boore, 2005; Putnam et al., 2008), (reviewed in (Cañestro, 2012)), including Hsa12 and Hsa19 
where the ohnologs PTH2 and PTHLH are located (blue circles), and other regions including Hsa1 and 
Hsa6, where PTH ohnologs are missing (PTH-OGM, red circle). 
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To investigate the evolutionary relationships of the pth4 of zebrafish and other 
teleosts in the context of the entire PTH-related gene family and to better understand the 
apparent absence of an ortholog of PTH4 in human, mouse, and other eutherian 
mammals, we performed a comparative analysis of conserved synteny. Dot-plot analysis 
of conserved syntenies for 20 Mb encompassing the genomic neighborhood of the human 
PTH gene located on chromosome 11 revealed that paralogs of most PTH neighbor genes 
landed on Hsa12 and Hsa19, where PTHLH and PTH2, respectively, were also located. 
This finding was consistent with a recent analysis of a 6 Mb window around PTH2 in 
Hsa19 (Yan et al., 2012). The dot plot also revealed other chromosomes, including Hsa1 
and Hsa6, with paralogs of numerous PTH neighbor genes, but in which no PTH-related 
gene has been identified (Figure 4B).This situation would be expected if these regions 
formed part of the 4 paralogons that would have been generated by the two rounds of 
WGD that took place during early vertebrate evolution (Dehal and Boore, 2005; Putnam 
et al., 2008),  (reviewed in (Cañestro, 2012)). Analysis of gene clusters using the Synteny 
Database (Catchen et al., 2009) revealed that paralogs of 21 of the 28 closest neighbor 
genes to the zebrafish pth4 gene in Dre22 were located in Hsa1 or Hsa6 (Figure 5). 
Comparison of the genomic neighborhood of Pth4 in chromosome 26 of chicken (Gga26), 
which is more closely related to human than to zebrafish, revealed that paralogs of 9 of 
the 10 nearest neighbor paralogs in a 150 kb window are specifically in Hsa6 (Figure 6). 
This finding strongly suggested that an ancestral PTH4 ohnolog was present in the last 
common ancestor of ray-finned fish (Actinopterygii, including zebrafish) and lobe-finned 
fish (Sarcopterygii, including coelacanth, chicken, and human), but was lost in the lineage 
leading to humans after the eutherian–metatherian split; furthermore, our analysis 
revealed that the PTH4-OGM (ohnolog gone missing) should have been in Hsa6 before it 
was lost, whereas it was preserved in other non-eutherian vertebrate lineages including 
chicken and teleosts, such as zebrafish. 
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5. Discussion  
In this study, we identified and performed the molecular characterization of the novel 
PTH family member, pth4, in zebrafish. The genomic organization of zebrafish pth4 gene 
consists of two exons which encode a putative protein of 121 amino acids. The predicted 
Pth4 protein includes PTH-specific motifs and dibasic cleavage sites for pre-pro 
sequences conserved in other secreted members of the PTH family (Gensure et al., 2004; 
Pinheiro et al., 2010). The bioactive N-terminal (1-34) peptide is the most conserved 
region of the mature protein. Regarding gene structure, pth4 is more related to the 
tetrapod PTH with the same exon-intron pattern; however, the mature protein contains the 
MHD motif which is typical of teleost Pthlh peptides. Due to the intermediary 
characteristics of piscine Pth4, it has been suggested that Pth4 may be the ancestral 
peptide that gave rise to PTH and PTHLH (reviewed in (Guerreiro et al., 2007)). In 
addition, the MHD motif is present in all the Pth family members identified in the ancient 
elephant shark, suggesting that the common vertebrate ancestor of the PTH family could 
contain this particular domain (Liu et al., 2010; On et al., 2015a). 
Expression analysis during zebrafish development revealed that pth4 is maternally 
transcribed. By 24 hpf, however, pth4 is expressed specifically in a bilateral subset of 
cells located in the lateral hypothalamus. In fish, pth paralogs are expressed in the lateral 
line, neural tube and skeletal elements such as jaw and branchial arches (Hogan et al., 
2005), while duplicated genes for pthlh display an expression in numerous tissues and 
organs (reviewed by (Abbink and Flik, 2007). In contrast to the diffuse and widespread 
expression of pth and pthlh members in teleosts, zebrafish pth4 gene expression is highly 
restricted to the hypothalamic region during early development but also in adult fish. The 
specific expression pattern suggests that Pth4 may have a role in the neuroendocrine 
system or in neurotransmission. 
To date, 3 ohnologs have been described belonging to PTH family of peptides (i.e., 
PTH, PTH2, and PTHLH) (Bhattacharya et al., 2011) that appear to have originated via 
two rounds of 1R/2R WGDs during early vertebrate evolution (Dehal and Boore, 2005). 
In teleosts, moreover, pth and pthlh have two paralogs (i.e., ptha/pthb and pthlha/pthlhb) 
that originated in the extra round of WGD that occurred during early teleost evolution 
(3R) (Braasch and Postlethwait, 2012; Yan et al., 2012). Our phylogenetic inferences and 
analysis of conserved syntenies shared by the pth4 genomic neighborhood in zebrafish 
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and its ohnologons in chicken and human provide evidence consistent with the hypothesis 
that PTH4 is the fourth missing PTH ohnolog resulting from 1R/2R-WGDs. Our genome 
survey shows that PTH4 is present in ray-finned fish and in non-eutherian vertebrates but 
absent in eutherians because of a gene loss that likely occurred at the base of the eutherian 
mammalian clade (i.e., a eutherian OGM). Our analysis of gene clusters reveled neighbor 
genes to the zebrafish pth4 gene in Dre22 distributed in two human chromosomes, which 
suggests that genome rearrangements may have occurred in the mammalian radiation and 
contributed to the loss of PTH4 in the eutherian lineage.  
Therefore, PTH, PTH2, PTHLH and PTH4 would be present in the last vertebrate 
ancestor after the 1R/2R-WGDs. Nevertheless, the origin of the PTH family still remains 
under debate and it has been hypothesized that the common ancestor would have a single 
gene with many functions and, after whole genome duplications, PTH members would 
diversified their roles across vertebrate evolution (Yan et al., 2012). Because of the 
important functions that PTH and PTHLH peptides have in bone mineral homeostasis and 
skeletal development, it has been proposed that the origin of the PTH family could be 
associated to emergence of an endoskeleton calcified in bony vertebrates (including ray-
finned fish and lobe-finned fish) (Pinheiro et al., 2010). However, the discovery of pth 
family genes including pth, pth2, pthlh and pth4 in the elephant shark (i.e., cartilaginous 
fish belonging to group of chimaeras) makes unlikely this hypothesis and suggests that 
PTH family members could have other fundamental roles unrelated to bone development 
in fish that lack of bony skeleton (Liu et al., 2010). Therefore, Pth family was already 
present in the genome of cartilaginous fish, which diverged from bony vertebrates after 
the 1R/2RWGD, 450 million years ago (Venkatesh et al., 2007). Additionally, pthlh and 
pth2 genes were also identified by in silico analysis (Pinheiro et al., 2012; Trivett et al., 
2005) in the primitive lamprey genome, as well as a predicted Pth4 (GL476611: 12889 to 
13246) that we have identified in the Petromyzon marinus genome database. Furthermore, 
the identification of potential Pth like peptides in the cephalochordate Branchiostoma 
florifae and urochordate Ciona intestinalis (Mirabeau and Joly, 2013) indicates that the 
origin of the PTH family probably occurred before the evolution of vertebrate lineage. 
Across evolution, the peptides belonging to PTH family likely conserved and/or 
diversified their biological roles related to mineral homeostasis and bone formation to 
facilitate the adaptation of distinct vertebrate lineages to aquatic and/or terrestrial 
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environments. In this context, further functional analysis of Pth4 in fish will allow us to 
step forward to decipher the evolutionary history of the PTH family. 
For the sake of clarity and to better reflect the evolutionary origin of the PTH family, 
we propose a change in the nomenclature of this vertebrate family, in which PTH and 
PTHLH should be renamed to PTH1 and PTH3, respectively. Accordingly, the 
nomenclature of teleost genes duplicated during the 3R of genome duplication, ptha and 
pthb should be thought of as pth1a and pth1b; pth2 remains as pth2; pthlha and pthlhb 
should be thought of as pth3a and pth3b. Finally, the newly isolated gene should be called 
pth4 as it is the fourth ohnolog identified of the PTH family.  
 

  
 
 
 
CHAPTER 2 
 
Promoter Analysis And 
Transcriptional Regulation  
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1. Abstract 
Parathyroid hormone 4 (Pth4) is an ancient peptide belonging to PTH family and it 
has recently been isolated in zebrafish. Whole-mount in situ hybridization revealed that 
pth4 mRNAs are specifically expressed in two clusters of hypothalamic cells in embryos 
and adult fish. However, the regulatory elements required for the pth4 gene expression are 
largely unknown. The purpose of this study was to explore the target genomic regions that 
regulate pth4 gene expression by in vivo functional characterization of the pth4 promoter 
and to uncover possible factors that modulate its transcriptional activity. By using reporter 
transgenic zebrafish lines, which provide useful models for understand the gene 
expression and regulation of particular cell types, we reported that eGFP expression 
pattern replicates the spatiotemporal pattern of endogenous pth4 expression. Moreover, 
Pth4:eGFP transgenic fish enabled mapping of axonal projections leading from the 
hypothalamus to the brainstem and spinal cord. Results from promoter deletions and site-
directed mutagenesis along with knockdown and rescue experiments showed that Runx2a 
is a trans-acting factor that regulates pth4 gene expression in zebrafish embryos.  
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2. Introduction 
Parathyroid hormone (PTH), parathyroid hormone-like hormone (PTHLH) and the 
newly identified parathyroid hormone 4 (PTH4) belong to a family of peptides that play 
important roles in calcium and phosphate homeostasis, bone turnover and skeletal 
formation in vertebrates (Broadus, A. and Stewart, 1994; Canario et al., 2006; 
Kronenberg, 2006; Pinheiro et al., 2010; Potts, 2005). Unlike mammals where PTH 
expression is essentially restricted to the parathyroid gland and exerts a crucial role in 
bone mineral homeostasis, the duplicated pth orthologs (i.e., ptha and pthb) show a more 
disperse expression in fish (Hogan et al., 2005) and they do not appear to have a critical 
role in such function. Based on the literature, Ptha was reported to act as a hypercalcemic 
factor via scale resorption in goldfish (Suzuki et al., 2011), while in sea bream Pthb seems 
to be a key factor that mobilizes calcium from scales (Canario et al., 2006). Also, other 
studies reported the involvement of Ptha, but not Pthb, in the calcium uptake as well as 
during the acclimation to low calcium water in zebrafish (Kwong and Perry, 2015; Lin et 
al., 2014). Therefore, the specific calciotropic role of both Pth co-orthologs is still under 
debate. Regarding  PTHLH, its widespread expression is related to its involvement in 
many developmental processes in mammals (reviewed in (McCauley and Martin, 2012). 
In fish, Pthlh peptides (i.e., Pthlha and Pthlhb) has been shown to participate not only in 
chondrogenesis and osteogenesis but also in mineral balance (Abbink and Flik, 2007; Yan 
et al., 2012). 
Although PTH and PTHLH expression patterns and function have been investigated 
in vertebrates, little is known about the transcriptional regulation of PTH family genes 
through trans-acting factors on cis-regulatory elements located in the gene promoter 
region. The promoter activity of mammalian PTH gene is repressed in vitro by binding of 
a complex formed by vitamin D, vitamin D receptor (VDR) and retinoic acid X receptor 
(RXR) (Demay et al., 1992; Kawahara et al., 2008; Naveh-Many et al., 2008), as well as 
by hepatocyte nuclear factor 1β (HNF1β) (Ferrè et al., 2013). On the other hand, some 
functional studies in cell lines revealed that transcription factors such as specificity 
protein 1 and 3 (SP1 and SP3) and nuclear factor-Y stimulate the PTH promoter activity 
(Alimov et al., 2005). Regarding human PTHLH, its transcriptional regulation is under 
three alternative promoters (i.e., distal P1, mid-region P2 and proximal P3) that give rise 
to three splice-variant isoforms (McCauley and Martin, 2012). Although the specific 
PTHLH promoter involved in skeletogenesis has not yet been identified, a previous report 
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showed that SOX9 transcriptional factor directly regulates the activity of the human 
PTHLH promoter P2, possibly in cooperation with SOX5 and SOX6 cofactors (Amano et 
al., 2009). Similarly, sox9a  has been shown to regulate pthlha gene expression in 
zebrafish, which in turn, regulates runx2b expression during craniofacial development 
(Yan et al., 2012); however, if Sox9a is a direct upstream transcriptional pthlha regulator 
has not yet been stablished. Apart from this zebrafish study, the trans-acting factors that 
regulate Pth family gene transcription by binding directly on cis-regulatory elements 
located in the gene promoter and 5′-flanking regions are virtually unexplored. 
In our previous work, we found a very specific pth4 gene expression in two clusters 
of hypothalamic cells during zebrafish embryonic and larvae development as well as in 
adult fish (Chapter 1). In Chapter 2, we investigate the trans-acting factors that regulate 
pth4 gene transcription by in vivo functional characterization of cis-regulatory elements 
located in the Pth4 promoter and 5′-flanking regions. To do that, we first generated 
reporter pth4 zebrafish transgenic lines and showed that eGFP reporter expression mimics 
the endogenous pth4 gene expression across zebrafish development. Then, deletions and 
site-directed mutagenesis on the promoter region along with morpholino knockdown 
analysis revealed that Runx2a is a crucial upstream regulator of pth4 promoter 
transcriptional activity. 
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3. Materials and methods 
3.1 Zebrafish 
Fish (Zebrafish, Danio rerio) were cultured as previously described (Westerfield, 
2007) and staged by hours post fertilization (hpf) or days post fertilization (dpf)  
following standard criteria (Kimmel et al., 1995). Experiments were performed with a 
TU-WT strain (Tuebingen (TU), Nüsslein-Volhard Lab). Embryo medium was 
supplemented with 0.003% (w/v) 2-phenylthiourea to inhibit embryo pigmentation 
(Westerfield, 2007). For in situ hybridization, dechorionated embryos were fixed 
overnight at 4°C in 4% paraformaldehyde in 1X PBS, washed in PBS, dehydrated 
through a methanol series and stored at -20 °C in 100% methanol. Ethical approval (Ref: 
AGL2014-52473R) for all studies was obtained from the Institutional Animal Care and 
Use Committee of the IIM-CSIC Institute in accordance with the National Advisory 
Committee for Laboratory Animal Research Guidelines licensed by the Spanish Authority 
(RD53/2013) and conformed to European animal directive (2010/63/UE) for the 
protection of experimental animals. 
 
3.2 Reporter transgene construction and microinjection 
To generate pth4 reporter transgenic lines, zebrafish pth4 promoter sequences 
containing 2 and 1 kb upstream to the ATG start site of the pth4 gene (GenBank 
accession No CU856139.10) for the Tol2 transposon constructs used in this study were 
amplified from 6 dpf zebrafish genomic DNA with KOD Xtreme Hot Start DNA 
Polymerase Platinum (Novagen) and specific primers (Table 1). The PCR products were 
diluted 1:10, and 1 μl was ligated into 1 μl of P-ENTR/D-TOPO Cloning Kit (Thermo 
Fisher Scientific) and transformed according to the manufacturer’s instructions. Both 
promoter sequences were then ligated by LR Clonase into the destination vector 
pToleGFPDest (Lawson Lab # 274) containing the eGFP sequence downstream, and 
sequenced. Construct P1 (1kb-pth4-Tol2-eGFP) contained 873 nucleotides upstream to 
the translation start site of pth4 gene. Construct P2 (2kb-pth4-Tol2-eGFP) contained 2377 
nucleotides upstream to the translation start site of the pth4 gene. Three P2 independent 
transgenic zebrafish lines Tg(pth4:eGFP)iim07, Tg(pth4:eGFP)iim08, and 
Tg(pth4:eGFP)iim09 were generated.  
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Table 1. Primer sequences used for PCR amplification of pth4 promoter and deletions constructs.  
Restriction sites are denoted in lowercase and “p” indicates 5´-phosphorylated deletion primers. 
Construct Forward primer sequence (5´-3´) Reverse primer sequence (5´-3´) Promoter (bp) 
2kb-pth4 caccTATGAATGTTGATTCCA GCATCTTCAACATGGTCCAC 2377 
1kb-pth4 caccTGTTCACATTCACAAAA GCATCTTCAACATGGTCCAC 873 
Δ941-262 
pTGGAGCGACACCCAA 
AACCACGACTGATCA 
pTGGAACAGGGTAAAGTCTAG 
ATCGGATCCCTGCTGGAAAATC 
1698 
Δ941-554 
pCATCAAGCGCTCGCATT 
CCTCACCTGTAGAAACCA 
pTGGAACAGGGTAAAGTCTAGA 
TCGGATCCCTGCTGGAAAATC 
1990 
Δ554-262 
pTGGAGCGACACCCAA 
AACCACGACTGATCA 
pAGGATCTGAGCGCTGATTCC 
TGCAGAGTCAAACACC 
2085 
 
To study the regulatory regions of pth4, potentially cis-acting transcription factor 
binding sites (TFBSs) located in the zebrafish pth4 promoter sequence were identified 
with MatInspector software (Cartharius et al., 2005). Deletion and substitution mutations 
were created as has been described (Wang and Wilkinson, 2001) or by using the 
QuickChange Site-Directed Mutagenesis Kit (Stratagene). The resulting clones were 
tested though restriction analysis and confirmed by sequencing. All Tol2 constructs 
(Tables 1 and 2) were dissolved in distilled nuclease-free water to a final concentration of 
50 μg/ml. A total of 250 pg of construct and synthetic 5´-capped mRNA (150 pg) 
encoding a transposase were coinjected into TU-WT embryos at the 1 or 2 cell stage, with 
1% of phenol red as a tracer. Microinjection was performed under a dissection 
microscope (MZ8, Leica) fitted with a MPPI-2 pressure injector (ASI Systems). The 
expression of eGFP was analyzed by direct observation of eGFP fluorescence under a 
fluorescence stereoscope and a confocal microscope. The number of embryos positive for 
eGFP fluorescence was determined and the fluorescence distribution was compared 
between different transgenic lines to score activity and tissue specificity. 
 
Table 2. Primer sequences used for site-directed mutagenesis and transcriptional factors targeted on the 
pth4 promoter. 
Construct Forward primer sequence (5´-3´)  Reverse primer sequence (5´-3´) Target factors 
Box 1 
CCACATCCAGGCTGTACT 
GCTATGGAGAGGGATGC 
GCATCCCTCTCCATAGCA 
GTACAGCCTGGATGTGG 
CREB/ HRE/ ATF6 
Box 2 
GCCATTGCCAAGCTAGGA 
ATCTCCAACGTAAAGGC 
GGCGCTTAATAGCTTGGC 
AATGGCGTCGGCGGGTT 
HMX2/ LXRE 
Box 3 
GGCATTTTAACTAGAACGCT 
CGTCACGGACACAAACAG 
CTGTTTGTGTCCGTGACGA 
GCGTTCTAGTTAAATGCC 
HOXA5/BRN5/LHX6/  
VAX2/ISL1 
Box 4 
CCTCATCTATTCTCCAGCT 
AATCCAATTCTCCGTCAGC 
GCTGACGGAGAATTGGATT 
AGCTGGAGAATAGATGAGG 
NFE2/PBX1_MEIS1/  
AP1/MEIS1/VDR_RXR 
Box 5 
CTGATTCACCTCTCCGGCC 
GCAGAATCACACTTCT 
AGAAGTGTGATTCTGCGG 
CCGGAGAGGTGAATCAG 
VMAF/CREB/ MARE 
Box 6 
CTCACCTGTAGAAATAGT 
ATCCATGACGTGCTGCT 
AGCAGCACGTCATGGAT 
ACTATTTCTACAGGTGAG 
RUNX2/ RUNX3 
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3.3 Morpholino knockdown and mRNA rescue 
Morpholino antisense oligonucleotides (MOs) (GeneTools) were designed against 
runx2a, runx2b and runx3 as previously described, including a splice-target MO against 
both runx2a isoforms (i.e., runx2a-001 and runx2a-002) and translational start blocking 
MOs targeting of each isoform of runx2b (i.e., runx2bT1 and runx2bT2) and runx3 
(Flores et al., 2006; Kalev-Zylinska et al., 2003). A scrambled MO with no known target 
in zebrafish, cMO, 5’-CCTCTTACCTCAGTTACAATTTATA-3’ was used as control. 
Additionally, runx-MOs and/or p53-MO (Robu et al., 2007) were used to target runx and 
p53 genes, respectively. The MOs were resuspended in water to a final concentration of 
0.5 mM. Approximately, 2 nl were injected into one or two cell stage in reporter 
transgenic embryos (up to 1pmol final dose), based on previously amounts tested in 
published papers (Flores et al., 2006; Kalev-Zylinska et al., 2003). Knockdown embryos 
were analyzed for eGFP fluorescence at 2 dpf, and pth4 gene transcription was assessed 
by in situ hybridization and real-time quantitative (q)PCR. 
For the rescue assay, full-length cDNA of zebrafish runx2a-001 isoform was 
amplified with Q5
®
 High-Fidelity DNA Polymerase (NEB) with specific primers (Table 
3) including a Kozac sequence upstream of ATG and cloned into pCS2+ vector. 
Construct was then sequenced for verification. Capped mRNA was transcribed in vitro 
using the mMessenger mMachine SP6 kit (Ambion) according to the manufacturer’s 
protocol. Rescue mRNA was injected into one or two cell stage embryos either alone or 
in the presence of runx2a-MO. The amount of mRNA injected was titrated to determine 
the optimal doses that generated reproducible phenotypes without causing early lethality. 
Approximately 2 nl of Runx2a-MO (0.5 mM) along with runx2a-001 mRNA (30 ng/ul or 
75 ng/ul) were injected into one or two cell stage embryos. 
 
3.4 RNA isolation,  RT-PCR and real-time quantitative PCR 
Total RNA from uninjected, control-MO injected and runx2a morphant embryos at 2 
dpf (n=6 pools of 5 embryos each) was isolated using Trizol reagent (Invitrogen) and first 
strand cDNA was synthesized according to the Maxima First Strand cDNA Synthesis Kit 
(Thermo Fisher Scientific) protocol starting with 100 ng of total RNA. Expression of pth4 
was analyzed by real-time qPCR using specific primers (Table 3). Each sample was 
amplified in triplicate containing 12.5 µl of Maxima® SYBR Green/ROX qPCR Master 
Mix (2X) (Thermo Fisher Scientific), 0.5 µl 0.2 µM of each primer, 10.5 µl nuclease-free 
water and 1 µl of cDNA template. Real-time qPCR reactions were analyzed on a 7500 
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Fast Real-Time PCR System (Applied Biosystems) with the following cycling conditions: 
initial denaturation at 95 °C for 10 min followed by 40 cycles at 95 °C for 15 s and 60 °C 
for 1 min. The gene expression was assessed in two independent experiments using the 
efficiency calibrated method as previously described (Pfaffl, 2001) and relative mRNA 
expression levels were normalized to eef1a1/1. 
Table 3. Primer sequences used for RT-PCR and real-time qPCR amplification. 
Gene Forward primer sequence (5´-3´) Reverse primer sequence (5´-3´) 
runx2a-001 GAATTCgtgATGCGCATTCCGGTAGATC CTCGAGCAGAGCATCTCAATATGGC 
pth4 GTCTGAAGCGTCTGATCTGG CCGGTACAGGTCGCTGAG 
eef1a1/1 CGAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC 
Primers design with Kozac sequence denoted in lowercase followed by the start codon ATG. 
 
3.5 In situ hybridization, immunohistochemistry and eGFP imaging 
Whole mount in situ hybridization (WISH) was performed using digoxigenin-labeled 
antisense pth4 riboprobe as previously described (Rotllant et al., 2008). Double labeling 
of eGFP immunofluorescence and fluorescence ISH (FISH) was performed in 2 dpf 
Tg(pth4:eGFP)iim07 zebrafish embryos. A sheep anti-DIG-POD antibody (1/500; Roche 
Diagnostics) was used and pth4 probe labeling was detected by tyramide signal 
amplification (TSA Plus Cyanine 3 and Fluorescein system, PerkinElmer). Expression of 
eGFP was visualized with a mouse anti-eGFP primary antibody (1/250; Roche 
Diagnostics) followed by a horse anti-mouse fluorescein-conjugated secondary antibody 
(1/200; Vector Laboratories). For cryostat sectioning, Tg(pth4:eGFP)iim07 adult fish 
were fixed in 4% paraformaldehyde overnight at 4°C, washed with 1X PBS, transferred to 
15% sucrose, followed by 30% sucrose, and then embedded and frozen in optimal cutting 
temperature medium. Cross-cryosections of 25 μm thickness were collected on polylysine 
slides (Thermo Fisher Scientific) and allowed to dry. Slides were washed in 1X PBS, 
mounted in Vectashield, and imaged on a TCS SP5 (Leica) confocal microscope. 
Tg(pth4:eGFP)iim07 embryos and larvae were fixed in 4% paraformaldehyde overnight 
at 4°C, washed with 1X PBS and stored at 4°C. Then, images were captured with a TCS 
SP5 (Leica) confocal microscope and Leica M165FC stereomicroscope. 
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3.6 Statistics 
Data were expressed as mean ± standard error of the mean (SEM). Differences 
between groups were assessed by Student’s-t test. A p-value <0.05 (asterisks) was 
considered statistically significant. Statistical analysis and figures were performed with 
PASW Statistics 18.0 and SigmaPlot 12.0, respectively. 
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4. Results 
4.1 A neural network for pth4-expressing cells 
Having shown that pth4 gene is specifically expressed in the hypothalamus (Figure 2, 
Chapter 1), we generated independent zebrafish Tg lines containing eGFP reporter 
constructs including 1 kb (P1=1kb-pth4-Tol2-eGFP) or 2 kb (P2=2kb-pth4-Tol2-eGFP) 
fragments upstream of the pth4 translation start site. A search for eGFP signal in all P1 
and P2 Tg zebrafish lines and in situs to the pth4 transcript was performed carefully 
throughout the organism and showed that the eGFP expression patterns replicated the 
spatiotemporal pattern of endogenous pth4 transcript (Figure 1). At 1 dpf, the P2 line 
labeled 2 bilateral clusters of 4–6 neural bodies each as well as their axonal projections, 
which extended both to the anterior and posterior part of the brain from the lateral 
hypothalamus (Figures 1A, B). Double labeling experiments showed a robust 
colocalization of endogenous pth4 transcripts and eGFP signal (Figures 1C´–C´´). At 3 
dpf, the number of labeled neuronal bodies had increased up to 14 per cluster, and long 
neural projections labeled by eGFP extended ventrally from the caudal part of the 
diencephalon through the midbrain and hindbrain and along the spinal cord (Figures 1D, 
E). Posterior projections were arranged in two parallel axes showing long-range neuronal 
fibers running through the spinal cord (Figure 1F). At 5 dpf, the number of neural cell 
bodies did not appear to have changed, but projections formed a complex and branched 
neural network (Figure 1G). One-year-old adult fish showed a high density of branched 
fibers around the cluster of neurons in the dorsal area of the periventricular hypothalamus 
(Figure 1I) and throughout the spinal cord (Figure 1H). To further characterize the cluster 
of neural bodies expressing pth4 in the hypothalamus, we crossed the P2 line to a 
Hrct:tdTomato line (hypocretin gene (hrct), a marker of the lateral hypothalamus in 
zebrafish embryos (Figure 1J). Although both genes were expressed in the hypothalamic 
region, they were expressed in different neural cell types, revealing the presence of 
different neural subpopulations in this part of the hypothalamus. The discovery of this 
complex pth4-expressing neural network sending widespread projections from the 
hypothalamus throughout the brain and spinal cord suggests that Pth4 is a neuropeptide 
playing a systemic role throughout the entire animal. 
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Figure 1. Whole-mount confocal imaging of the stable Tg(pth4:eGFP)iim07 zebrafish line. (A-G) Pth4 
cells and projections at 1 (A, B), 2 (C-C´´), 3 (D-F), and 5 dpf (G) monitored as eGFP fluorescence. Double 
labeling of eGFP immunofluorescence and fluorescence pth4 ISH (FISH) on 2 dpf Tg(pth4: eGFP)iim07 
zebrafish line (C-C´´) demonstrates identical expression of eGFP (green color) and endogenous pth4 
transcripts (red color). Confocal imaging of 25 μm cross-sections from adult fish, showing the Pth4 
anterior-posterior caudal projections in the spinal cord (H) and Pth4 bilateral clusters in the periventricular 
hypothalamic area (I). (J) Double Pth4:eGFP and Hrct:tdTomato zebrafish line showing the specific spatial 
colocalization of Pth4 and Hrct neural clusters in the lateral hypothalamus at 5 dpf. Abbreviations: e, eye; 
hd, dorsal hypothalamus; hv, ventral zone of periventricular hypothalamus; hy, hypothalamus; m, midbrain; 
SC, spinal cord; TPp, periventricular nucleus of posterior tuberculum; VC, vertebra centra. Scale bars: 100 
μm (A-C, F-I); 50 μm (D, E, J). 
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4.2 Functional characterization of pth4 promoter and upstream runx regulation 
The minimal regulatory region required for pth4 promoter activity was identified by 
generating serial deletions of the 2 kb promoter sequence upstream of the pth4 ATG start 
site and directed mutagenesis of the 1 kb promoter sequence upstream of the ATG start 
site (Figure 2A). Injection of the 2kb-pth4-Tol2-eGFP (n=174) or 1kb-pth4-Tol2-eGFP 
(n=208) reporter constructs showed the same efficient eGFP expression, suggesting that 
essential regulatory elements of pth4 were located in the first 1 kb sequence. Promoter 
efficiency in all reporter constructs injected was normalized to the 2kb-pth4-Tol2-eGFP 
construct activity. Deletion of the region 941-554 bp did not alter the pth4 pattern 
replicated by eGFP expression, but decreased the efficiency of expression to 43%. 
Deletion of the region 554-262 bp, however, resulted in a complete loss of eGFP 
expression in all of 144 injected embryos, demonstrating that this critical 292 bp fragment 
contained regulatory elements essential for pth4 expression. TRANSFAC sequence 
analysis revealed the presence of at least six potential transcription factor binding boxes 
within this critical 292 bp (Figure 2B). Mutations designed to disrupt consensus-binding 
sequences of the predicted transcription factors (Figure 2B) significantly affected eGFP 
expression in all injected embryos. Mutations in boxes 1 and 4 decreased the number of 
embryos expressing eGFP by 50%, similar to the 941-554 deletion (Figure 2A). 
Mutations in boxes 2, 3, and 5 decreased the efficiency of expression by 77% or more of 
the injected embryos. Mutation in box 6 resulted in a complete loss of eGFP expression in 
all injected embryos. This mutated conserved region had homology to the core binding 
site for RUNX transcription factors (i.e., RUNX2/RUNX3). Thus, these results suggested 
that RUNX transcription factors most likely act as key regulators of pth4 promoter 
activity.  
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Figure 2. Functional analysis of the pth4 promoter. (A) DNA fragments containing 2 kb and 1 kb sequences 
upstream from the ATG of pth4 are in gray. Vertical lines mark increments of the functional 2kb-pth4 
promoter deleted. Filled circles: conserved regions selected for mutations. Box 1, positions -413-419 
(TFBSs): CREB/HRE/ATF6); box 2, -339-345 (TFBS:HMX2/LXRE); box 3, -303-308 (TFBS: 
HOXA5/BRN5/LHX6/VAX2/ISL1); box 4, -235-244 (TFBS: 
AP1/NFE2/MEIS1/PBX1_MEIS1/VDR_RXR); Box 5, -227-229 (TFBS: VMAF/CREB/MARE); and box 
6, -424-428 (TFBS: RUNX2/RUNX3). Arrow and hatched section: the start of transcription and 5´UTR, 
with eGFP coding sequences substituting at the native translation start site. Promoter activity was assessed 
as the proportion of embryos displaying one or more fluorescent Pth4 cells at 3 dpf and normalized to the 
wild-type 2kb-pth4 promoter results. (B) Nucleotide sequence of the zebrafish pth4 gene showing the 
distribution in the promoter region of targeted transcription-factor binding boxes for site-directed 
mutagenesis. Nucleotides are shown in uppercase letters and numbered on the left of the sequence. The 
transcription start site (TSS) is denoted by (+1) and the coding region, in italics, shows the ATG start site 
denoted by (+95). TFBSs of interest in white box and mutated nucleotides in red. The TATA box is marked 
by black overhead lines. 
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4.3 In vivo promoter activity of pth4 is modulated by Runx2a, but not by an 
interaction with Runx2bT1 or Runx3 trans-acting factors 
The in silico survey of the zebrafish pth4 promoter sequence along with deletions and 
site-directed mutations revealed a core binding site to RUNX2/RUNX3 trans-acting 
factors as critical for pth4 promoter activity. Then, to test whether zebrafish Runx2 and/or 
Runx3 transcriptionally regulates in vivo the pth4 promoter, we used runx-specific 
antisense morpholino-knockdown approach and tested for 2kb-pth4-Tol2-eGFP activity. 
We injected the previously characterized morpholino-antisense oligonucleotides targeting 
runx2a, runx2bT1, runx2bT2 and runx3 (Flores et al., 2006; Kalev-Zylinska et al., 2003) 
in Tg(pth4:eGFP)iim07 embryos. Knockdown by injecting runx2a-MO into the P2 
reporter transgenic line revealed that the formation of the two clusters of neuronal eGFP 
positive cell bodies was significantly altered compared with controls at 2 dpf (Figures 3A-
F). The 6.3% (7/111) of injected embryos did not show any eGFP positive cell, 41.4% 
(46/111) showed absence of eGFP in one of the neural clusters and in the other cluster the 
eGFP expression was severely reduced (in most cases only 1 eGFP positive cell) and the 
52.3% (58/111) showed two clusters but with a reduced number of positive cells. To 
provide further evidence that the runx2a morphant phenotypes are specific and not related 
to nonspecific off target effects (e.g., p53 mediated apoptosis (Robu et al., 2007)), we also 
analyzed eGFP expression in vivo in runx2a morphants that were coinjected with a p53 
morpholino (Figures 3G-I). Similar to previous experiments, the two eGFP positive 
clusters of neurons were severely affected suggesting that our phenotype was not caused 
by nonspecific off target effect. We found a total absence of eGFP positive cells 
(8/95=8.4%), absence of eGFP expression in one neuronal cluster (37/95=38.9%) and 
reduced expression of eGFP in the two clusters (50/95=52.6%). Animals injected with 
p53-MO alone have a normal phenotype (Figure 3C).  
We also injected runx2bT1-MO (Figure 3J) and runx2bT1-MO along with p53-MO 
(Figure 3K) but we did not find significant phenotypic alterations in the eGFP expression 
compared with 2 dpf control embryos (Figures 3A, B). However, to test whether 
runx2bT1 could interact with runx2a in the transcriptional regulation of the pth4 promoter 
activity, we coinjected each morpholino targeting runx2a and runx2bT1 at half dose 
(0.5pmol). Combined injection resulted in morphants with a reduced eGFP expression in 
the two clusters of pth4 positive cells (Figure 3L), similar to those treated only with the 
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runx2a-MO (Figure 3D), suggesting that this phenotype could be due to 0.5pmol dose of 
runx2a-MO.  
 
Figure 3. Knockdown of runx2a, runx2bT1 and runx3 transcriptional factors in Tg(pth4:eGFP)iim07 
embryos at 2 dpf. (A, B, C) Uninjected, control-MO and p53-MO injected embryos. (D-F) Different 
phenotypes found  indicated as % of runx2a morphants or (G-I) runx2a and p53 double morphants,  
displaying two clusters of a reduced number of eGFP positive cells (D, G), absence of one positive cluster 
(E, H) or total absence of two clusters of GFP positive cell bodies (F, I).  (J, K, L) runx2bT1-MO, 
runx2bT1-MO/p53-MO and runx2bT1-MO/runx2a-MO injected embryos, (M, N, O) runx3-MO, runx3-
MO/p53-MO and runx3-MO/runx2a-MO injected embryos. Ventral view. Scale bars: 100 μm.  
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To examine whether runx2bT2 isoform could affect pth4 promoter activity, we 
injected runx2bT2-MO to Tg(pth4:eGFP)iim07 embryos. At 2 dpf, MO-injected embryos 
showed severe axis defects that caused an alteration in the normal body and head 
development. Therefore, we could not properly assess Runx2bT2 transcription factor 
activity in the reporter gene assays. 
The injection of runx3-MO resulted in an abnormal head and body shape at 2 dpf, 
including the decrease of eGFP expression in the two hypothalamic neuronal clusters 
(Figure 3M). Coinjection of runx3-MO and p53-MO results in 
a complete recovery of normal phenotype (Figure 3N), which indicates that runx3 
morphant phenotype is probably mediated by p53-dependent apoptosis. When we reduced 
the runx3-MO concentration to 0.5pmol, we did not find any phenotypic abnormality in 
injected embryos, but also no differences in the eGFP positive cells were found compared 
with control embryos. In addition, we coinjected 0.5pmol of both runx3-MO and runx2a-
MO to ensure that there is no a possible interaction between these two Runx factors in the 
pth4 promoter regulation. Similar to runx2a-MO injected embryos (Figure 3D), 
runx2a/runx3 double morphants exhibited a reduced eGFP expression in the two pth4 
neuronal clusters (Figure 3O) supporting the effect of runx2a-MO on the promoter 
activity of pth4 gene. 
 
4.4 Runx2a-001 is a trans-acting factor that regulate pth4 gene expression 
Morpholino knockdown results revealed that the decrease of runx2a expression 
affected the 2kb-pth4-Tol2-eGFP promoter activity in Tg(pth4:eGFP)iim07 embryos. To 
further examine the hypothesis that runx2a is a trans-acting factors that regulates pth4 
gene expression, we also analyzed the pth4 transcript expression level by whole mount in 
situ hybridization (Figures 4A-H) and real-time qPCR (Figure 5) in runx2a morphant and 
control embryos. Our results showed a significant reduction of pth4 expression levels in 
runx2a morphants (Figures 4C-F). Embryos coinjected with runx2a-MO and p53-MO 
(Figures 4E, F) showed also a significant reduction of pth4 gene expression level. 
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Figure 4. Knockdown of runx2a affects pth4 gene expression in Tg(pth4:eGFP)iim07embryos at 2 dpf. 
Whole mount in situ hybridization using pth4 riboprobe on uninjected and control-MO embryos (A, B);  
runx2a morphants (C, D); runx2a and p53 double morphants (E, F); runx2a-MO plus synthetic runx2a-001 
mRNA (30ng/μl) (G) or (75ng/μl) (H) injected embryos. Ventral view. Scale bars: 100 μm.  
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To further verify the specificity of the observed runx2a knockdown phenotype, we 
rescued runx2a-MO injected embryos by coinjecting synthetic runx2a-001 mRNA. 
Nearly complete rescue was achieved (Figures G, H). Therefore, the expression of pth4 in 
the two clusters of neurons was recovered after coinjection (0.5mM runx2a-MO plus 75 
ng/ul runx2a-001 mRNA) in the 91% (96/106) of the microinjected embryos (Figure H). 
 The penetrance and severity of the phenotype was dose dependent, not complete rescue 
was achieve when using 30 ng/ul runx2a-001 mRNA (Figure 4G). Therefore, our results 
indicate that exogenous runx2a-001 mRNA is capable to recover pth4 gene expression in 
the two clusters of neural bodies produced due to the runx2a knockdown, which suggest 
that Runx2a-001, expressed early during zebrafish development, is an upstream activator 
of pth4 transcription. 
Additionally, we selected runx2a-MO and runx2a-MO/p53-MO injected embryos 
showing one reduced cluster of eGFP positive cells in order to quantitatively analyze the 
pth4 gene expression. According to the real-time qPCR results, pth4 transcript levels were 
significantly decreased in morphant embryos (Figure 5).  
 
 
 
Figure 5. Real-time qPCR analysis of pth4 expression in control (white bars), runx2a-MO-injected (black 
bars), and runx2a-MO and p53-MO coinjected (gray bars) Tg(pth4:eGFP)iim07 embryos at 2 dpf. Results 
normalized to eef1a1/1 are expressed as mean ± SEM of two independent experiments. **p<0.025, 
***p<0.01.  
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5. Discussion  
In this chapter, we took advantage of combining reporter transient and transgenic 
zebrafish lines, promoter bashing experiments and morpholino knockdown studies to 
understand the transcriptional regulation of pth4 gene. We described the generation of 
eGFP reporter transgenic lines and reported the in vivo functional analysis of pth4 
promoter, where Runx2a was identified as a trans-acting factor required for normal pth4 
gene expression. 
Stable Tg(pth4:eGFP)iim07 reporter zebrafish transgenic line expressing eGFP under 
the pth4 promoter showed two clusters of neurons in the lateral hypothalamus of larvae 
and periventricular hypothalamus of adult fish. Transgenic reporter lines expressing eGFP 
and RFP under the pth4 and hrct promoters, respectively, identified two distinct 
subpopulations of neuronal cell bodies in the lateral hypothalamus. The Pth4:eGFP 
reporter line also mapped a pth4-positive complex network of long axonal projections 
from the hypothalamic region to the brainstem and spinal cord. Thus, eGFP expression 
pattern in transgenic reporter lines mirrors that of the endogenous pth4 gene in zebrafish. 
Promoter dissection identified a region of 554–262 bp that is critical for pth4 
expression. Results of TRANSFAC sequence prediction, promoter region deletions and 
directed mutagenesis uncovered six potential regulatory elements driving pth4 gene 
expression. Particularly, Runx-factor binding sites (RUNX2/RUNX3) appeared to be 
critical for pth4 gene expression. In vertebrates, RUNX family of paralogs (i.e., RUNX1, 
RUNX2 and RUNX3) are known DNA-binding transcriptional factors of a myriad genes 
involved in cellular proliferation and differentiation during skeletogenesis but also in 
neurogenesis and hematopoiesis (Coffman, 2003; Sullivan et al., 2008). Here, the loss of 
Runx2a activity abrogated both pth4 gene expression and the activity of the Pth4:eGFP 
reporter line, demonstrating that pth4 is downstream of runx2a. Whole mount in situ 
hybridization of runx2a-MO injected embryos and quantitative analysis of pth4 transcript 
in runx2a morphants showed a significantly decreased pth4 gene expression. Despite a 
redundant and/or cooperative function among Runx members has been described (Flores 
et al., 2006; Li et al., 2009; Yoshida et al., 2004), we did not find any crucial interaction 
among runx2a, runx2bT1 and runx3 paralogs modulating the pth4 promoter activity, as 
shown by morpholino knockdown analysis. However, it was not possible to conduct a 
similar knockdown study for runx2bT2 because of the strongly dorsalized phenotype of 
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the MO-injected embryos, which is characteristically produced by the loss of ventral gene 
expression during early development (Flores et al., 2008). Therefore, we cannot exclude 
the possibility that runx2bT2 interacts with runx2a upstream of pth4 gene expression. 
RUNX2 is a multifunctional transcription factor involved in bone development and 
mineralization by regulating numerous genes of chondrogenic/osteogenic signaling 
pathways. In murine osteoblasts, Runx2 was reported to directly promote the transcription 
of matrix gla protein (Mgp) in response to PTH treatment (Suttamanatwong et al., 2009) 
but also, it was showed to regulate the transcription of the xenopus Mgp gene to enhance 
or inhibit bone mineralization (Fazenda et al., 2010). The promoters of type X collagen 
gene (Col10a1) and osterix (Sp7) were reported to be downstream of Runx2 in murine 
chondrocytes (Nishio et al., 2006; Zheng et al., 2003). In zebrafish, two Runx2 isoforms 
were showed to activate the col10a1 distal promoter in cartilage and bone cells (Simões et 
al., 2006). Although Runx2 has been mainly reported to act as a transcriptional regulatory 
factor in skeletal cells, other studies have shown Runx2 expression in non-skeletal tissue 
such as pituitary and brain, suggesting a regulatory function in numerous body tissues 
(Jeong et al., 2008; Reale et al., 2013). In our study, runx2a-MO significantly reduced the 
pth4 transcript number in hypothalamic neurons of runx2a morphant embryos. We 
rescued the pth4 transcript levels by coinjecting runx2a-001 mRNA, providing evidence 
that the knockdown phenotype is due specifically to impairment of Runx2a-001 function.  
In summary, our findings show that zebrafish pth4 is expressed by a specific 
population of hypothalamic neurons, which form a complex neural network from the 
brain extending throughout the fish body. By using complementary techniques we 
provided evidence that Runx2a is a trans-acting factor required for normal pth4 gene 
expression.
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1. Abstract 
Remodeling of skeletal tissues is required for development, growth, mechanical 
adaptation, repair and mineral homeostasis in vertebrates. Parathyroid hormone (PTH) 
and parathyroid hormone like hormone (PTHLH) are the key PTH family members 
involved in bone turnover and mineral homeostasis in mammals; nevertheless, to date 
there is no evidence that fish Pth peptides participate in mineral homeostasis through bone 
remodeling. In this Chapter, we investigated the role of the most recent member identified 
of the PTH family, Pth4, on bone mineral homeostasis. Gain-of-function analysis of pth4 
by overexpression assays using transposon-mediated genome manipulation indicated that 
pth4 is a regulator of exo (dermal) skeleton and endoskeleton mineral density. 
Overexpression of pth4 can alter whole-body calcium/phosphorus levels and affects 
expression of genes involved in phosphate homeostasis. Moreover, we show that Pth4 can 
activate cAMP signaling mediated by Pth receptors.   
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2. Introduction 
Bone is a highly specialized vertebrate tissue that functions as a supporting structure 
characterized by its resistance, stiffness, and high capacity for regeneration and repair. To 
achieve these characteristics, bones are first shaped during early life and then constantly 
remodeled throughout adulthood. Thus, bone remodeling is a lifelong process that not 
only preserves the structural integrity of the skeleton but also maintains the mineral 
homeostasis throughout life (Raggatt and Partridge, 2010; Sims and Gooi, 2008). 
In tetrapods, parathyroid hormone (PTH) is synthesized by the parathyroid glands 
(PTGs) and plays a pivotal role in bone turnover by regulating the metabolism of calcium 
and phosphate (Bergwitz and Jüppner, 2010; Mundy and Guise, 1999; Potts, 2005). In 
response to low blood calcium or high phosphate levels, PTH is secreted by PTGs and, as 
an endocrine factor, directly acts on bone and kidney through parathyroid hormone type I 
receptor (PTH1R). In kidney, PTH reduces the calcium excretion in the distal tubule and 
blocks the phosphate reabsorption in the proximal tubule. Moreover, PTH induces the 
synthesis of vitamin D (1,25(OH)2D) which, in turn, increases intestinal calcium and 
phosphate absorption. In bone, PTH increases the expression of the master 
osteoclastogenesis cytokines (i.e., RANKL, CSF and OPG) in osteoblasts, to control the 
osteoclast development and, therefore, bone resorption (Kini and Nandeesh, 2012; 
Raggatt and Partridge, 2010). However, the PTH actions on bone are not trivial and 
involve an intricate dual effect in mammals. From a pharmacological perspective, 
continuous administration of the hormone induces bone resorption by activating 
osteoclasts indirectly through their actions on osteoblastic cells. On the other hand, 
intermittent administration of PTH results in new bone mineral formation via osteoblasts, 
although the precise mechanisms involved remain elusive (Datta and Abou-Samra, 2009; 
Esbrit and Alcaraz, 2013; Silva et al., 2011). Due to the prominent anabolic action that 
PTH exerts in bone, recombinant PTH(1-34) peptide or intact PTH(1-84) are currently the 
only approved anabolic agents for the treatment of osteoporosis in humans (Cosman et al., 
2017; Moen and Scott, 2006; Silverman and Nasser, 2011). On the other hand, 
parathyroid hormone like hormone (PTHLH) participates in bone formation in normal 
physiological conditions (Kronenberg, 2006), but also it has been shown to mimic the 
anabolic and catabolic PTH effects on bone via PTH1R which suggested a role in bone 
remodeling (Miao et al., 2005). 
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Fish have homologs of PTH and PTH-like peptides (i.e., Ptha, Pthb, Pthlha, Pthlhb 
and Pth4), but, in contrast to tetrapods, none of these fish Pth peptides were reported to 
regulate calcium and phosphate metabolism during bone turnover. Pthlh co-othologs have 
traditionally been considered the main hypercalcemic hormones in fish which participate 
in the calcium uptake from waters (Canario et al., 2006; Guerreiro et al., 2001) as well as 
calcium mobilization from scales by stimulating in vitro the osteoclast activity (Canario et 
al., 2006; Rotllant et al., 2006). Teleost Ptha and Pthb have also been reported to enhance 
the calcium influx and ionic mobilization from scales, but their roles are poorly defined 
and, eventually, they appear to be contradictory on the literature (Canario et al., 2006; 
Kwong and Perry, 2015; Lin et al., 2014; Suzuki et al., 2011). Furthermore, the most 
recent identified member of PTH family, Pth4, was initially reported to act as a 
calciotropic factor through in vitro scale assays (Canario et al., 2006). Nevertheless, apart 
from this preliminary analysis, subsequent functional studies have not been carried out in 
teleosts and the Pth4 action on endoskeleton for mineral homeostasis maintenance is 
currently unknown. 
In the present work, we have taken a reverse genetic approach to elucidate the 
potential function in bone mineral metabolism of Pth4 in zebrafish. We first generated a 
pth4 overexpression transgenic zebrafish line and gain-of-function analysis provided 
functional evidence that Pth4 is a powerful regulator of bone mineral accrual probably by 
acting through phosphate homeostasis. Transgenic fish showed a disturbance in the 
expression of phosphate homeostasis markers as well as bone mineralization-related 
factors. Additionally, we examined the ability of interaction of Pth4 with three Pth 
receptors which contributes for the understanding of physiological action mode in mineral 
homeostasis-related tissues. Taken together, our results suggest a new brain to bone 
signaling pathway involving Pth4 from the hypothalamus to receptors on bone. 
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3. Materials and methods 
3.1 Zebrafish 
Fish (Zebrafish, Danio rerio) were cultured as previously described (Westerfield, 
2007) and staged by hours post fertilization (hpf) or days post fertilization (dpf)  
following standard criteria (Kimmel et al., 1995). Experiments were performed with a 
TU-WT strain (Tuebingen (TU), Nüsslein-Volhard Lab). Ethical approval (Ref: 
AGL2014-52473R) for all studies was obtained from the Institutional Animal Care and 
Use Committee of the IIM-CSIC Institute in accordance with the National Advisory 
Committee for Laboratory Animal Research Guidelines licensed by the Spanish Authority 
(RD53/2013) and conformed to European animal directive (2010/63/UE) for the 
protection of experimental animals. 
 
3.2 Transgene construction and microinjection 
To ectopically express pth4, three independent transgenic (Tg) zebrafish lines were 
generated with the Tol2 transposon system: Tg(Xla.Eef1a1:pth4)iim010, 
Tg(Xla.Eef1a1:pth4)iim011, and Tg(Xla.Eef1a1:pth4)iim012. The Tol2 vector was kindly 
provided by Koichi Kawakami, National Institute of Genetics, Mishimi, Japan 
(Kawakami, 2007). The pth4 PCR product was subcloned into pGEM-T easy vector 
(Promega) with BamHI and NotI restriction sites. pGEM-T-pth4 was digested with 
BamHI and NotI and subcloned into pT2AL200R150G cut with the same restriction 
enzymes. The Tol2-transposon-based vector pT2AL200R150G contained an eGFP gene 
under the control of the constitutive promoter of the elongation factor 1-α (Eef1a1). We 
replaced the eGFP gene with the pth4 gene. The resulting clones were tested through 
restriction analysis and confirmed by sequencing. Tol2 constructs were dissolved in 
distilled nuclease-free water to a final concentration of 50 μg/ml. A total of 250 pg of 
construct and synthetic 5´-capped mRNA (150 pg) encoding a transposase were 
coinjected into TU-WT embryos at the 1- or 2-cell stage, with 1% of phenol red as a 
tracer. Microinjection was performed under a dissection microscope (MZ8, Leica) fitted 
with aMPPI-2 pressure injector (ASI Systems). 
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3.3 Micro-CT scanning and whole-body mineral contents 
Volumetric bone mineral density (vBMD) and whole-body calcium, phosphorus, and 
magnesium were determined in TU-WT and Tg(Xla.Eef1a1:pth4)iim010 adult male 
zebrafish (n=20). Fish were euthanized with 2-phenoxyethanol (1:500), fixed in 2%PFA, 
and scanned with a high-resolution micro-CT SkyScan 1172 (micro-CT NV; Bruker, 
Kontich, Belgium) at 60 KV X-ray source voltage and 167 μA source current with an 
image pixel size of 5 μm. Internal structures were reconstructed according to the 
Feldkamp convolution back-projection algorithm (Feldkamp et al., 1984). In the scanned 
area, including a portion of the head and the rostral portion of the spine, four different 
volumes of interest (VOIs) were selected to determine the vBMD, using standard 
software provided with the equipment (SkyScan CT-Analyzer 1.10.0.2; Bruker). The 
VOIs selected were: VOI1, from end lapilli otoliths to end of sagittal otoliths; VOI2, from 
end sagittal otoliths to five vertebrae (included pectoral fins and scales); VOI3, end 
sagittal otoliths to five vertebrae but including only a cylinder (diameter of 1 mm) with 
the center in the middle of the vertebral bodies; and VOI4,  VOI1 plus VOI2. vBMDs 
were calculated by direct calibration against the attenuation coefficients of two 
hydroxyapatite phantoms with known densities (250 and 750 mg/cm
3
).  
For whole-body calcium, phosphorus, and magnesium determination, fish were 
freeze dried until dry (dry weight) and dissolved in concentrated nitric acid (70%; 3 ml/g 
dry weight; Sigma-Aldrich). Nitric acid sample digestion were diluted 500 fold with 
demineralized water and analyzed for calcium, phosphorus and magnesium using 
inductively coupled plasma optical emission spectrophotometry (4300DV, Optima; 
Perkin Elmer). Mineral content was expressed in milligrams per gram dry weight, based 
on the fish dry weight and the total sample digestion volume. 
 
3.4 RNA isolation, real-time quantitative PCR and RT-PCR 
Total RNA from TU-WT and Tg(Xla.Eef1a1:pth4)iim010 adult male zebrafish (n = 6 
per group) and from adult tissues using Trizol reagent (Thermo Fisher Scientific) and 
first-strand cDNA was synthesized according to the Maxima First Strand cDNA Synthesis 
Kit (Thermo Fisher Scientific) protocol starting with 300 ng of total RNA. Each sample 
was amplified in triplicate containing 12.5 μl of Maxima SYBR Green/ROX qPCR 
Master Mix (2X) (Thermo Fisher Scientific), 0.5 μl 0.2 μM of each primer, 10.5 μl 
nuclease-free water, and 1 μl cDNA template. Real-time quantitative (q)PCR reactions 
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were analyzed on a 7500 Fast Real-Time PCR System (Thermo Fisher Scientific) with the 
following cycling conditions: initial denaturation at 95°C for 10 min, followed by 40 
cycles at 95°C for 15 s and 60°C for 1min. Gene markers of phosphocalcic metabolism 
were assessed in two independent experiments (primers sets used are listed in table 1) 
using the efficiency calibrated method (Pfaffl, 2001), and relative mRNA expression 
levels were normalized to 18S. Gene expression of pth1ra was assessed by RT-PCR and 
eef1a1/1 cDNA was amplified as a positive control (primers in table 2). 
Table 1. Primer sequences used for real-time qPCR gene expression analysis. 
Gene Forward primer sequence (5´-3´) Reverse primer sequence (5´-3´) 
pth4 GTCTGAAGCGTCTGATCTGG ACCGGTTTCTCCGGTTCTCCGAG 
fgf23 ATGCTGCATTCATCCGTCCT GATGTATCTCCGCGGGTTCC 
phospho1 TGAAAACAGGAGCAGCTGTAAA GGGGCTGGAGATCTGCTT 
phex CCGTCATCACGGTATCACAA TCTGAGCCATGGGTAAATCC 
entpd5 ATATGCCTGAAAAGGGTGGA TACTTCTTTGACCTCATTCAGCAG 
npt2a CAACACAGATTTCCCGTATCC GCGGGCAGCTTCTCTTTG 
npt2b CGCCATCATTGTCAACATTC ACTTGCAGCAACAGCAACAG 
stc1l GAGGACACAGTGGAGGTGGT GAAGCCGGTTTGACTCTCAG 
18s TCGCTAGTTGGCATCGTTTATG CGGAGGTTCGAAGACGATCA 
 
3.5 cAMP based β-galactosidase reporter gene assay 
To demonstrate whether Pth4 was able to bind and signal through Pth receptors, we 
performed cyclic adenosine monophosphate (cAMP)-based β-galactosidase reporter gene 
assays. We amplified the predicted region for the pth4 mature peptide and full coding 
regions of the pth1ra, pth2r (splice variant pth2r  (Rubin et al., 1999)) and pth1rb 
(previous names: pth1r, pth2r, and pth3r, respectively) from cDNA template by PCR 
using Pfu Ultra II HS DNA polymerase (Agilent Technologies) and specific primers 
(Table 2), and cloned the fragments into pSC-B-amp/kan (Agilent Technologies). Inserts 
were directionally subcloned into pcDNA3 (Thermo Fisher Scientific). All constructs 
were verified by sequencing both DNA strands.  
Signaling via cAMP was assessed using a human embryonic (HEK)-293 cell clone 
(Clon-Q) that stably expresses β-galactosidase under the control of human vasoactive 
intestinal peptide promoter placed downstream of tandem repetitions of cAMP response 
elements (Sánchez et al., 2009a). Cells were transfected with 1.5 μg for pcDNA3-pth4 or 
1 μg of pcDNA3-pth1ra, pcDNA3-pthr2, or pcDNA3-pth1rb, using Lipofectamine LIX 
and Plus Reagent according to the manufacturer’s protocol (Thermo Fisher Scientific). A 
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construct carrying the eGFP gene under the control of a cytomegalovirus constitutive 
promoter was also transfected to standardize transfection levels. After 24 h, transfection 
was assessed by analyzing the eGFP fluorescence and transfected cells with receptors 
were plated in 96-well plates (50,000 cells/ well). Cells expressing Pth4 mature peptides 
were rinsed with PBS and lysed by thermal shock; spin dried at 1100 relative centrifugal 
force (rcf) for 5 min at 22°C, and the supernatant collected. Recombinant cells expressing 
each receptor were stimulated for 6 h at 37°C with 100 ml of decreasing concentrations 
(1:2, 1:4, 1:8, 1:16, 1:32, 1:64, and 1:128 dilutions) of peptide solution from cellular 
lysates containing 0.1 mM of 3-isobutyl-1-methylxantine (IBMX, Sigma-Aldrich), a 
phosphodiesterase inhibitor that prevent enzymatic degradation of cAMP. As positive 
controls, we used 0.001mM forskolin and 10
-6 
M synthetic human (h) PTH (Sigma-
Aldrich) (Hoare et al., 2000b). Negative controls were performed using cells transfected 
with empty pcDNA3 vector (Thermo Fisher Scientific). All experiments were performed 
in triplicate. Data are presented as a percentage of negative control values.  
cAMP based β-galactosidase reporter gene assays were performed, as previously 
described (Chen et al., 1995; Sánchez et al., 2009b). After stimulation, the medium was 
removed and 50 µl of lysis buffer containing 250 mM Tris zHCl, pH 8 and 0.1% Triton 
X-100 were added. After one round of (-80°C) freezing and thawing, 10 µl of the lysate 
were preserved for protein assays. Forty µl of phosphate saline buffer containing 0.5% 
BSA and 60 µl of substrate buffer (1 mM MgCl2, 10 mM KCl, 5 mM β-mercaptoethanol 
and 200 mg/ml o-nitrophenyl-β-D-galactopyranoside, ONPG) were added to the 
remaining lysate volume. The plate was incubated at 37°C for 5 h and the absorbance was 
read at 405 nm in a 96-well plate reader (Tecan). Measurements were normalized for the 
protein content, determined using the BCA protein assay kit (Pierce).  
Table 2. Primer sequences used for RT-PCR amplification. 
Gene  Forward Primer Sequence (5´-3´)  Reverse Primer Sequence (5´-3´)  
pth4*  AAGCTTagtATGGCGGTCACAGAGCACCA  CTCGAGTTATTTCTCCGGTTCTCCGAG 
pth1ra  AGGATGGGAGCCACGCTGATCGTA TCACATGACGGTTTCTCTTTC 
Pth1rb  AGCATGGTGTCAGTGGAGGTCTCT TCAAAGCATCGTTTCTAGTTC 
pth2r  AGGATGCTGACGGTGTCATTATTG CTACAGAGTTTCCTCATCGTCCT 
eef1a1/1 CTTCTCAGGCTGACTGTGC CCGCTAGCATTACCCTCC 
(*) Region coding for predicted mature peptide. Primers design with Kozac sequence denoted in lowercase 
followed by the start codon ATG. 
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3.6 In situ hybridization 
For in situ hybridization of adult sections (360 dpf) zebrafish, samples were fixed in 
4% paraformaldehyde and 0.1 M phosphate buffer, for 2 days at 4°C, dehydrated and 
embedded in Paraplast (Sherwood, St Louis). Serial 10 μm rostro-caudal transverse 
sections were cut using a rotary microtome. Sections were mounted on 3-
aminopropyltriethoxylane (TESPA) treated slides, air-dried at room temperature (RT) 
overnight and stored at 4°C under dry conditions and used for hybridization. Images were 
captured with a Leica M165FC stereomicroscope. In situ hybridization was performed 
using digoxigenin-labeled antisense riboprobe for pth1ra. First, pth1ra coding sequence 
cloned into pcDNAI (Thermo Fisher Scientific) was linearized with EcoRI and 
transcribed using SP6 polymerase for synthesis of the riboprobe. 
 
3.7 Statistics 
Data were expressed as mean ± standard error of the mean (SEM). Differences 
between groups were assessed by Student’s-t test. A p-value <0.05 (asterisks) was 
considered statistically significant. Comparisons between numerical data were evaluated 
by 1-way ANOVA with the Tukey’s post hoc test. Data were deemed to be statistically 
similar if they shared at least 1 letter. Statistical analysis and figures were performed with 
PASW Statistics 18.0 and SigmaPlot 12.0, respectively. 
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4. Results 
4.1 Overexpression of  pth4 induces loss of vBMD and changes in whole-body 
mineral contents in Tg zebrafish 
To investigate the biological role of Pth4 in adult fish, we created a zebrafish Tg line 
ubiquitously expressing pth4 driven by the Eef1a1 promoter Tg(Xla.Eef1a1:pth4)iim010. 
The strong, widespread, and stable Tg Pth4 expression was assessed by real-time qPCR in 
adult zebrafish (Figure 1). Then, characterization of whole-body mineral contents (i.e., 
calcium, phosphorus, and magnesium) by spectrophotometry in adult male fish (n = 20) 
showed a significant decrease in minerals in pth4 Tg fish compared with control TU-WT 
(Figure 2).  
 
Figure 1. Real-time qPCR analysis of pth4 gene expression levels in TU-WT (white bars) and 
Tg(Xla.Eef1a1:pth4)iim010 (pth4-Tg) adult male zebrafish (black bars). Results normalized to 18s are 
expressed as mean ± SEM of two independent experiments, with ***p < 0.01. 
 
 
Figure 2. Whole-body calcium, phosphorus and magnesium analysis in TU-WT (control) and 
Tg(Xla.Eef1a1:pth4)iim010 (pth4-Tg) adult male zebrafish. Results are expressed as means ± SEM, with 
***p < 0.01. 
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Next, we wondered whether the decrease in whole-body mineral contents could be 
related to ion mobilization from bone. To test this hypothesis, we analyzed volumetric 
bone mineral density (vBMD) and found a significantly lower vBMD in all volumes of 
interest analyzed in pth4 Tg zebrafish (Figure 3). The vBMD was significantly decreased 
in bone volumes including only the endoskeleton (such as VOI3 formed by vertebral bone 
and VOI1 formed by craniofacial bones), but also in the VOI2 and 4 which include both 
endoskeleton and dermal bone (i.e., scales). We concluded, therefore, that Pth4 can 
mobilize minerals from bone to extracellular fluids and then the increase of mineral 
concentration at the extracellular level leads to its removal from the body, which affects 
calcium/phosphorus composition in the whole-body and skeletal structure. 
 
Figure 3. Representative images of three-dimensional (3D) reconstruction from micro-CT scans of adult 
male zebrafish; VOI1: end lapilli otoliths to end of sagittal otoliths; VOI2: end sagittal otoliths to five 
vertebrae (included pectoral fins and scales); VOI3: end sagittal otoliths to five vertebrae but includes only 
a cylinder (diameter of 1 mm) with the center in the middle of the vertebral bodies; and VOI4: VOI1+VOI2. 
vBMD (volumetric Bone Mineral Density) analysis in TU-WT (control) and Tg(Xla.Eef1a1:pth4)iim010 
(pth4-Tg) adult male zebrafish. a, anal fin; c, caudal fin; d, dorsal fin; pec, pectoral fin; pel, pelvic fin. 
Results are expressed as means ± SEM. *p <0.05, **p <0.025, ***p <0.01. 
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4.2 Phosphate homeostasis is disrupted in pth4 Tg zebrafish 
To investigate whether pth4-dependent changes in body calcium/phosphorus contents 
and in vBMD could be related to alterations in expression levels of genes involved in 
mineral homeostasis, we performed real-time qPCR to determine the levels of expression 
of several phosphocalcic metabolism regulatory genes in adult fish of both TU-WT and 
pth4-Tg lines (Figure 4). Results revealed that pth4-Tg fish had a significant (p<0.05) 
upregulation of the solute carrier family 34 (type II sodium/phosphate cotransporter) 
member 2a gene (slc34a2a = npt2b) but a significant (p <0.01) downregulation of a set of 
phosphate-regulating genes, including the endopeptidase on the X chromosome (phex), 
ectonucleoside triphosphate diphosphohydrolase 5 (entpd5), and solute carrier family34 
(type II sodium/phosphate cotransporter) member 1a (slc34a1a = npt2a). Notably, the 
downregulation of npt2a was accompanied by a significant (p <0.025) upregulation of 
fgf23, which has been described as a key regulator of phosphate homeostasis (Hori et al., 
2011). Finally, no significant differences were found on stanniocalcin-1-like (stc1l) gene 
expression levels.  
 
 
Figure 4. Real-time qPCR analysis of mineral homeostasis regulatory factors in TU-WT (white bars) and 
Tg(Xla.Eef1a1:pth4)iim010 (pth4-Tg) adult male zebrafish (black bars). mRNA expression levels of 
fibroblast growth factor 23 (fgf23), phosphatase orphan 1 (phospho1), phosphate-regulating gene with 
homologies to endopeptidase on the X chromosome (phex), (entpd5), solute carrier family 34 (type II 
sodium/phosphate cotransporter), member 1a (slc34a1a, npt2a), member 2a (slc34a2a, npt2b), and 
stanniocalcin-1-like (stc1l) were determined. Results normalized to 18S are expressed as means ± SEM of 
two independent experiments.*p <0.05, **p <0.025, ***p <0.01. 
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Overall, results of pth4-overexpression experiments revealed that pth4 not only had 
an important role affecting the expression of effector proteins responsible for bone 
metabolism through regulation of phosphate homeostasis (i.e., phex, phospho1 and 
entpd5) but also affected a regulatory pathway fgf23-npt2a and npt2b gene expression. 
 
4.3 Pth4 interacts with all three zebrafish Pth receptors 
Analysis of the zebrafish genome revealed the presence of three Pth receptors (i.e., 
Pth1ra ENSDARG00000020957, Pth1rb ENSDARG00000018418, and Pth2r 
ENSDARG00000006678) that can act downstream of Pth4. To determine whether a 
specific receptor mediates Pth4 signaling, we expressed zebrafish Pth receptors in HEK-
293 cells and performed a cAMP-based β-galactosidase reporter gene assay. All receptors 
showed similar basal induced cAMP production. Pth4 stimulation induced a dose–
response increase in cAMP production and no significant differences were detected with 
any of the three receptors transiently transfected (Figure 5A).  
 
Figure 5. Pth4 interaction with zebrafish Pth receptors. Effects of recombinant Pth4 mature peptide 
dilutions (A) and synthetic hPTH (B) on galactosidase activity in HEK-293 cells stably expressing cAMP-
responsive β-galactosidase reporter gene and transiently transfected with zebrafish pth1ra, pth1rb, and 
pth2r genes in the presence of a phosphodiesterase inhibitor, IBMX. Results represent the means ± SEM of 
two independent biological replicate experiments, each performed with three technical replicates. 
Measurements were normalized for protein content and expressed as a percentage of basal levels (HEK-293 
cells transfected with empty pcDNA3 vector). Values of p <0.05 (indicated by letters on bars) were 
considered statistically significant. Data are statistically similar if bars share at least 1 letter.  
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These results suggest that Pth4 signaling could be mediated promiscuously by all 
three Pth receptors. We also transfected cells with human Pth and found that all three 
zebrafish receptors increased cAMP production, with Pth1ra being activated the most 
efficiently and Pth2r the lowest, which is consistent with in vitro analysis published using 
human PTH and zebrafish receptors (Hoare et al., 2000b) (Figure 5B). It is interesting to 
note that zebrafish Pth4 activated Pth1ra with efficiency similar to that of human PTH, 
suggesting that human PTH and zebrafish Pth4 exert equivalent effects at the ligand-
receptor level.  
 
4.4 Specific pth1ra expression in mineral-regulating target tissues 
In humans, PTH peptides play crucial roles in bone homeostasis via PTH1R on 
osteoblasts (Gardella and Jüppner, 2001). Therefore, in addition to Pth4-Pthr signaling, 
we also analyzed the spatial expression of zebrafish pth1ra in adult zebrafish by in situ 
hybridization and RT-PCR. Expression of pth1ra was specifically found in gills (Figures 
6A, B); craniofacial bones, such as ceratobranchial and operculum (Figure 6A); intestinal 
epithelium (Figure 6C), and spinal cord (Figure 6D). Tissue distribution analyzed by RT-
PCR confirmed the pth1ra expression in gills and intestine (Figure 6E). We also found 
pth1ra transcripts in scales, vertebral bone and brain, apparently not detected by in situ 
hybridization analysis. However, we could not detect pth1ra gene expression in kidney 
(Figure 6E). 
These results are consistent with a Pth4-Pth1ra signaling pathway controlling bone 
mineral metabolism through the main target organs (i.e., gills, intestinal epithelium, and 
bone) that are known to promote ionic fluxes via absorption/reabsorption or mobilization.  
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Figure 6. In situ hybridization of adult zebrafish sections shows specific pth1ra gene expression in gills (A, 
B), craniofacial bones (A), intestine (C), and spinal cord (D). g, gills; op, opercular bone; cb, 
ceratobranchial bone; sc, spinal cord; pl, primary lamella; sl, secondary lamella; ie, intestinal epithelium. 
Scale bars: 400 μm (A); 50 μm (B); 200 μm (C); 100 μm (D). (E) Gene expression of pth1ra and positive 
control eef1a1/1 by RT-PCR in adult tissues. 
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5. Discussion  
In the current study, we took a gain-of-function approach to explore the role of Pth4 
in bone mineral homeostasis. For this purpose, we generated a transgenic zebrafish line 
overexpressing pth4 under the control of a constitutive promoter and investigated the 
biological responses to the stable and strong pth4 expression in adult fish. Our results 
revealed that an excess of this neuropeptide induces a significant reduction of whole body 
calcium/phosphorus levels and results in a significant loss of vBMD. A previous study 
concerning the Pth4 function in mineral metabolism was performed in fish. Similar to Pth 
and Pthlh peptides, Pth4 was reported to act as a hypercalcemic hormone by promoting 
the calcium influx from water as well as calcium mobilization from scales (Canario et al., 
2006) . In fact, due to its strong calciotropic action, it was hypothesized that Pth4 in fish 
could have a function equivalent to that of tetrapod PTH (Canario et al., 2006). Our 
findings show that overexpression of Pth4 in adult zebrafish produced a similar effect in 
bone resorption (including dermal skeleton and endoskeleton) to that produced in 
mammals under continuous PTH administration, where minerals are mobilized from bone 
matrix (Esbrit and Alcaraz, 2013; Silva et al., 2011). Although it is now clear that skeletal 
tissues also act as mineral reservoirs in fish, the extent of involvement of the endoskeleton 
in the calcium homeostasis has been matter of debate as fish has direct access to calcium 
from surrounding waters. On the contrary, phosphorus is the limiting factor in water and 
so a phosphate-driven bone remodeling has been proposed (Lall and Lewis-McCrea, 
2007; Witten and Huysseune, 2009).  
Our analysis of factors involved in the regulation of phosphate levels revealed that 
pth4 overexpression also induced a significant increase in fgf23 and npt2b levels and a 
decrease in npt2a, phospho1, phex and entpd5 expression levels. FGF23 is a key 
phosphaturic factor that acts in the bone-kidney axis in mammals and provides a signal 
from bone to adjust phosphate fluxes through NPT2a in kidney by promoting phosphate 
excretion or reabsorption (Hori et al., 2011; Martin et al., 2012). In addition, systemic 
phosphate levels are managed by NPT2b through active transport in the small intestine 
(Radanovic et al., 2005). In zebrafish, fgf23 is expressed in the Corpuscles of Stannius 
(CS, special endocrine organs in the fish kidney), to regulate ion homeostasis. Expression 
of npt2b in the intestine plays an important role in phosphate absorption (Graham et al., 
2003). Thus, the significant decrease in whole-body phosphorus content in transgenic fish 
could be related to upregulation of fgf23 and down-regulation of npt2a, which in turn 
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would produce phosphate excretion through the kidney. Such an effect may be 
counteracted by phosphate absorption via the intestine, consistent with high levels of 
npt2b. Further, in accordance with our results, recent studies have demonstrated that loss 
of function of phospho1, phex, or entpd5 in hypophosphatemic disorders led to a 
significant decrease in vBMD and abnormalities in mineralization (Christov and Jüppner, 
2013; Huitema et al., 2012; Yadav et al., 2011). One of our most striking results was that 
despite hypocalcemic conditions in transgenic fish, no differences were found in stc1l 
expression, contrary to the expected role in fish (Tseng et al., 2009). This result suggests 
that anti-hypercalcemic hormones other than stc1l (e.g., calcitonin) may act in teleosts to 
reduce calcium transport across epithelia as its mammalian counterpart (Khanal and 
Nemere, 2008). 
In mammals, the biological actions of PTH and PTHLH on bone are mediated via 
PTH1R, which activates 3´-5´cyclic-adenosine-monophosphate/protein kinase A 
(cAMP/PKA) cascade more robustly than phospholipase C/protein kinase C (PLC/PKC) 
pathway (Gardella and Jüppner, 2000). Here, we demonstrated that Pth4 can recognize 
the three zebrafish Pth receptors (i.e., Pth1ra, Pth1rb, and Pth2r) to activate cAMP/PKA 
signaling. Interestingly, this activation pattern of Pth4 appears to be similar to that of 
human PTH in all zebrafish receptors found by (Hoare et al., 2000b), which suggests 
structural similarity between zebrafish Pth4 and human PTH that might lead to a 
functional conservation of both peptides across vertebrates. With regard to the tissue 
distribution of the Pth receptors, in situ hybridization and RT-PCR analysis showed that 
pth1ra is expressed in the skeleton, including craniofacial and vertebral bones as well as 
scales. Furthermore, we detected pth1ra gene expression in the gills, intestinal epithelium, 
spinal cord and brain. In fish, previous analyses by RT-PCR also found pth1ra transcripts 
in the kidney (Guerreiro et al., 2010; Kwong and Perry, 2015) and expression of  pth2r in 
the central nervous system, kidney and scales (Bhattacharya et al., 2011; Rubin et al., 
1999; Suzuki et al., 2011). Gene expression of pth1rb was detected in the kidney, 
intestine, and vertebral bone (Anjos et al., 2013; Guerreiro et al., 2010; Rotllant et al., 
2006). The fact that Pth4 shows the same affinity for all three receptors in cell culture 
suggests that this neuropeptide not only acts on the skeleton, either directly or indirectly 
through the spinal cord, but also, has the potential to function in gills, intestine, kidney, 
all of which are involved in bone mineral homeostasis. On the other hand, the expression 
Chapter 3   
92 
 
of pth1ra and pth2r in brain and nervous system suggests that Pth4 signaling could also 
be important for neuronal function.  
In conclusion, this study shows a new role for zebrafish Pth4 in bone mineral 
homeostasis. Our findings suggest that Pth4, expressed by hypothalamic neurons, could 
participate in the maintenance of systemic phosphate homeostasis via control of bone 
mineral content in fish. However, we cannot exclude potential actions of Pth4 in gills 
intestine and kidney for absorption/reabsorption of phosphate through epithelia. We 
propose a new brain-to-bone pathway in zebrafish, but further studies will be necessary to 
identify the mechanism underlying the Pth4 signaling. 
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1. Abstract 
Skeletal development and mineralization are essential processes driven by the 
coordinated action of neural signals, circulating molecules and local factors. Our previous 
gain-of-function studies revealed that the novel neuropeptide Pth4, synthesized by 
hypothalamic cells, was involved in bone metabolism possibly via phosphate regulation 
in adult zebrafish. Here, we investigate the role of Pth4 and the Pth4 cells during skeletal 
development using single-cell resolution, two-photon laser ablation of Pth4:eGFP-
expressing cells and confocal imaging in vivo. Using the stable transgenic 
Tg(pth4:eGFP)iim07 zebrafish line, we identify Pth4:eGFP-expressing cells as post-
mitotic neurons. After targeted ablation of eGFP-expressing cells in the hypothalamus, 
the experimental larvae exhibited impaired mineralization of the craniofacial bones 
whereas cartilage development was normal. In addition to a decrease in pth4 transcript 
levels, we noted altered expression of phex and entpd5, genes associated with phosphate 
homeostasis and mineralization, as well as a delay in the expression of osteoblast 
differentiation markers such as sp7 and sparc. Taken together, these results suggest that 
Pth4-expressing hypothalamic neurons participate in the regulation of bone mineral 
metabolism during zebrafish development.  
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2. Introduction 
Recent studies have provided evidence suggesting that the central and peripheral 
nervous systems can directly control bone homeostasis. In this context, the hypothalamus 
has been recognized as a potent regulator of skeletogenesis through efferent neural signals 
via the sympathetic (SNS) and parasympathetic nervous systems (PSNS) (Bajayo et al., 
2012) and/or neuroendocrine factors. Secreted neural factors can be processed through the 
pituitary gland or directly released into the blood stream (Blair et al., 2008; Driessler and 
Baldock, 2010; Elefteriou, 2008; Quiros-Gonzalez and Yadav, 2014). Due to its ability to 
act as a sensor, the hypothalamus integrates physiological information from the whole 
body and sends inputs to bone cells that regulate bone homeostasis accordingly. The 
coordinated activities of the bone-forming cells (osteoblasts) and bone-resorbing cells 
(osteoclasts) modulate a response in bone tissue (Kular et al., 2012). Therefore, beyond 
the traditional view linked to endocrine, autocrine and paracrine modulators regulating 
skeletal development and remodeling, bone metabolism is also regulated by neural input.  
Mineralization is a key step in the formation of the bone, making it an important 
reservoir of calcium and phosphate that contributes to mineral balance via remodeling 
throughout the life span of vertebrates. Mature osteoblasts are responsible for bone matrix 
mineralization through the formation and accumulation of hydroxyapatite (HA) crystals. 
Thus, besides calcium, adequate phosphate levels are crucial for normal skeletal 
mineralization and healthy bone (Bonjour, 2011). At a systemic level, the parathyroid 
hormone (PTH) interacts with vitamin D and fibroblastic growth factor 23 (FGF23) in the 
bone-parathyroid-kidney axis to control the phosphate balance in mammals (Martin et al., 
2012; Razzaque, 2011). If minerals are required, PTH also causes resorption in bone 
directly through parathyroid hormone receptor type I (PTH1R) (Potts, 2005).  Another 
known regulator of phosphate is PHEX (phosphate regulating gene with homologies to 
endopeptidases on the X chromosome), which was identified as the gene mutated in X-
linked hypophosphatemic rickets (XLH) syndrome (Francis et al., 1995). Loss of PHEX 
function causes hypophosphatemia, mineralization defects of bone and teeth, and 
abnormal vitamin D metabolism (Rowe, 2004).  
In addition, phosphate homeostasis and mineralization are locally dependent on the 
concentration of the two phosphate inorganic forms in the bone environment. Elevated 
pyrophosphate levels block the ability of phosphate to mineralize along with calcium and 
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prevent HA formation (Sapir-Koren and Livshits, 2011; Terkeltaub, 2001). The interplay 
of different factors expressed by osteoblasts regulates the balance between phosphate and 
pyrophosphate, acting as enhancers or inhibitors for mineral deposition, respectively. 
Along those lines, PHOSPHO1 (phosphatase orphan 1) and ENTPD5 (ectonucleoside 
triphosphate/diphosphohydrolase) have been shown to play an important role in 
phosphorus homeostasis, a critical process for an optimal calcium–phosphate product for 
the mineralization of bone (Huitema et al., 2012; Yadav et al., 2011).  
Previously, we identified Parathyroid hormone 4 (Pth4), as a neuropeptide produced 
by two bilateral clusters of cells in the hypothalamus (Chapters 1 and 2). We showed that 
this peptide is involved in bone mass accrual possibly through phosphate homeostasis 
regulation in adult zebrafish (Chapter 3), which indicates a new functional link between 
brain and bone. To better understand Pth4 and its role during skeletal development, we 
have characterized Pth4:eGFP-expressing cells and performed single-cell resolution two-
photon laser ablation and confocal imaging in vivo. Here, we demonstrate that 
Pth4:eGFP-expressing cells are post-mitotic neurons and that targeted Pth4:eGFP-
expressing cell ablation results in abnormal bone mineralization as well as altered 
expression of osteoblast differentiation markers and genes associated with impaired 
mineralization. 
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3. Materials and methods 
3.1 Zebrafish 
Wild-type (AB) and transgenic zebrafish lines were maintained according to 
Institutional Animal Care and Use Committee of the California Institute of Technology. 
Embryos were grown as previously described (Kimmel et al., 1995) and staged 
(Westerfield, 2007). Embryo medium was supplemented with 0.003% (w/v) 1-phenyl-2-
thiourea (PTU) to prevent pigment formation. Transgenic lines used and their 
abbreviations are Tg(pth4:eGFP)iim07=Pth4:eGFP and Tg(bactin2:H2A-mCherry) = 
Bactin2:mCherry. 
 
3.2 Two photon laser ablation and confocal imaging 
Embryos were mounted in custom-designed embryo-shaped 1% agarose/30% 
Danieau molds to provide support while immersed in 2-3% methylcellulose/30% Danieau 
solution with standard working concentrations of tricaine anesthetic and PTU (to prevent 
pigmentation) added. Embryos were maintained at 28.5°C during imaging and laser 
ablation. 
Pth4:eGFP zebrafish were visualized throughout development. The hypothalamic 
area was imaged in vivo at 1, 2, 3 and 7 days post-fertilization (dpf). The two clusters of 
eGFP-expressing cells and the number of cells in each stage of development were 
evaluated by analyzing each 2µm thick z-plane slice from a full confocal z-stack 
projection and scored.  
For cell ablation experiments, Pth4:eGFP and Bactin2:mCherry adult fish were 
crossed and double positive embryos were selected for experiments. 
Pth4:eGFP+/Bactin2:mCherry+ embryos (n=26  per experimental group) were mounted 
into the mold ventral side down to allow ablation of two subsets of neural bodies. Using 
confocal imaging, eGFP-expressing Pth4 cells were detected and specifically selected for 
ablation based on red fluorescence from the ubiquitous nuclear marker. Targeted laser 
ablation was done with a two-photon laser at 770 nm for 10 cycles at 65% power on a 
Zeiss LSM 710 inverted confocal microscope with an LD C-Apochromat 40x/1.1 W Corr 
objective and Zen 2009 software’s ‘Regions’ tool for cell selection. Each step of the 
ablation process (before ablation, during ablation of selected cells, and after ablation) was 
captured as a single plane image, and full z-stacks were captured at the beginning and 
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immediately at the end for each experimental embryo. Imaged embryos were analyzed to 
determine degree of ablation and overall health of both targeted cells and surrounding 
untargeted cells. 
Two rounds of ablations were performed per experimental embryo at different time 
points (1 and 2 dpf). This protocol was chosen as the most efficient of several attempted 
iterations for a complete ablation process at each time point and to achieve low neuronal 
recovery during development. Afterwards, ablated and control larvae were captured as 
full z-stack images at 3 and 7 dpf to monitor recovery of the Pth4-expressing neurons. 
Images collected were analyzed using Imaris software (Bitplane) and exported as TIFF 
files.  
 
3.3 Immunohistochemistry 
Pth4:eGFP transgenic embryos at 1 and 2 dpf  were fixed with 4% PFA and washed 
in PBST. They were then washed in PBDT (1% BSA, 1% DMSO, 0.1% Triton X-100 in 
PBS, pH 7.4), blocked in 10% normal goat serum/PBDT, and incubated overnight at 4°C 
with primary antibodies to HuC/D (1/100; Invitrogen # A-21271) and GFP (1/400; 
Abcam # 6673). Further PBST washes and blocking were followed by secondary 
antibodies (Invitrogen) overnight at 4°C. Hoechst 34580 was added to stain nuclei 
(1:2500). After further PBDT and PBS washes, embryos were mounted for confocal 
imaging in custom-designed molds as described before. 
 
3.4 Real-time quantitative PCR 
After laser cell ablation, control and ablated 7dpf larvae were homogenized in Trizol 
for real-time quantitative (q)PCR analysis. Total RNA was isolated using Direct-zol RNA 
MiniPrep (Zymo Research) and 50 ng of RNA was reverse-transcribed according to the 
Maxima First Strand cDNA Synthesis Kit (Thermo Scientific) protocol. Experimental and 
control samples (n=6 per group) were amplified by triplicate containing 12.5 µl of 
Maxima® SYBR Green/ROX qPCR Master Mix (2X) (Thermo Scientific), 0.5 µl 0.2 µM 
of each primer, 10.5 µl nuclease-free water and 1 µl of cDNA template. Real-time qPCR 
reactions were analyzed on a 7500 Fast Real-Time PCR System (Applied Biosystems) 
with the following cycling conditions: initial denaturation at 95 °C for 10 min followed 
by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. Expression of phosphate metabolism 
genes and osteoblast differentiation markers was assessed in two independent 
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experiments using the efficiency calibrated method as previously described (Pfaffl, 2001). 
Relative mRNA expression levels were normalized to the housekeeping actin, beta 
1(actb1) gene. Primer sets used for each gene are listed in Table 1. 
 
Table 1. Primer sequences used for real-time qPCR gene expression analysis and PCR amplification. 
Gene Forward primer sequence (5´-3´) Reverse primer sequence (5´-3´) 
pth4 GTCTGAAGCGTCTGATCTGG CCGGTACAGGTCGCTGAG 
actb1 CGAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC 
fgf23 ATGCTGCATTCATCCGTCCT GATGTATCTCCGCGGGTTCC 
phospho1 TGAAAACAGGAGCAGCTGTAAA GGGGCTGGAGATCTGCTT 
phex CCGTCATCACGGTATCACAA TCTGAGCCATGGGTAAATCC 
entpd5 ATATGCCTGAAAAGGGTGGA TACTTCTTTGACCTCATTCAGCAG 
npt2a CAACACAGATTTCCCGTATCC GCGGGCAGCTTCTCTTTG 
npt2b CGCCATCATTGTCAACATTC ACTTGCAGCAACAGCAACAG 
sp7 GACATCCGGGATCCTGGATA TACCGTACACCTTCCCGCA 
runx2b CTTCAATGACCTGCGCTTTGT TCGGAGAGTCATCCAGCTTC 
sparc CCCTCTGCGTGCTCCTCTTA GCATCGCACTGCTCAAAGAA 
 
 
3.5 Skeletal staining and whole-mount in situ hybridization 
Ablated and control 7 dpf larvae were fixed in 2% PFA in 1X PBS for 1 h at room 
temperature and stored at 4°C. Alcian Blue/Alizarin Red staining to visualize respectively 
cartilage and bone were performed essentially as described (Walker and Kimmel, 2007). 
Samples were washed in 100 mM Tris pH 7.5/10 mM MgCl2 for 10 minutes, stained in 
0.04% Alcian blue/10 mM MgCl2/70% ethanol (EtOH) pH 7.5 for 1h and 30 minutes, 
taken through graded EtOH series (80% EtOH/100 mM Tris pH 7.5/10 mM MgCl2; 50% 
EtOH/100 mM Tris pH 7.5; 25% EtOH/100 mM Tris pH 7.5), washed twice in 25% 
glycerol/0.1% KOH for 10 minutes each, stained in 0.01% Alizarin red/25% glycerol/100 
mM Tris pH 7.5 for 1 h, and de-stained with two washes of 50% glycerol/0.1% KOH.  
For whole-mount in situ hybridization, 3dpf larvae were fixed in 4% PFA in 1X PBS 
overnight at 4°C and stored in 100% methanol. Whole mount in situ hybridization was 
performed as previously described (Rotllant et al., 2008) using digoxigenin-labeled 
antisense riboprobes for sp7, runx2b and dlx2b. First, sp7 cDNA fragment encoding 596 
pb was cloned into pGEM-T easy vector (Promega) using primers 5´-
GACATCCGGGATCCTGGATA-3´ and 5´-TTAAATCTCCAGCAGTCCACTG-3´. 
Linearized vector with NcoI were transcribed using SP6 polymerase for synthesis of the 
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riboprobe.  In adittion, the runx2b cDNA cloned into pcDNA3 vector and dlx2b cloned 
into pBSK vector were used as templates to generate the antisense RNA probes. 
 
3.6 Statistical analysis 
Student´s t-test was used when two samples were compared and data is presented as 
mean ± SEM, with signiﬁcance inferred from p values of 0.05 or less. Statistical analysis 
and figures were performed with PASW Statistics 18.0 and SigmaPlot 12.0, respectively.  
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4. Results 
4.1 Hypothalamic Pth4:eGFP-expressing cells are post-mitotic neurons 
Our previous work using the Pth4:eGFP transgenic reporter line showed the pth4 
promoter driving eGFP expression in two bilateral clusters of cells in the ventral part of 
the lateral hypothalamus. These cells project axons that extend to the anterior region of 
the brain as well as through the midbrain, hindbrain and spinal cord in two parallel 
bundles projecting caudodorsally along the body (Chapter 2).  
To perform a detailed analysis of the development of these neurons and the formation 
of connections, we used confocal imaging to observe the Pth4 expressing cells as a 
function of developmental time in Pth4:eGFP transgenic zebrafish (Figure 1).  
 
 
Figure 1. Stable transgenic Pth4:eGFP zebrafish line shows eGFP-expressing cells through development. 
Whole mount confocal imaging showing eGFP-expressing cells and axonal projections at 1, 3 and 7 dpf (A, 
B and C). Confocal z-stack projection showing two clusters of Pth4:eGFP-expressing cells on the lateral 
hypothalamus in a ventral view (D, E and F) or dorsal view (G). The total number of eGFP cells was 
measured by analyzing each 2µm thick z-plane slice from the full confocal z-stack projection in each stage 
of development: (D) 14±2 eGFP cells at 1dpf , (E) 22±2 eGFP cells at 2dpf, (F) 29±2 and (G) 33±1 eGFP 
cells at 3 and 7dpf, respectively). Note that the number of cells increases over time and axonal projections 
become more abundant and branched (B, G). Two groups of Pth4:eGFP-expressing cells move gradually 
from a caudo-ventral to a more rostro-dorsal position. Abbreviation: e, eye; hy, hypothalamus; m, midbrain; 
sc, spinal cord. Scale bars: 100 μm (A-C) 50 μm (D-G). 
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By 1 dpf, we found 13-16 eGFP-expressing cell bodies forming two separate and 
distinct groups in the lateral hypothalamic area and incipient neuronal projections 
extending to the anterior region of the brain (Figures 1A, D). From 2 dpf onwards, the 
two bilateral clusters of cells were closer together and moved to a rostral and slightly 
dorsal position (Figures 1E-G). The number of cells observed was 20-25 at 2 dpf (Figure 
1E), 27-30 at 3 dpf (Figures 1C, F), and 32-34 by 7 dpf (Figures 1B, G). Cell projections 
were visualized ventrally between the two groups of eGFP positive cells (Figures 1D-F). 
Over time, the number of neuronal projections progressively increased, and at 7 dpf, we 
observed a complex network of axonal fibers from a dorsal view (Figures 1B, G). 
In order to further characterize these eGFP-expressing cells, we performed 
immunostaining on Pth4:eGFP-positive embryos at 1 and 2 dpf using HuC/D antibody, a 
marker for young post-mitotic neurons (Kim et al., 1996). The results showed that eGFP 
expression co-localized with that of HuC/D in every cell from the two subsets, confirming 
that these eGFP-expressing cells are post-mitotic neurons (Figures 2A, B).  
 
 
Figure 2. Zebrafish Pth4:eGFP-expressing cells are post-mitotic neurons. Double immunostaining in 
Pth4:eGFP transgenic embryos using anti-eGFP antibody (A and B) and anti-HuC/D antibody (A´and B´) 
shows complete co-localization at 1 and 2 dpf (A´´ and B´´). Ventral views with anterior to the top. 
Pth4:eGFP: green; HuC/D: red; nuclear stain: blue. Abbreviation: e, eye. Scale bar: 50 μm. 
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4.2 Two-photon laser ablation of Pth4:eGFP+/Bactin2:H2A-mCherry+ neurons 
severely reduces pth4 gene expression in larvae 
We next performed two-photon laser ablation of Pth4:eGFP and Bactin2:H2A-
mCherry double-positive cells during early development in order to investigate whether 
the elimination of Pth4:eGFP-expressing neurons causes a down-regulation the pth4 gene 
expression and, consequently, result in skeletal abnormalities. First, the ablation process 
was performed at 1 dpf, and approximately 13-16 cells were eliminated per experimental 
embryo. Despite complete Pth4:eGFP-positive neuronal ablation, we observed that this 
early and single round of ablation at 1 dpf was followed by partial replenishment of 
Pth4:eGFP-expressing cells at 2 dpf, which increased over time until similar levels were 
found to those in 7 dpf control larvae, suggesting some regenerative ability. Our 
observations suggested that the production of new eGFP-expressing cells decreased as the 
embryo developed. Therefore, we next attempted cell ablation at 2 dpf and found that the 
capacity of Pth4-expressing cells to recover after ablation was markedly reduced 
compared with that observed in 1 dpf experiments. However, nearly double of the number 
of Pth4-expressing neurons were present at 2 dpf versus 1dpf, making timely single cell 
ablation more difficult. To optimize the specific elimination of Pth4-expressing cell 
bodies without impairing surrounding cells, we decided to perform two rounds of laser 
ablation per embryo, one each at 1 and 2 dpf (Figure 3). The first round of laser ablation 
of Pth4:eGFP/Bactin2:H2A-mCherry double-positive cells resulted in the elimination of 
13-16 cell bodies at 1 dpf embryos (Figures 3A, B).  Targeted cells expressing eGFP and 
mCherry markers were detected, selected and ablated (Figures 3C, C´, C´´) until 
elimination of Pth4:eGFP-expressing cells was complete (Figure 3B). Prior to the second 
round of laser ablation at 2 dpf, we observed approximately 10 eGFP-expressing cells in 
ablated embryos (Figure 3D) that were selected and ablated (Figure 3E) in a second round 
of laser ablation (Figures 3F, F´, F´´).   
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Figure 3. Two-photon laser ablation of Pth4:eGFP-expressing cells at 1 dpf and 2 dpf. Before ablation 1 
and 2, Pth4:eGFP+/Bactin2:H2A-mCherry+ transgenic embryo shows two bilateral clusters of neurons in the 
hypothalamic area (A and D). After several rounds of ablation the eGFP-expressing cells are completely 
eliminated (B and E). Ablation processes example (C-C´´ and F-F´´): (C and F) arrows indicate eGFP-
expressing cells chosen for ablation; nuclear region of interest for targeted elimination of Pth4:eGFP 
neurons is defined by circles, based on red fluorescence from nuclear marker Bactin2 (C´ and F´); 
immediately after ablation Pth4:eGFP neurons are eliminated (marked by arrows in C´´ and F´´). Note that 
the untargeted cells around the eGFP-expressing cells ablated are intact (C´´ and F´´). A confocal z-stack 
projection (A, B, D and E) or single 2 µm thick z-plane slice (C-C´´ and F-F´´) are shown. Scales bars: 50 
µm (A, B, D and E); 15 µm (C-C´´ and F-F´´). 
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Afterwards, no eGFP-positive cells were detected in some larvae at 3dpf or as few 
as 1 to 7 eGFP-expressing cells at 3 dpf (Figure 4G), but never more than 10 cells by 7 
dpf (Figure 4H). Therefore, this two-round ablation strategy resulted in a significant 
reduction of Pth4:eGFP-expressing cells to a level around three- to four-fold less than that 
in control embryos at 7dpf (Figures 4D, H). To further validate the efficiency of this 
method and to determine whether the laser ablation of eGFP-expressing cells caused a 
reduction in pth4 gene expression, we quantitatively analyzed pth4 expression levels by 
real-time qPCR analysis. The results revealed significantly (***p<0.001) reduced pth4 
gene expression in ablated larvae at 7 dpf when compared with non-ablated controls 
(Figure 4I). 
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4.3 Bone mineralization is impaired in larvae after early Pth4:eGFP-expressing cells 
ablation 
Since previous functional characterization of Pth4 neuropeptide demonstrated its 
involvement in bone mineral homeostasis in adult zebrafish, we asked whether 
Pth4:eGFP-expressing neuronal ablation would affect skeletal development and 
mineralization. Skeletal staining was performed using Alcian Blue/Alizarin Red to stain 
cartilage and mineralized bone matrix on 7 dpf ablated and control larvae (Figure 5). 
There was no change in cartilage morphology (Figures 5A-D), a useful internal control 
for normal embryonic development.  However, ablated larvae displayed a lack of some 
common mineralized structures such as notochord tip (nt), operculum (op), otolith (ot), 
cleithrum (cl) and ceratobranchial arch 5 (cb5) (Figures 5B, D), which would normally be 
calcified at this developmental stage (Figures 5A, C). Furthermore, we detected a slight 
mineral deposit on teeth (t) (Figures 5B, D). 
 
Figure 5. Ablated larvae exhibit impaired 
mineralization of the craniofacial skeleton but 
normal cartilage development. Skeletal staining 
in 7 dpf control larvae (A and C) shows 
calcification of the craniofacial bones unlike 
ablated larvae (B and D) with a widely non-
mineralized skeleton except an incipient mineral 
deposit on teeth. Ventral views (A and B) and 
lateral views (C and D). Abbreviations: nt, 
notochord tip; op, operculum; ot, otolith; cb5, 
ceratobranchial arch 5; cl, cleithrum; t, teeth. 
Scale bars: 100 μm.  
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4.4 Ablated larvae show specific effects on markers of bone homeostasis 
The lack of mineralization in most craniofacial structures in ablated zebrafish larvae 
at 7 dpf prompted us to evaluate several bone mineral homeostasis gene markers. We 
found that Pth4 gain-of-function leads to a dysregulation of genes that are involved in 
regulating phosphate homeostasis and bone mineralization in adult fish (Chapter 3). To 
investigate the relationship between the alteration of mineralization in ablated larvae and 
gene expression of phosphate metabolism markers, we performed real-time qPCR 
analysis in ablated and control larvae at 7 dpf. We analyzed the gene expression levels of 
fgf23, npt2a and npt2b, which are well-known regulators of systemic phosphate 
maintenance (Razzaque, 2011; Sabbagh et al., 2009), and phospho1, phex and entpd5 that 
locally facilitate skeletal mineralization by promoting phosphate availability through 
paracrine/autocrine pathways in bone (Huitema et al., 2012; Ichikawa et al., 2012; Yadav 
et al., 2011). Interestingly, we found significant down-regulation of phex and enpd5 in 7 
dpf ablated larvae when compared to control larvae gene expression (Figure 6). Transcript 
levels of fgf23, npt2a, npt2b and phospho1 remained unchanged (Figure 6).   
 
Figure 6. Mineralization and phosphate metabolism markers are altered post-ablation. Real time (q)PCR on 
7 dpf larvae shows significant down-regulation of phex (**p<0.025) and entpd5 (*p<0.05) expression in 
ablated larvae (black bars) compared with controls (white bars). Results normalized to actb1 are expressed 
as mean ± SEM. 
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4.5 Early Pth4:eGFP-positive neuronal ablation affects sequential gene expression 
during the process of osteoblast differentiation 
As in mammals, zebrafish require orchestrated gene expression during all stages of 
osteoblastogenesis (Li et al., 2009). We asked whether ablation of Pth4:eGFP-expressing 
neurons in zebrafish would alter the differentiation of osteoblasts and perhaps prevent 
proper mineralization of the head bony structures. To test this hypothesis, we examined 
expression of osteoblast lineage markers by whole mount in situ hybridization in 3 dpf 
ablated and control larvae. Transcript expression of osterix (sp7) was significantly 
decreased in the operculum and cleithrum (Figures 7A, B). Sp7 is a marker for the 
intermediate stage of osteoblast differentiation (Li et al., 2009) and this reduced gene 
expression suggests an alteration in the maturation process of osteoblasts. No significant 
changes were found in runt-related transcription factor 2b (runx2b) gene expression, 
which is a marker of early osteoblast differentiation (Figures 7C, D) (Komori et al., 1997; 
Li et al., 2009). Since skeletal staining showed normal tooth mineralization in ablated 
larvae, we also tested dlx2b, a dental epithelium marker required for tooth formation 
(Jackman et al., 2004). No differences were found in distal-less homeobox 2b (dlx2b) 
gene expression among ablated and control larvae (Figures 7E, F). 
 
 
Figure 7. Whole mount in situ hybridization shows 
the gene expression pattern of osteoblast 
differentiation markers at 3 dpf in control (A, C and 
E) and ablated larvae (B, D and F) from lateral 
view. Expression of sp7 is detected in operculum, 
cleithrum, teeth and parasphenoid (A). Note the 
absence of expression in cleithrum and operculum 
in ablated larvae (B).  runx2b and dlx2b display the 
same expression pattern before ablation (C, E) and 
after ablation (D, F). Abbreviations: ps, 
parasphenoid; op, operculum; cb5, ceratobranchial 
arch 5; t, teeth; cl, cleithrum. Scale bars: 100 μm. 
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To further investigate whether the abnormal craniofacial mineralization observed in 7 
dpf ablated larvae was caused by the absence of mature osteoblasts, as suggested by the 
decrease of sp7 gene expression at 3 dpf, or if instead mature osteoblasts were present but 
not mineralizing, we also analyzed sp7, runx2b and sparc transcript levels at 7 dpf by 
real-time qPCR (Figure 8). We found no significant differences in sp7 and runx2b gene 
expression levels. However, a known marker of mineralizing osteoblasts, sparc (Li et al., 
2009), showed a significant down-regulated expression in ablated zebrafish larvae (Figure 
8). 
 
Figure 8. Real-time qPCR analysis of early (runx2b), intermediate (sp7) and late (sparc) stage markers of 
osteoblast differentiation in 7 dpf ablated (black bars) and control larvae (white bars). Results show 
significant down-regulation of sparc gene expression (*p <0.05) when compared with controls. Results 
normalized to actb1 are expressed as mean ± SEM. 
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5. Discussion  
Bone formation and mineralization are dynamic processes that begin during larval 
stages and continue throughout adult life, so that it is expected that most of cellular and 
molecular mechanisms involved are common for early development and skeletal 
modeling and remodeling (Javed et al., 2010). In the present study, we found that 
Pth4:eGFP-expressing cells are hypothalamic post-mitotic neurons, and early laser 
ablation of these cells caused a severe alteration in the mineralization of craniofacial 
bones in larvae as well as a dysregulation of the expression of some phosphate 
metabolism and bone mineralization gene markers. 
The Pth4:eGFP transgenic line and confocal live imaging allowed us to visualize 
Pth4:eGFP-expressing cells during zebrafish development. Immunostaining revealed 
Pth4:eGFP-expressing cells as post-mitotic neurons. By observing the two clusters of 
neurons in the lateral hypothalamus as a function of time, we detected a progressive 
increase in the number of neurons from 13-16 cells at 1 dpf to 27-30 cells at 3 dpf to 32-
34 cells at 7dpf. In the first week of development, bilateral clusters of neural cells 
changed from a caudo-ventral to a more rostro-dorsal position as projections 
progressively increased and branched. The increase observed in the number of these 
differentiated neurons does not appear to be due to cell proliferation of eGFP-expressing 
cells, given that these cells are post-mitotic neurons and they have possibly lost their 
ability to divide. Instead, embryonic neural stem cells or their progeny might be recruited 
from proliferative areas in the brain in order to migrate to this particular hypothalamic 
area where they would differentiate into post-mitotic Pth4 neurons (Schmidt et al., 2013).  
The study of novel neural pathways that control bone mass, sheds light on complex 
skeletal metabolism and its multi-scale regulation. A growing number of peptides and 
hormones synthesized in the hypothalamus have been shown to participate in the central 
control of the bone mass in vertebrates (reviewed in (Quiros-Gonzalez and Yadav, 
2014)). Here, we used a functional approach to evaluate whether the targeted deletion of 
Pth4:eGFP-expressing cells at early stages affected skeletal development and bone 
mineralization. The cell ablation strategy based on two rounds of ablations at 1 and 2 dpf 
allowed us to perform specific elimination of the vast majority of Pth4:eGFP-expressing 
cells without damaging neighboring cells. We detected some regenerative ability possibly 
resulting in production of some new Pth4:eGFP-expressing neurons, but the degree of 
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reduction was sufficient to promote a significant down-regulation of pth4 gene 
expression. 
We find that early laser ablation of Pth4:eGFP-expressing neurons results in 
important changes in the mineralization of craniofacial structures such as the notochord 
tip, operculum, otolith and ceratobranchial arch 5 in 7dpf larvae. Since mineralization 
requires a controlled expression of phosphate regulating genes at systemic level but also 
in the bone environment, we analyzed some phosphate homeostasis markers at 7dpf 
larvae after ablation. The ablated fish larvae with impaired mineralization display a 
significant decrease of phex and entpd5 gene expression. In mammals, PHEX is expressed 
by osteoblasts and osteocytes in bone and by odontoblasts in teeth (Ruchon et al., 1998). 
PHEX deficiency results in defective bone mineralization and renal phosphate wasting 
(Rowe, 2004). It has been suggested that PHEX acts directly or indirectly upstream of 
FGF23 in bone, because the loss of PHEX leads an increase of FGF23 and 
hypophosphatemia (Ichikawa et al., 2012; Kiela and Ghishan, 2009). Although our results 
showed a significant decrease in phex expression levels in ablated zebrafish larvae, fgf23 
gene expression did not change, which suggests that phex could also regulate skeletal 
mineralization through other mechanisms. The small ASARM peptide (acidic serine 
aspartate-rich MEPE-associated peptide) is a mineralization inhibitor which is hydrolyzed 
by PHEX for bone homeostasis maintenance (Rowe, 2012). Also, entpd5 is specifically 
expressed by osteoblasts and has been identified as a crucial factor for bone formation 
and mineralization in zebrafish since it promotes inorganic phosphate availability in the 
bone microenvironment (Huitema et al., 2012). Parathyroid hormone (PTH) family 
members (i.e., PTH and parathyroid hormone like hormone, PTHLH) are known to 
directly regulate the expression of numerous genes in osteoblastic cells to control bone 
mineral metabolism as well as skeletal development (Kronenberg, 2006; Lavi-Moshayoff 
et al., 2010). Loss of function of pthlha and pthlhb in zebrafish caused deformities in 
craniofacial cartilage structures and delay or inhibition of bone mineralization through its 
downstream target runx2 (Yan et al., 2012). Also, Pthlh participates in mineralization of 
scales promoting the down-regulation of sparc gene expression for calcium mobilization 
(Redruello et al., 2005). Because our results indicate a strong alteration in the craniofacial 
skeleton mineralization, we examined whether pth4 transcript down-regulation, due to 
laser ablation of Pth4:eGFP-expressing cells, could affect sequential gene expression 
during osteoblast differentiation. In this context, the bony structures-forming cells in 
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ablated larvae could be mature osteoblasts unable to mineralize the bone matrix or, on the 
contrary, immature osteoblasts. The osteoblast differentiation process from 
osteoprogenitor cells to mature osteoblasts is characterized by an orchestrated gene 
expression, which seems to be conserved between mammals and fish (Li et al., 2009). 
Our gene expression analysis of osteoblast lineage markers using both whole mount in 
situ hybridization and real-time qPCR revealed no differences in runx2b expression, 
while sp7 gene expression, decreased in 3 dpf ablated larvae, recovered to normal levels 
by 7 dpf. Although RUNX2 seems to act upstream of SP7 during bone formation (Nishio 
et al., 2006), other studies showed that SP7 regulates osteoblast differentiation in a 
RUNX2-independent pathway (Matsubara et al., 2008). On the other hand, runx2b has 
been shown as a key modulator for chondrocyte differentiation and proliferation in 
zebrafish (Flores et al., 2006), which may explain the normal development of craniofacial 
cartilage in ablated larvae.  Additionally, by 7 dpf a significant decrease in sparc 
transcript levels was found, suggesting a possible alteration in the ability of mature 
osteoblasts to mineralize. Taken together, these results reveal a delay in the sequential 
expression of osteoblast differentiation markers after laser ablation of Pth4:eGFP-
expressing cells. In the short term, the osteoblast maturation process was disturbed, 
resulting in osteoblasts unable to mineralize the bone matrix in 7 dpf ablated zebrafish 
larvae. Therefore, cartilage and bone development do not seem to be affected but 
mineralization is uncoupled from bone formation.  
In conclusion, we show that hypothalamic Pth4:eGFP-expressing cells are 
differentiated neurons, and the decrease of pth4 transcript levels caused by laser ablation 
of Pth4:eGFP-expressing neurons leads a significant reduction of phex and entpd5 gene 
expression as well as delayed expression of genes involved in osteoblast differentiation 
such as sp7 and sparc. Additionally, ablated zebrafish larvae exhibit impaired craniofacial 
bone mineralization likely due to the presence of non-mineralizing osteoblasts. Therefore, 
our results provide new evidence regarding neuronal regulation of the bone through Pth4 
and suggest that Pth4 could be an essential neuropeptide for skeletal mineralization in 
zebrafish. Although we cannot rule out the possibility that signaling factors other than 
Pth4 and synthesized by Pth4-expressing cells could also contribute to bone mineral 
metabolism. 
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Pth4, initially isolated by in silico analysis in pufferfish, belongs to the PTH family 
of peptides that play important roles in calcium-phosphate homeostasis, bone remodeling 
and skeletal development in vertebrates (Broadus, A. and Stewart, 1994; Kronenberg, 
2006; Pinheiro et al., 2010; Potts, 2005). Even though an in vitro calciotropic role was 
reported in fish scales (Canario et al., 2006), it is unknown whether Pth4 would be able to 
regulate mineral homeostasis (mainly phosphate balance as it is the limiting factor in fish) 
through bone remodeling. Furthermore, a better comprehension of bone mineral 
homeostasis-regulating factors is required to gather information on the optimal needs of 
phosphate, and to ultimately minimize the environmental impact of fish farming.                                                                                                                                                                                                                    
Based on that, the main goal of the present thesis was to characterize the pth4 gene 
and to investigate its function in bone mineral metabolism in zebrafish, a common animal 
model. For this purpose, we first identified the pth4 gene by in silico analysis and 
examined the evolution of pth4 across vertebrates in the context of the PTH family. Then, 
pth4 gene and its promoter were cloned to study the spatial and temporal expression and 
the elements required for its transcriptional regulation. Finally, in vivo functional analyses 
were carried out to explore pth4 actions in bone and phosphate homeostasis. 
Our studies demonstrate that Pth4 is an ancient PTH family ohnolog unique to non-
eutherian vertebrates that acts as a neuropeptide produced by a specific subset of neurons 
located in the hypothalamus, with axonal projections leading from the hypothalamus to 
the whole body. Our data show that Runx2a is an upstream regulator of Pth4 and, 
downstream, all Pth receptors facilitate activating cAMP signaling. Functional 
experiments provide evidence that Pth4 and Pth4-expressing hypothalamic neurons are 
crucial in regulating bone mineral density and skeletal mineralization, probably acting 
through phosphate homeostasis. Taken together, our results reveal a new brain to bone 
signaling pathway involving Pth4 from the hypothalamus to receptors on bone. 
 
PTH, PTHLH (here renamed as PTH1 and PTH3, respectively) and PTH2 were 
proposed to be ohnologs, paralogs derived from the R1 and R2 rounds of whole genome 
duplication (R1/R2 WGD) that occurred at the base of the vertebrate radiation 
(Bhattacharya et al., 2011; Dehal and Boore, 2005). The pth4 was isolated in pufferfish 
genome by in silico analysis (Canario et al., 2006) as well as in other non-mammalian 
vertebrates (Pinheiro et al., 2010). In the Chapter 1, we isolated the pth4 gene of the 
zebrafish genome and investigated the evolutionary relationships of pth4 and other PTH 
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family genes to test the hypothesis that PTH4 is the fourth ohnolog of the PTH family in 
vertebrates. Our phylogenetic analysis showed a well-supported PTH4 clade, where 
predicted Pth4 proteins were identified in ray-finned fish (i.e., Actinopterygii) such as 
teleosts fish (zebrafish, fugu, medaka and stickleback) and the holostean fish spotted gar; 
as well as in lobe-finned fish (i.e., Sarcopterygii) including coelacanth, chicken, chinese 
softshell turtle and two marsupials mammals (opossum and Tasmanian devil). However, 
no Pth4 genes were found in eutherian mammals such as mouse or human genome, 
according to a previous study (Pinheiro et al., 2010). Moreover, genomic neighborhood 
surrounding Pth4 gene in zebrafish and chicken, and their chromosomal paralogons in 
human showed extensive conserved synteny, which provides consistent evidences with 
the hypothesis that PTH4 is the fourth PTH ohnolog lost in eutherians (i.e., a eutherian 
ohnolog gone missing, OGM).  Based on our findings, we suggest that PTH4 was already 
present in the last common ancestor of Actinopterygii and Sarcopterygii after 1R/2R 
WGDs, and although it was conserved across vertebrate evolution, this fourth ohnolog 
was lost in the lineage leading to placental mammals (Figure 1) probably after the 
eutherian-metatherian split. One plausible hypothesis is that chromosomal rearrangements 
in the mammalian radiation may have contributed to the loss of PTH4 in eutherians. 
Similarly, the absence of pth2 or pth4 duplicated genes in teleosts species after the third 
round of genome duplication (3R TGD) (Figure 1) may be due to substantial 
rearrangements that gave rise to concomitant gene losses. 
Furthermore, the four pth family genes were in silico identified in the chondrichthyan 
elephant shark (Liu et al., 2010); also pthlh (Trivett et al., 2005), pth2 (Pinheiro et al., 
2012) and pth4 (GL476611: 12889 to 13246) were found in the genome of lamprey, one 
of the most ancient living vertebrates. Elephant shark and lampreys have a cartilaginous 
skeleton and so, the evolutionary origin of the PTH family would not be related to the 
development of a calcified endoskeleton in vertebrates, as initially proposed (Pinheiro et 
al., 2010). Even, putative pth-related genes found in cephalochordates and urochordates 
(Mirabeau and Joly, 2013) could contribute to stablish the origin of the PTH family 
further back in the evolutionary history, prior to the emergence of vertebrates.  
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Figure 1: Evolutionary model and revised nomenclature proposed for PTH family in vertebrate lineages. 
PTH family genes (PTH1, PTH2, PTH3 and PTH4) are ohnologs that arose from a PTH ancestor because of 
two rounds of whole genome duplication (1R WGD and 2R WGD) that occurred at the base of the 
vertebrate radiation. An additional third round of genome duplication was specific to the teleost lineage (3R 
TGD) and gave rise to duplicated pth1a/pth1b and pth3a/pth3b. The hypothetical loss of a pth2 and pth4 co-
orthologs in fish is denoted by gray dashed line. The PTH4 ohnolog gone missing (OGM), absent in 
eutherian mammals, is indicated by red dashed line. 
 
PTH and PTHLH hormones have extensively been studied in eutherian mammals 
but, unfortunately, the physiological functions of most fish Pth peptides have not been 
thoroughly investigated. In mammals, PTH, synthesized and secreted by parathyroid 
glands (PTGs) is responsible for mineral homeostasis and bone remodeling through 
endocrine signaling (Bergwitz and Jüppner, 2010; Mundy and Guise, 1999; Potts, 2005). 
PTHLH, with a widespread distribution and multiples physiological activities, 
fundamentally plays a paracrine role in skeletal development (Kronenberg, 2006). In fish, 
Pthlha/Pthlhb were proposed to act as paracrine factors in skeletogenesis, but also as 
endocrine factors in mineral homeostasis (Yan et al., 2012). Duplicated Pthlh co-
orthologs, have been reported to promote calcium uptake from surrounding water via 
branchial and intestinal epithelia (Abbink et al., 2006; Fuentes and Figueiredo, 2006; 
Guerreiro et al., 2001), as well as calcium mobilization from scales (Rotllant et al., 2005). 
Besides its functional role in calcium regulation, Pthlh also seems to affect phosphate 
concentration in the serum of fish species (Guerreiro et al., 2010).  In turn, Ptha/Pthb 
produced in gills, lateral line and jaw among other tissues were proposed to be involved 
in chondrogenesis (Kwong and Perry, 2015) and to play a hypercalcemic role, similar to 
that of Pthlh peptides (Canario et al., 2006; Kwong and Perry, 2015; Lin et al., 2014; 
Suzuki et al., 2011). However, the precise roles of Ptha/Pthb in mineral balance and their 
mechanism of action remain unclear.  
General Discussion   
 
122 
 
Pth4, recently isolated in fish, has been reported to play a calciotropic role in scales 
and calcium uptake (Canario et al., 2006) but, however, there are currently no studies 
concerning its expression and its physiological role in bone. According to Chapters 1 and 
2 of this doctoral dissertation, pth4 gene is expressed in two bilateral clusters of 
differentiated neurons located in the hypothalamus of larvae and adult zebrafish. Neural 
pth4 gene expression is regulated by the master transcription factor for skeletogenesis, 
Runx2a. Moreover, the complex pth4-expressing neural network from the hypothalamus 
throughout the brain and spinal cord, suggests that Pth4 is a neuropeptide playing a 
systemic role throughout the entire animal. Specifically, our results of overexpression 
functional analysis show Pth4 as a regulator of bone mineral metabolism in zebrafish. In 
contrast to eutherians mammals, there is no previous evidence that Pth, Pthlh or Pth4 
peptides play a role in mineral homeostasis via fish endoskeleton, and only calcium 
mobilization from scales (i.e., dermal skeleton) was reported in vitro (Canario et al., 
2006; Rotllant et al., 2005; Suzuki et al., 2011). Our results show that Pth4 action caused 
a decrease of mineral density, not only in the dermal skeleton (including scales) but also 
in the endoskeleton, as well as a disturbance of systemic and local phosphate homeostasis 
markers (Chapter 3). Therefore, we suggest the existence of a new brain-to-bone pathway 
involving Pth4 neural signals from the hypothalamus to bone cells controlling bone 
mineral homeostasis in fish. The existence of this neural signaling pathway is consistent 
with the results presented in Chapter 4. The targeted elimination of pth4-expressing 
neurons at early stages led to abnormal skeletal mineralization during zebrafish 
development, which was supported by the dysregulation of the expression of osteoblast 
differentiation markers and some genes associated with phosphate balance for bone 
mineralization. Therefore, in addition to endocrine/paracrine modes of action proposed 
for other Pth peptides in fish, hypothalamic Pth4 appears to be involved in a efferent 
neural signaling pathway via spinal cord to control bone homeostasis and mineralization. 
With this in mind, neural signals in mammals have been reported to control bone 
remodeling via autonomous nervous system (i.e., sympathetic (SNS) and parasympathetic 
(PSNS) nervous systems) through receptors on the surface of bone cells (Bajayo et al., 
2012; Takeda, 2008; De Vernejoul, 2013). The sympathetic innervation is mainly based 
on the neurotransmitter noradrenalin that regulates bone resorption via β2-adrenergic 
receptor (β2AR) activation, which is present in osteoblasts (Elefteriou, 2005). 
Interestingly, it has been reported a functional interaction between β2AR and PTH1R, 
both expressed in bone cells, since that the anabolic effect of intermittent PTH treatment 
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was suppressed in β2AR-deficient mice (Hanyu et al., 2012). Thus, the PTH endocrine 
action via PTH1R appears to depend on the coordinate action with SNS release in the 
mammalian bone. 
Pth4 possibly signals via Pth receptors, because the peptide is able to recognize the 
three zebrafish Pth receptors (i.e., Pth1ra, Pth1rb and Pth2r) to activate 3´-5´cyclic-
adenosine-monophosphate/protein kinase A (cAMP/PKA) intracellular cascade. Similar 
to PTH1R in mammals, we detected pth1ra in craniofacial and vertebral bones as well as 
in scales, which supports Pth4 actions directly in skeletal cells in zebrafish. In addition to 
pth1ra, pth2r and pth1rb were also detected in scales (Suzuki et al., 2011) and fish 
vertebral bone (Anjos et al., 2013), respectively. On the other hand, in situ gene 
expression analysis showed pth1ra expression in spinal cord and brain as well as in other 
tissues involved in mineral homeostasis including gills and intestine. In previous studies, 
the three Pth receptors were also found in nervous system, kidney and intestine 
(Bhattacharya et al., 2011; Guerreiro et al., 2010; Kwong and Perry, 2015; Rotllant et al., 
2006; Rubin et al., 1999). Therefore, we suggest that Pth4 could act on the fish skeleton, 
but also, potential Pth4 actions could occur in the central nervous system and in mineral 
homeostasis-related organs to control absorption/excretion of ions. Further investigations 
are needed to fully understand the Pth4 system, and whether Pth4 mode of action implies 
an efferent neural signaling via spinal cord or if a neuroendocrine pathway would also be 
feasible. 
Human PTH (hPTH) also binds and activates the three zebrafish receptors (Hoare et 
al., 2000b), which suggests a structural similarity between zebrafish Pth4 and hPTH that 
might lead to a functional conservation of both peptides in vertebrates. It is important to 
note that the percentage of similarity between the bioactive N-terminal (1-34) peptide of 
zebrafish Pth4 and hPTH is 68%. This highly conserved region corresponds to the PTH 
domain of the mature protein and it is the most important region for signaling and 
biological activity (Gardella and Jüppner, 2000). The strong calciotropic action initially 
reported for pufferfish Pth4(1-34)  led the authors to hypothesize that Pth4 in fish could 
have a function equivalent to that of tetrapod PTH regarding to the endocrine calcium 
regulation (Canario et al., 2006). Nevertheless, fish face an environment totally distinct 
from that of terrestrial vertebrates where plenty of calcium is present in surrounding 
water. Although they have hypercalcemic and hypocalcemic hormones to control serum 
calcium levels via ion absorption/excretion, mostly through the branchial epithelium 
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(Abbink et al., 2006; Flik and Verbost, 1993; Guerreiro and Fuentes, 2007; Tseng et al., 
2009), they do not seem to need to mobilize calcium from endoskeleton. Instead, the 
postcranial dermal skeleton (scales) (Canario et al., 2006; Rotllant et al., 2005) would be 
more susceptible to resorption than the endoskeleton. Conversely, due to the limited 
supply of phosphate in aquatic environments, dietary phosphorus is very important for 
phosphate homeostasis and proper skeletal mineralization in fish, just as it does in 
mammals. In conditions of severe phosphate shortage (e.g., low dietary phosphate 
availability or systemic phosphate homeostasis-related disorders), fish would need 
expeditious mobilization of phosphate ions to ensure the survival. Under these 
circumstances, the scales and endoskeleton would be faster and more accessible sources 
for phosphate mobilization (Lall and Lewis-McCrea, 2007; Roy et al., 2002; Witten and 
Hall, 2003). Therefore, it appears plausible that the ancient Pth4, through a neural 
pathway, can to act in the skeleton to mobilize phosphate via bone remodeling in fish.  
Different vertebrate lineages have different PTH peptides and variations in their 
biological functions. PTH is the principal regulator of calcium/phosphate metabolism and 
bone remodeling in eutherian mammals (Broadus, A. and Stewart, 1994; Kronenberg, 
2006; Potts, 2005) but, as mentioned above, Pth4 plays a crucial role in the skeleton for 
bone mineral homeostasis in fish. This finding suggests that the bony ancestral function in 
the mineral balance maintenance could be attributed to Pth4 in the common ancestor of 
bony fish (i.e., Osteichthyes), conserved in non-eutherian vertebrates but, however, lost in 
eutherian mammals. 
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Figure 2: Zebrafish (A) and human (B) diagrams represent the equivalent function between Pth4 and PTH 
peptides in bone mineral homeostasis. (A) Pth4 neuropeptide from hypothalamus and (B) PTH hormone 
from parathyroid glands act in endoskeleton and provoke similar responses in phosphate homeostasis by 
regulating the expression of the same regulatory genes in homologous organs. 
 
It is well-known that the conquest of the land by amphibians and early tetrapods, 
which abandoned the water habitats, was a crucial event in the skeleton vertebrate’s 
evolution. The challenging land area characterized by a higher gravidity and a total 
absence of external mineral sources,  not only of phosphate but also of calcium, entailed a 
major stress on the skeleton and, consequently, the combination of multiples adaptive 
mechanisms (Bouillon and Suda, 2014). Thus, a solid and dynamic bone along with a 
more efficient system for mineral regulation was required in terrestrial vertebrates. Based 
on the current knowledge, it is believed that during the movement from an aquatic to a 
terrestrial environment, the parathyroid glands (PTGs) arose in tetrapods via 
transformation of the gills (Okabe and Graham, 2004) and so, the functions in 
calcium/phosphate and bone homeostasis were centralized in PTH as the endogenous 
master regulator of bone mineral metabolism. We hypothesized that during the evolution 
of tetrapods, PTH gradually became the principal PTH family regulator of bone 
homeostasis and Pth4, with a redundant function in bone mineral homeostasis, was then 
lost in the genome of eutherians vertebrates. 
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Overall, evidences obtained from the studies that integrate this PhD project show the 
ancient Pth4 neuropeptide as a central regulator of bone mineral metabolism in zebrafish. 
The neural regulation of the bone is an unknown and emergent field of research that is 
necessary to explore in order to broaden the understanding of new regulatory pathways. 
Thus, further functional analysis will allow characterize the precise Pth4 modes of action 
in the whole fish body. Zebrafish is a vertebrate animal model with cellular bone and, 
therefore, insights from other teleosts with lacking-osteocytes bone (acellular bone) will 
be useful to understand the biological importance of Pth4 on fish bone. On the other hand, 
interesting questions remain to be addressed about the bone-unrelated functions of Pth4 in 
early vertebrates. Lampreys are surviving ancestral vertebrates which apparently evolved 
over 540 million years ago, and they have a crucial phylogenetic position between 
invertebrates and jawed vertebrates. Future functional studies of Pth4 in basal vertebrates 
will help to step forward to decipher the complete evolutionary history of PTH family. 
 
 
  
 
 
 
CONCLUSIONS 
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 Parathyroid hormone 4 (pth4), isolated in zebrafish, has a two-exon gene structure, 
which encodes a putative secreted protein with a conserved N-terminal (1-34) mature 
peptide. 
 
 Phylogenetic and comparative genomic analysis reveals that PTH4 is the fourth 
ohnolog of the vertebrate PTH family that was lost in eutherians (i.e., an eutherian 
ohnolog gone missing, OGM).  
 
 Zebrafish pth4 gene is specifically expressed by two clusters of neurons in the 
hypothalamus and it is transcriptionally regulated by the Runx2a trans-acting factor. 
Furthermore, long-range axonal projections arise from the Pth4 neurons and extend 
to the brainstem and spinal cord. 
 
 Overexpression of pth4 induces loss of bone mineral density as well as changes in 
whole-body minerals contents in transgenic adult zebrafish.  
 
 Pth4 is able to interact with all three Pth receptors. Therefore, our findings suggest 
that Pth4 could participate in the maintenance of phosphate homeostasis via control 
of bone mineral content in fish but, potential actions in others mineral metabolism-
related tissues as well as in the nervous system should not be excluded.  
 
 Targeted laser ablation of Pth4-expressing neurons results in abnormal larval bone 
mineralization. 
 
 Based on these conclusions, we demonstrate the existence of a new brain-to-bone 
signaling pathway that involves Pth4 as a hypothalamic neural signaler that controls 
bone mineralization in fish. 
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INTRODUCCIÓN 
1. Homeostasis mineral ósea 
Los minerales son esenciales en numerosos procesos fisiológicos de todos los 
organismos, por lo que el mantenimiento de la homeostasis mineral es clave para alcanzar 
el equilibrio interno y evitar el desarrollo de enfermedades. Particularmente, el calcio y el 
fósforo están íntimamente relacionados en el desarrollo de su principal función biológica 
en vertebrados: la mineralización del hueso (Lewis-McCrea and Lall, 2010; Moe, 2008; 
Stathopoulou et al., 2012). Así, la homeostasis mineral ósea hace referencia al preciso 
balance de los niveles intracelulares y extracelulares de calcio y fósforo en tres órganos 
diana: intestino (sitio de absorción neta), riñón (sitio de excreción neta) y hueso, que 
actúa como el mayor reservorio de estos dos elementos en el cuerpo (Peterlik, 2010). En 
humanos, aproximadamente el 99% de calcio y el 85% de fósforo (como fosfato 
inorgánico, Pi) se encuentran almacenados en el esqueleto en forma de  hidroxiapatita 
(HA) (Favus et al., 2006; Moe, 2008). De forma similar, el esqueleto de los peces 
(incluyendo el endoesqueleto y el esqueleto dérmico) contiene la misma composición 
relativa de calcio y fosfato que los humanos (Lovell, 1998). Los iones de calcio y fosfato 
libres en la sangre, que representan una proporción muy pequeña con respecto al total, 
son las formas minerales biológicamente activas para el mantenimiento de la homeostasis 
ya que pueden ser intercambiadas libremente entre el hueso, el fluido intracelular y el 
fluido extracelular (Favus et al., 2006).  
 
Dinámicas del calcio y fósforo 
Los vertebrados tienen un cierto grado de independencia del medio externo gracias a 
la capacidad de mantener el balance de los niveles de calcio y fosfato, aunque en última 
instancia, la disponibilidad de minerales depende de la absorción a través de la dieta y/o 
del medio ambiente que los rodea. Desde una perspectiva ecológica, la mayor diferencia 
entre los vertebrados acuáticos y terrestres es la capacidad de absorber minerales disueltos 
en el agua. En los vertebrados terrestres la única vía de entrada de calcio y fósforo es la 
dieta, por lo que la absorción mineral tiene lugar a través del intestino. Por su parte, los 
peces son capaces de captar minerales a través del agua y ajustar sus necesidades con 
respecto a la ingesta. Los sistemas acuáticos (tanto de agua dulce como de agua salada) 
presentan una elevada concentración de calcio disponible que los peces pueden absorber 
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principalmente a través del epitelio branquial (Flik and Verbost, 1993). Así, el agua 
circundante se considera una fuente suficiente de calcio para el mantenimiento de las 
funciones vitales de los peces. El escenario es totalmente opuesto con respecto a la 
cantidad de fósforo disuelto en el agua, ya que su concentración es generalmente baja y, 
por lo tanto, la principal fuente externa de fósforo es la dieta (Lall, 2002; Lovell, 1998).  
El esqueleto es un tejido dinámico que participa en la homeostasis mineral a través de 
la remodelación ósea. Para mantener los niveles minerales dentro unos estrechos límites, 
el calcio y el fosfato pueden ser movilizados a la sangre mediante la reabsorción ósea o 
depositados en el hueso para su almacenamiento  (Kini and Nandeesh, 2012). En base a 
esto, otra diferencia importante entre vertebrados acuáticos y terrestres desde un punto de 
vista ecológico, es la participación del endoesqueleto en el mantenimiento de la 
homeostasis del calcio y del fosfato. Como hemos mencionado antes, los peces tienen un 
acceso ilimitado al calcio a través de las branquias por lo que la deficiencia de este 
mineral no es común. Además, en condiciones de baja disponibilidad de calcio la 
reabsorción de las escamas tendría lugar antes que la del endoesqueleto (Witten and 
Huysseune, 2009). Sin embargo, debido a que el fosfato es limitante en el agua es más 
probable que este mineral sea el factor clave en la regulación de la remodelación ósea en 
peces (Lall and Lewis-McCrea, 2007; Witten and Huysseune, 2009).  
 
La remodelación del hueso 
La remodelación ósea es un proceso continuo a través de la vida en el que participan 
de forma coordinada osteocitos (i.e., células atrapadas en la matriz del hueso que actúan 
como sensores respondiendo a señales hormonales y mecánicas), osteoblastos (i.e., 
células que forman nuevo tejido óseo) y osteoclastos (i.e., células que degradan el tejido 
óseo) (Hadjidakis and Androulakis, 2006; Seeman, 2009). Los teleósteos se caracterizan 
por presentar una gran diversidad de tejidos óseos. Así, la mayoría de los teleósteos 
primitivos de agua salada o agua dulce (salmónidos y ciprínidos, como el pez cebra) 
presentan “hueso celular” similar a los tetrápodos (clado al que pertenecen los mamíferos) 
con osteocitos, osteoblastos y osteoclastos multinucleados. Sin embargo, los grupos de 
teleósteos más avanzados (como perciformes) tienen principalmente “hueso acelular” 
(i.e., hueso sin osteocitos) y una predominancia de osteoclastos mononucleados 
(Apschner et al., 2011; Witten and Huysseune, 2009). Aunque la reabsorción ósea ha sido 
vinculada al hueso celular, en ausencia de osteocitos, en el hueso acelular de los peces 
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también tiene lugar el proceso de remodelación (Atkins et al., 2014) aunque los 
mecanismos son todavía desconocidos.  
 
2. La regulación del metabolismo mineral óseo 
La regulación del metabolismo mineral óseo implica una compleja interacción entre 
numerosos factores sistémicos y locales que actúan en los órganos efectores: intestino, 
riñón y hueso (Favus et al., 2006). Así, el equilibrio interno se mantiene gracias a la 
acción de factores endocrinos, productos de señalización celular que actúan de forma 
paracrina/autocrina, señales neurales y bucles de retroalimentación negativa. 
Tradicionalmente, la hormona paratiroidea (PTH), vitamina D (1,25(OH)2D) y 
calcitonina (CT) han sido considerados los principales factores endocrinos que regulan la 
homeostasis del calcio en mamíferos (Bergwitz and Jüppner, 2010; Mundy and Guise, 
1999; Potts, 2005), siendo la homeostasis del fosfato menos estudiada. En la última 
década, la información genética proveniente de enfermedades del metabolismo mineral en 
humanos ha permitido el descubrimiento de nuevos factores implicados en el balance de 
fosfato, como son FGF23 (factor de crecimiento fibroblástico 23) y PHEX (endopeptidasa 
reguladora de fosfato) (Bergwitz and Jüppner, 2010; Sapir-Koren and Livshits, 2011). De 
forma similar a mamíferos, el control hormonal de la homeostasis mineral en peces ha 
sido estudiado principalmente en base al calcio (Guerreiro and Fuentes, 2007). La 
identificación de nuevas hormonas tanto en mamíferos como en teleósteos (estaniocalcina 
(Stc), proteína relacionada con la PTH (Pthlh) y Fgf23) ha permitido investigar la posible 
conservación de las rutas que controlan el metabolismo mineral en los peces. Por otro 
lado, el equilibrio entre las formas inorgánicas de fosfato y pirofosfato (Pi/Pii) que actúan 
de forma paracrina/autocrina en el hueso, regula la mineralización a nivel local (Sapir-
Koren and Livshits, 2011). Además de la compleja red de factores endocrinos, paracrinos 
y autocrinos, recientes estudios en mamíferos han señalado la importancia del cerebro en 
la regulación central de la homeostasis del hueso (Quiros-Gonzalez and Yadav, 2014; 
Takeda, 2008). En base a esto, se han identificado tres principales rutas: la primera 
implica factores neuroendocrinos producidos por neuronas hipotalámicas y procesados a 
través de la glándula pituitaria; la segunda ruta se basa en péptidos hipotalámicos 
secretados a la sangre directamente; y la tercera consiste en señales neurales eferentes a 
través del sistema nervioso simpático (SNS) y parasimpático (SNPS) (Bajayo et al., 2012; 
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De Vernejoul, 2013). Sin embargo, la regulación neural del hueso es un campo todavía no 
explorado en peces. 
 
La familia de la hormona paratiroidea (PTH) 
Particularmente, la familia PTH está formada por un grupo de péptidos que realizan 
importantes funciones en el metabolismo mineral óseo y en el desarrollo embrionario del 
esqueleto así como de otros tejidos en vertebrados (Broadus, A. and Stewart, 1994; 
Kronenberg, 2006; Pinheiro et al., 2010; Potts, 2005). En mamíferos, hay tres hormonas: 
PTH, PTHLH (PTHrP) y péptido tuberoinfundibular 39 (TIP39 o PTH2) que actúan a 
través de dos receptores acoplados a proteínas G (PTH1R y PTH2R). PTH, secretada por 
las glándulas paratiroides, es el principal regulador endocrino de la homeostasis mineral y 
remodelación ósea en mamíferos (Potts, 2005). PTHLH presenta una amplia distribución 
espacial y participa en procesos de desarrollo esquelético de forma autocrina/paracrina 
(Kronenberg, 2006; Philbrick et al., 1996). Además PTH y PTHLH, a través del PTH1R, 
ejercen un efecto paradójico en el hueso en función de la dosis farmacológica aplicada: la 
exposición continua causa reabsorción ósea y la exposición intermitente estimula la 
formación del hueso (Datta and Abou-Samra, 2009; Silva et al., 2011). PTH ha 
demostrado ejercer un mayor efecto y, por ello, las hormonas recombinantes humanas 
PTH(1-34) y PTH(1-84) son los únicos agentes anabólicos aprobados en la actualidad 
para el tratamiento de la osteoporosis (Cosman et al., 2017; Jilka, 2007; Moen and Scott, 
2006; Silverman and Nasser, 2011). En peces, la familia PTH adquiere una mayor 
complejidad y está formada por un total de 6 péptidos (Ptha, Pthb, Pthlha, Pthlhb, Pth2 y 
Pth-like) y tres receptores (Pth1ra, Pth1rb y Pth2r) (revisado en (Guerreiro et al., 2007)). 
A diferencia de mamíferos, Ptha/Pthb no parecen tener una función decisiva en la 
homeostasis mineral del hueso mientras que Pthlha/Pthlhb actúan principalmente como 
factores hipercalcémicos y participan en el desarrollo esquelético (Yan et al., 2012). 
Varios estudios han mostrado que los ortólogos Pthlh estimulan la absorción de calcio a 
través del epitelio branquial e intestinal (Abbink et al., 2006; Fuentes and Figueiredo, 
2006; Guerreiro et al., 2001), la excreción de fosfato en el riñón (Guerreiro et al., 2010), 
así como la movilización de calcio de escamas a través de ensayos in vitro (Canario et al., 
2006; Rotllant et al., 2005). Además, Pth-like (Pth-l) se aisló por primera vez in silico en 
el pez globo (Takifugu rubripes) y un único estudio in vitro ha revelado una acción 
calciotrópica en escamas de dorada (Sparus auratus) y en la absorción de calcio (Canario 
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et al., 2006). Sin embargo, no se han llevado a cabo más estudios funcionales en 
teleósteos. 
 
3. Anomalías en el metabolismo mineral óseo de peces de acuicultura 
Como hemos mencionado anteriormente, los peces dependen de la absorción de 
fosfato a través de la dieta (Lall, 2002) y, en este sentido, diversos estudios han mostrado 
que la deficiencia de fosfato produce alteraciones en la homeostasis mineral del hueso y 
trastornos fisiológicos (Baeverfjord et al., 1998; Lall and Lewis-McCrea, 2007; Lewis-
McCrea and Lall, 2010; Roy et al., 2002; Witten et al., 2016; Witten and Hall, 2003). A 
causa de ello, en el cultivo de peces de acuicultura es común el uso de dietas enriquecidas 
en fosfato para reducir la incidencia de anomalías esqueléticas, garantizar la salud y 
maximizar el crecimiento. Sin embargo, se ha observado que niveles excesivos de fosfato 
pueden tener efectos nocivos sobre los animales. Además, el exceso de fosfato presente 
en los efluentes de estos sistemas de cultivo ocasiona un grave problema ambiental 
produciendo la eutrofización de los sistemas acuáticos (Cho and Bureau, 2001; Hixson, 
2014). Por lo tanto, uno de los puntos fundamentales para la sostenibilidad de la 
acuicultura a largo plazo es reducir los residuos de fosfato sin comprometer la salud y 
bienestar de los peces. Para ello, la caracterización de la regulación de la homeostasis 
mineral del hueso nos ayudará a entender los requerimientos de los peces y, en última 
instancia, establecer nuevas formulaciones de las dietas.  
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OBJETIVOS 
La familia PTH está implicada en la homeostasis mineral y remodelación ósea en 
vertebrados. Recientemente, el gen pth-like (pth-l) ha sido identificado en el pez globo, 
pero, sin embargo, se desconoce su función biológica y los mecanismos que regulan su 
expresión. Por lo tanto, el principal objetivo de la presente tesis doctoral es realizar la 
caracterización molecular y funcional del gen pth-l (aquí nombrado como pth4) en una 
especie modelo de vertebrados, el pez cebra (Danio rerio). Para ello, nos centraremos en 
los siguientes objetivos específicos: 
1- Análisis molecular del nuevo gen pth4 en el pez cebra (Capítulo 1). Para la 
consecución de este objetivo realizamos el análisis génico in silico, el clonaje 
molecular y la determinación de la expresión génica espacial y temporal. 
2- Análisis evolutivo del gen pth4 en el contexto de la familia PTH (Capítulo 1). Los 
análisis filogenéticos y los estudios de genómica comparada basados en sintenias 
conservadas nos permitieron estudiar la evolución del gen pth4 y dilucidar las 
relaciones con otros miembros de la familia. 
3- Caracterización del promotor de pth4 y su regulación transcripcional (Capítulo 2). 
Para alcanzar este objetivo, generamos líneas transgénicas de pez cebra que 
expresan eGFP bajo el promotor del gen pth4 y exploramos in vivo la región 
promotora de pth4 a través de deleciones, mutaciones y estudios de “pérdida de 
función” del gen. 
4- Caracterización funcional in vivo del gen pth4 (Capítulos 3 y 4). Para llevar a 
cabo este objetivo, utilizamos un enfoque de “ganancia de función” del gen 
basado en la manipulación genómica mediada por transposón y un enfoque de 
ablación celular con láser. 
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CAPÍTULO 1. Análisis molecular y evolutivo del gen pth4 
La familia PTH incluye PTH, PTHLH y TIP39, que han sido identificados como 
ohnólogos resultantes de dos rondas de duplicaciones genómicas completas (R1/R2 
WGDs) que se produjeron durante la temprana evolución de los vertebrados. Un nuevo 
miembro de esta familia, denominado inicialmente Pth-like, ha sido identificado en 
vertebrados no mamíferos. En teleósteos, solamente un estudio ha mostrado un posible 
papel hipercalcémico de Pth-l in vitro. En el estudio que aquí se presenta, aislamos y 
caracterizamos el gen pth-l (nombrado pth4) en el pez cebra. La evaluación de la 
organización genómica de pth4 mostró una estructura formada por dos exones que 
predicen una proteína de 121 aminoácidos. Los estudios de expresión de pth4 
demostraron que este gen se expresa específicamente en dos grupos de células en el 
hipotálamo a lo largo del desarrollo del pez cebra. El análisis de genómica comparada 
reveló nuevos datos sobre la evolución molecular y funcional de la familia PTH en 
vertebrados, donde PTH4 es el cuarto ohnólogo que se perdió en mamíferos placentarios 
después de la divergencia entre el clado de mamíferos marsupiales y placentarios. 
Además, con el objetivo de reflejar adecuadamente el origen evolutivo de la familia PTH 
proponemos un cambio en la nomenclatura de esta familia, donde PTH y PTHLH 
deberían llamarse respectivamente PTH1 y PTH3; ptha y pthb en teleósteos serían 
nombrados como pth1a y pth1b así como pthlha y pthlhb serían llamados pth3a y pth3b; 
mientras pth2 conservaría su nomenclatura. Por último, el nuevo gen sería nombrado 
como pth4 ya que es el cuarto ohnólogo identificado en esta familia. 
 
CAPÍTULO 2. Análisis del promotor y regulación transcripcional del gen pth4 
La hormona paratiroidea 4 (Pth4) es un péptido ancestral que pertenece a la familia 
PTH y ha sido aislada en el pez cebra. Tal y como se muestra en el Capítulo 1, las 
técnicas de hibridación in situ revelaron que el RNA mensajero de pth4 se expresa de 
forma específica en dos grupos de neuronas hipotalámicas tanto en embriones como en 
peces adultos. Sin embargo, los elementos reguladores necesarios para la expresión 
génica de pth4 no han sido identificados. El objetivo de este estudio fue investigar la 
secuencia genómica del promotor proximal que regula el gen pth4 mediante la 
caracterización funcional in vivo de la región promotora y descubrir los posibles factores 
que modulan su actividad transcripcional. La generación de líneas transgénicas de pez 
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cebra que expresan eGFP bajo la actividad de un promotor génico son modelos útiles para 
estudiar la expresión y la regulación de genes en células específicas. En este Capítulo, 
presentamos que el patrón de expresión de eGFP en peces transgénicos reproduce el 
patrón espacio-temporal de la expresión endógena de pth4. Además, la línea transgénica 
Pth4:eGFP nos permitió detectar múltiples proyecciones axonales que se extienden desde 
las neuronas hipotalámicas al resto del cuerpo a través de la médula espinal. El análisis de 
la secuencia promotora combinado con deleciones, mutaciones dirigidas y estudios de 
“pérdida de función” reveló que  Runx2a es un elemento regulador crítico actuando en 
“trans” para la expresión del gen pth4 en embriones de pez cebra. 
 
CAPÍTULO 3. Caracterización funcional del gen pth4: Un enfoque basado en la 
manipulación genómica mediada por transposón 
La remodelación del hueso es necesaria para el desarrollo, crecimiento, adaptación 
mecánica, regeneración y homeostasis mineral en vertebrados. Las hormonas peptídicas 
PTH y PTHLH desempeñan importantes funciones en el remodelado óseo y en la 
homeostasis mineral en mamíferos. No obstante, actualmente no hay ningún estudio en la 
bibliografía que demuestre que los péptidos de la familia PTH controlan la homeostasis 
mineral a través de la remodelación del hueso en peces. En este Capítulo, hemos 
investigado el papel de Pth4 en la homeostasis mineral ósea. Los análisis de “ganancia de 
función” del gen pth4, a través de la sobreexpresión génica mediante manipulación 
genómica basada en el uso de elementos genéticos transponibles o transposones, 
revelaron que pth4 es un regulador de la densidad mineral del hueso en peces. La 
sobreexpresión del gen pth4 alteró los niveles totales de calcio y fósforo, así como la 
expresión de genes implicados en la homeostasis de fosfato (un incremento en la 
expresión génica de fgf23 y npt2b y una disminución en la expresión de npt2a, phospho1, 
phex y entpd5). Por último, los estudios farmacológicos realizados mostraron que Pth4 
puede activar la cascada de señalización vía cAMP a través de los 3 receptores Pth. 
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CAPÍTULO 4. Caracterización celular y funcional de Pth4: un enfoque basado en la 
ablación celular in vivo mediante tecnología láser 
El desarrollo esquelético y la mineralización son procesos esenciales basados en la 
acción coordinada de señales neurales, moléculas circulantes y factores locales. Los 
estudios realizados en el Capítulo 3 revelaron que pth4, producido por neuronas 
hipotalámicas, está implicado en el metabolismo del hueso probablemente a través de la 
regulación de la homeostasis de fosfato en el pez cebra adulto. En este capítulo, 
investigamos el papel del neuropéptido Pth4 y de las células que expresan Pth4 durante el 
desarrollo esquelético utilizando un enfoque basado en la ablación láser de células 
Pth4:eGFP y microscopía confocal in vivo en peces transgénicos. La caracterización de 
las neuronas que expresan Pth4:eGFP a través de técnicas inmunocitoquímicas mostró 
que estas neuronas son post-mitóticas. Además, después de la ablación neuronal 
específica de las células Pth4:eGFP en la región hipotalámica, las larvas mostraron una 
fuerte alteración de la mineralización de los huesos craniofaciales, aunque el desarrollo 
del cartílago fue normal. Como consecuencia de la ablación celular de las neuronas Pth4 
se produjo una disminución significativa de los niveles del transcrito; pero también una 
reducción de la expresión de genes asociados con la homeostasis del fosfato y 
mineralización (phex y entpd5), así como de la expresión de marcadores de diferenciación 
de osteoblastos (sp7 y sparc). Por lo tanto, estos resultados sugieren que las neuronas 
hipotalámicas que expresan Pth4 participan en la regulación del metabolismo mineral 
óseo durante el desarrollo del pez cebra. 
 
DISCUSIÓN 
PTH, PTHLH (aquí nombrados como PTH1 y PTH3) y PTH2 han sido propuestos 
como ohnólogos (Bhattacharya et al., 2011; Dehal and Boore, 2005). Previamente, el gen 
pth4 ha sido aislado en el genoma del pez globo mediante un análisis in silico (Canario et 
al., 2006), así como en otros vertebrados no mamíferos (Pinheiro et al., 2010). En el 
Capítulo 1, aislamos el gen pth4 en el genoma del pez cebra e investigamos las relaciones 
evolutivas de pth4 con otros miembros de la familia PTH para testar la hipotésis basada 
en que PTH4 es el cuarto ohnólogo de la familia PTH en vertebrados. Los análisis 
filogenéticos y sintenias conservadas entre pth4 de pez cebra, pollo y humanos confirman 
que PTH4 es el cuarto ohnólogo perdido en mamíferos placentarios. Una posible hipótesis 
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que explicaría la pérdida de PTH4 son los reordenamientos cromosómicos que tuvieron 
lugar durante la radiación de los mamíferos. De forma similar, la ausencia de genes 
duplicados de pth2 o pth4 en el genoma de teleósteos (que sufrieron una tercera ronda de 
duplicación genómica, TGD) puede ser debida a reordenaciones genómicas que 
desencadenaron la pérdida simultánea de genes. Por otro lado, los cuatro genes de la 
familia pth han sido identificados in silico en el pez elefante (i.e., pez cartilaginoso del 
grupo de las quimeras) (Liu et al., 2010); también pthlh (Trivett et al., 2005), pth2  
(Pinheiro et al., 2012) y pth4 (GL476611: 12889 to 13246) han sido identificados en el 
genoma de la lamprea, uno de los vertebrados vivientes más antiguos. El pez elefante y la 
lamprea tienen un esqueleto cartilaginoso por lo que el origen evolutivo de la familia pth 
podría no estar relacionado con el desarrollo de un endoesqueleto calcificado en 
vertebrados, como inicialmente había sido propuesto (Pinheiro et al., 2010). Incluso, 
genes similares a pth se han identificado en cefalocordados y urocordados (Mirabeau and 
Joly, 2013), lo que podría contribuir a establecer el origen de esta familia de péptidos 
antes de la aparición de los vertebrados. 
Aunque PTH y PTHLH han sido ampliamente estudiadas en mamíferos, sus 
funciones en peces apenas han sido caracterizadas. En mamíferos PTH, secretada por las 
glándulas paratiroideas (PTGs), actúa de forma endocrina en la homeostasis mineral y en 
la remodelación ósea (Bergwitz and Jüppner, 2010; Mundy and Guise, 1999; Potts, 2005). 
PTHLH, con una amplia distribución espacial, juega principalmente un papel paracrino en 
el desarrollo esquelético (Kronenberg, 2006). En peces, las hormonas Pthlha/Pthlhb 
también han sido caracterizadas como factores paracrinos durante el desarrollo 
esquelético y como moléculas endocrinas en la homeostasis mineral (Yan et al., 2012), 
estimulando la absorción de calcio a través del epitelio branquial e intestinal  (Abbink et 
al., 2006; Fuentes and Figueiredo, 2006; Guerreiro et al., 2001), así como la movilización 
de este mineral desde las escamas (Rotllant et al., 2005). Además, Pthlha/Pthlhb parecen 
afectar también a la concentración de fosfato sérico en peces (Guerreiro et al., 2010). Sin 
embargo, Ptha/Pthb producidas en las branquias, línea lateral y mandíbulas, entre otros 
tejidos, han sido vinculadas con la formación del cartílago (Kwong and Perry, 2015) pero 
su papel hipercalcémico y los mecanismos de acción  todavía no han sido bien definidos 
(Canario et al., 2006; Kwong and Perry, 2015; Lin et al., 2014; Suzuki et al., 2011). En 
los Capítulos 1 y 2 de esta tesis doctoral, mostramos que el nuevo gen pth4 se expresa en 
dos grupos de neuronas hipotalámicas en el pez cebra y que Runx2a parece ser un factor 
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transcripcional clave en la regulación de la actividad del promotor de pth4. La compleja 
red de proyecciones axonales identificadas desde el hipotálamo a todo el cuerpo del pez, 
sugiere que el neuropéptido Pth4 puede jugar un papel sistémico en el animal. 
Específicamente, la caracterización funcional in vivo revela que pth4 es un regulador del 
metabolismo mineral óseo, no sólo del esqueleto dérmico (que incluye las escamas), sino 
también del endoesqueleto del pez cebra (Capítulo 3), a diferencia de estudios previos in 
vitro donde Pth4, Pth y Pthlh parecen actuar solamente en escamas (Canario et al., 2006; 
Rotllant et al., 2005; Suzuki et al., 2011). Pth4 causó una disminución de la densidad 
mineral del hueso y también una alteración de diferentes marcadores sistémicos y locales 
implicados en la homeostasis de fosfato. La existencia de esta nueva ruta cerebro-hueso 
es consistente con los resultados presentados en el Capítulo 4. La eliminación específica 
de las neuronas Pth4 ocasionó una alteración en la mineralización ósea y una disminución 
en la expresión de marcadores de diferenciación de osteoblastos, así como de genes 
asociados con la homeostasis del fosfato. Por lo tanto, además de un modo de acción 
endocrino y paracrino de los péptidos de la familia Pth, Pth4 parece estar implicado en 
una ruta de señalización neural eferente a través de la médula espinal para controlar la 
homeostasis del hueso y la mineralización. Pth4 es capaz de actuar a través de los tres 
receptores Pth (i.e., Pth1ra, Pth1rb and Pth2r) en el pez cebra. De forma similar a 
mamíferos, el pth1ra en peces se localiza en el hueso vertebral y craniofacial así como en 
las escamas, branquias, intestino, médula espinal y cerebro. En estudios anteriores ya se 
detectó la expresión de pth1ra y de otros receptores Pth en los tejidos relacionados con la 
homeostasis mineral y el sistema nervioso (Anjos et al., 2013; Bhattacharya et al., 2011; 
Guerreiro et al., 2010; Kwong and Perry, 2015; Rotllant et al., 2006; Rubin et al., 1999; 
Suzuki et al., 2011); por lo que Pth4 podría actuar en el esqueleto de los peces pero 
también en otros órganos. No obstante, el modo de acción de Pth4 no se ha definido 
completamente por lo que podría implicar una señalización neural eferente vía médula 
espinal y/o una ruta neuroendocrina. 
La PTH humana y la Pth4 de peces presentan una gran similitud estructural y son 
capaces de actuar a través de los tres receptores Pth (Hoare et al., 2000b). Además la 
actividad calciotrópica atribuida a la sintética Pth4 (1-34) del pez globo llevó a formular 
la hipótesis que Pth4 podría tener una función endocrina equivalente a PTH en la 
regulación de la homeostasis de calcio (Canario et al., 2006). Sin embargo, los peces 
hacen frente a un medio ambiente donde el factor limitante es el fosfato y no parecen 
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movilizar calcio del endoesqueleto. En su lugar, parece razonable pensar que Pth4 podría 
actuar en el endoesqueleto para movilizar fosfato en condiciones de escasez de fosfato en 
la dieta. Durante la transición evolutiva de los vertebrados desde el medio acuático al 
terrestre, estos se enfrentaron a un ambiente nuevo y desafiante caracterizado por una 
mayor gravedad y una ausencia total de minerales procedentes del medio externo. Esto 
supuso la combinación de múltiples adaptaciones que dieron lugar a un esqueleto más 
sólido y dinámico, así como a un sistema eficiente de regulación mineral (Bouillon and 
Suda, 2014). Actualmente se cree que las glándulas paratiroides surgieron en tetrápodos a 
partir de la transformación de las branquias durante esta transición del medio acuático al 
terrestre (Okabe and Graham, 2004) y así, las funciones de regulación de la homeostasis 
de calcio y fosfato y remodelación del hueso se centralizaron en PTH, el principal 
regulador del metabolismo mineral óseo. Aquí proponemos que durante la evolución de 
los tetrápodos, PTH se convertiría gradualmente en el principal regulador de la 
homeostasis mineral y del hueso y Pth4, con un papel redundante, se perdería finalmente 
en el genoma de mamíferos placentarios. 
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CONCLUSIONES 
 La hormona paratiroidea 4 (pth4), aislada en el pez cebra, tiene una estructura basada 
en dos exones, que codifican una supuesta proteína secretada formada por un péptido 
maduro (1-34) conservado. 
 Análisis filogenéticos y de genómica comparada revelan que PTH4 es el cuarto 
ohnólogo de la familia PTH en vertebrados pero que ha sido perdido en mamíferos 
placentarios (i.e., OGM). 
 El gen pth4 del pez cebra se expresa de forma específica en dos grupos de neuronas 
en el hipotálamo y su transcripción es regulada por el factor Runx2a. Además, las 
proyecciones axonales se extienden desde las neuronas Pth4 a través del tronco 
encefálico y la espina dorsal. 
 La sobreexpresión de pth4 induce la pérdida de la densidad mineral del hueso, así 
como la alteración del contenido de minerales en peces transgénicos adultos.  
 Pth4 es capaz de interaccionar con los tres receptores Pth. Por lo tanto, nuestros 
resultados sugieren que Pth4 podría participar en el mantenimiento de la homeostasis 
de fosfato a través del control del contenido mineral del hueso en peces. No obstante, 
no podemos excluir acciones potenciales de Pth4 en otros tejidos involucrados en el 
metabolismo mineral así como en el sistema nervioso. 
 La ablación láser de neuronas Pth4 causa una alteración del proceso de 
mineralización del hueso en larvas. 
 Basado en estas conclusiones, demostramos la existencia de una nueva ruta de 
señalización cerebro-hueso que implica Pth4 como un factor neural hipotalámico que 
controla el proceso de mineralización del hueso en peces. 
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